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Abstract 
Insulin is an important regulator of glucose homeostasis. Insulin stimulation of fat and 
muscle cells results in the rapid translocation of the glucose transporter GLUT4 to the 
plasma membrane from its intracellular stores, allowing uptake of glucose into the cells 
from the blood. This tethering, docking and fusion event is driven by the formation of a 
SNARE complex at the plasma membrane consisting of the t-SNAREs Syntaxin 4 (Sx4) 
and SNAP23 and the v-SNARE VAMP2. The formation of this complex is regulated by the 
SM protein Munc18c. It has been shown that Sx4 is phosphorylated at residues Y115 and 
Y251 following insulin stimulation; however the effects of these phosphorylation events 
have yet to be studied. In addition phosphorylation of Y521 in Munc18c is also increased 
following insulin stimulation. This study aimed to first elucidate the effects of Sx4 
phosphorylation on SNARE protein interactions and GLUT4 trafficking, then to begin to 
examine the impact of phosphorylation of both Sx4 and Munc18c. 
I have used an in vitro approach to assess the affect Sx4 phosphorylation has on SNARE 
complex assembly. I have shown, using phospho-mimetic recombinant proteins, that the 
phosphorylation state of Sx4 affects the rate of SNARE complex assembly and its binary 
interactions with VAMP2 and SNAP23. Moreover, that this may be due to a 
conformational change in the protein. I have also shown, for the first time, that it is likely 
that Sx4 can be phosphorylated on Y115 and Y251 simultaneously. In addition I have 
used a HA-GLUT4-GFP expressing HeLa cell line to show that expression of phospho-
mimetic Sx4 increases translocation of GLUT4 to the PM under basal conditions. Finally, I 
have begun to investigate the implications of both Sx4 and Munc18c phosphorylation on 
their in vitro interactions. This data provides insights into the direct regulation of 
membrane trafficking proteins by the insulin-signalling pathway. Increased understanding 
of the regulation of GLUT4 translocation could help to develop future therapies for type 2 
diabetes, where GLUT4 trafficking is impaired. 
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1 Introduction 
1.1 Membrane trafficking 
Eukaryotic cells are compartmentalised into a series of membrane bound organelles. 
These organelles consist of specific sets of proteins and other molecules and they are 
highly spatially and temporally regulated. Eukaryotes rely on membrane trafficking in order 
to regulate the functions of the cell and the organelles within it (Dacks and Field, 2007). 
There are two main types of membrane trafficking pathways that cells rely on: the 
endocytic and secretory pathways. 
1.1.1 The endocytic and secretory pathways 
Extracellular and plasma membrane (PM) proteins are internalised into cells by 
endocytosis. Defined regions of the PM invaginate and pinch off to form endocytic 
vesicles (Parkar et al., 2009). Proteins in the endocytic vesicles are then sorted in the 
early endosome where many of the vesicles are recycled back to the PM - thus 
maintaining and regulating the composition of the plasma membrane (Grant and 
Donaldson, 2009). Proteins that are not recycled are then transported to the lysosome, 
where they are degraded, or to late endosomes and the trans-Golgi network (Van Vliet et 
al., 2003).  
In a seminal study, over 40 years ago, it was shown that newly synthesised proteins that 
were to be secreted first pass through a series of organelles; the endoplasmic reticulum 
(ER), Golgi apparatus and secretory vesicles (Palade, 1975). This corresponds to what is 
now termed the secretory or exocytic pathway. There are two types of secretory pathways 
– constitutive and regulated. The former delivers newly synthesised proteins to the PM via 
the Golgi apparatus in a constitutive manner. In the latter, proteins are stored in 
specialised secretory vesicles that are mobilised to their site of action, typically in 
response to an extracellular signal. Regulated exocytic events are mainly found in cells 
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specialised in secreting molecules such as hormones and neurotransmitters (Van Vliet et 
al., 2003). 
1.2 Membrane fusion 
Membrane trafficking relies on the formation of vesicles from a ‘donor’ compartment and 
their subsequent fusion with an ‘acceptor’ compartment. The process can involve two 
similar (homotypic) or two different (heterotypic) compartments. In order for the contents 
of these vesicles to be successfully delivered to their target membrane fusion must occur 
to allow for content and membrane lipid mixing of donor and acceptor compartments. The 
process of membrane fusion involves several distinct steps; tethering, docking and finally 
fusion. It is imperative that the correct donor vesicles fuse with the correct acceptor 
membranes and so the process is subject to multiple stages of regulation. 
1.2.1 Vesicle tethering and docking 
Prior to membrane fusion, vesicles are tethered to the appropriate membrane by often far-
reaching tethering proteins or complexes (Dubuke and Munson, 2016) (discussed in more 
detail in section 1.4.3). The vesicles are then brought closer together into a more tightly 
bound docked state. It is thought these tethering and docking proteins represent an 
important point of regulation on membrane fusion (Pfeffer, 1999).  
1.2.2 Membrane fusion 
Membrane fusion occurs when two separate lipid bilayers come into close contact and 
fuse to become one lipid bilayer. Complete membrane fusion is now thought to occur via a 
hemifusion intermediate state (Chernomordik and Kozlov, 2003). The hemifusion 
hypothesis states that the two outer monolayers of compartments fuse, leaving the two 
inner monolayers of the compartments intact. A fusion pore then forms and complete 
fusion occurs, i.e. the inner monolayers fuse. More work is still needed on understanding 
the biophysical aspects of membrane fusion. The process is not energetically favourable 
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and so research into how the cells overcome energy barriers to allow fusion in of great 
importance (Weber et al., 1998). One family of proteins known to participate in nearly all 
membrane fusion events, and thought to be crucial to overcoming this energy barrier, are 
SNARE proteins. Indeed in an in vitro assay recapitulating membrane fusion, SNARE-
mediated fusion was shown to transit through a hemifusion intermediate state (Xu et al., 
2005). 
1.3 SNARE proteins and the SNARE hypothesis 
SNARE proteins are involved in all known membrane fusion events (Malsam et al., 2008). 
SNAREs were first identified in studies that sought to define membrane trafficking events 
using both genetic and biochemical approaches. NSF (N-ethylmaleimide Sensitive Factor) 
was first identified (Glick and Rothman, 1987) and found to be required for membrane 
fusion (Beckers et al., 1989; Diaz et al., 1989; Malhotra et al., 1988). Subsequently, NSF’s 
binding partner α-SNAP (Soluble NSF Attachment protein) was discovered (Clary et al., 
1990). Characterisation of these two proteins led to the discovery of SNARE proteins. An 
affinity column containing both NSF and α-SNAP was used to isolate binding partners 
from bovine brain lysates (Söllner et al., 1993). Four ‘SNAP-receptors’ (SNARE) proteins 
were identified, all of which localised to the synapse. These discoveries led to the 
hypothesis that the proteins were components of a universal fusion apparatus.  
1.3.1 The SNARE hypothesis 
Following the identification of the aforementioned SNARE proteins from bovine brain 
lysates, much research has been carried out in identifying more SNAREs. To date 36 
SNARE proteins have been identified in Homo sapiens (Malsam et al., 2008). 
Furthermore, genome sequencing projects have unveiled SNARE proteins are a 
conserved family, with homologues in all eukaryotes (Bock et al., 2001). SNARE proteins 
are broadly split into two categories - t-SNAREs, which are present on the target 
membrane, and v-SNAREs, present on the donor vesicle membrane. The localisation of 
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SNARE proteins is thought to enhance fusion specificity and influence their function (Chen 
and Scheller, 2001). Figure 1.1 summarises the localisation of SNARE proteins in the 
secretory and endocytic pathways.  
 
Figure 1.1 Intracellular localisation of mammalian SNARE proteins in the secretory 
and endocytic pathways 
Schematic of the localisation of SNARE proteins in the secretory and endocytic pathways. 
Blue = syntaxin family members, green = SNAP family members, red = VAMP family 
members. Blue arrow represents the secretory pathway. Proteins are trafficked through 
the Golgi apparatus, trans-Golgi network and secretory vesicles. Red arrow represents 
the endocytic pathway. Proteins are endocytosed from the plasma membrane through 
early and late endosomes, and often to the lysosome where they are degraded. 
 
The discovery of multiple SNARE proteins has led to the development of the SNARE 
hypothesis (Söllner et al., 1993). The SNARE hypothesis states that specific SNARE 
proteins from both donor and acceptor membranes form a complex that mediates docking 
of the membranes and leads to membrane fusion (Figure 1.2). The specificity of SNARE 
proteins has since been called into question as they have been shown to be promiscuous 
in vitro (Gagescu, 2000). However a study by McNew and colleagues in 2000 
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demonstrated that, when yeast SNARE proteins were reconstituted into liposomes only 5, 
out of a possible 33 combinations, resulted in fusion (McNew et al., 2000).  
 
 
Figure 1.2 The SNARE hypothesis 
A schematic of the SNARE hypothesis. V-SNAREs on the donor membrane come into 
close proximity to t-SNAREs on the target membrane. The proteins form the trans-SNARE 
complex, where the two families of SNARE proteins are on opposing membranes, 
providing the energy required for membrane fusion. Following fusion SNARE proteins 
remain in the cis-SNARE complex on the same membrane until the complex is dismantled.  
 
 
1.3.2 The SNARE core complex 
The SNARE complex is a helical bundle of four SNARE domains, three from t-SNAREs 
and one from the respective v-SNARE (Poirier et al., 1998a) (Figure 1.2). However since 
SNARE proteins are involved in homotypic fusion, fusion of two compartments of the 
same type, a more sophisticated classification system was required. SNARE proteins 
were therefore subsequently classified by the highly conserved structural features that 
contribute to the core SNARE complex (Fasshauer et al., 1998). SNAREs were therefore 
then categorised as Q- or R-SNAREs.  
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The SNARE complex formed by Sx1a, SNAP25 and VAMP2 is the most thoroughly 
characterised complex to date. In 1998, Sutton and colleagues reported the structure of 
this SNARE complex using x-ray crystallography at 2.4 Å resolution (Sutton et al., 1998). 
The structure revealed a highly twisted four helical bundle with an ionic layer at the centre 
comprised on one arginine and three glutamine residues from each of the four helices 
(Figure 1.3). Comparisons of sequences and subsequent structural analysis of the 
endosomal core SNARE complex consisting of syntaxin 7, syntaxin 8, vti1b and VAMP-8 
suggests the core structure is a conserved of assembled SNARE complexes (Antonin et 
al., 2002).  
The interactions of the SNARE complex have been shown to be extremely strong. The 
complexes are resistant to proteases, SDS and to cleavage by clostridial neurotoxin 
(Hayashi et al., 1994; Poirier et al., 1998b). In contrast to syntaxins, SNAP and VAMP 
proteins are unstructured prior to SNARE complex formation (Fasshauer et al., 1997). 
Circular dichroism (CD) analysis shows an increase in α-helicity and stability of the 
proteins upon assembly of SNARE complexes. It is thought this change from unstructured 
peptides to a highly-structured tightly packed complex is an energetically favourable 
process that assists in overcoming the energy barrier required for membrane fusion 
(Fasshauer et al., 1997). 
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Figure 1.3 Structure of the SNARE core complex 
A Ribbon drawing of the synaptic SNARE complex, helices from syntaxin1a (red), 
SNAP25 (green) and VAMP2 (blue). B The ionic ‘0’ layer of the neuronal SNARE complex. 
An arginine residue from VAMP2 interacts with three glutamine residues from Syntaxin1a 
and SNAP25. Figure adapted from Sutton et al., 1998.  
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1.3.3 Classification of SNARE proteins 
The defining feature of all SNARE proteins in the presence of a 60-70 amino acid region 
of heptad-repeats, termed the SNARE motif (Hong, 2005). This motif is critical for SNARE 
complex assembly and has been shown to be important for fusion specificity (Paumet et 
al., 2004). As stated previously, SNAREs were originally split into two catagories – Q-
SNAREs (t-SNAREs) or R-SNAREs (v-SNAREs).  
Q-SNAREs are labelled as such due to the glutamine residue in their SNARE motifs that 
is crucial for formation of the core of the SNARE complex (Fasshauer et al., 1998) (Figure 
1.3). Q-SNAREs generally correspond to t-SNAREs and have been further classified into 
Qa, Qb and Qc SNAREs depending on their position in the SNARE complex (Hong, 2005). 
In contrast R-SNAREs are named such due to the arginine residue that they contribute to 
the central layer of the SNARE complex (Fasshauer et al., 1998). R-SNAREs can typically 
also be classified as v-SNAREs. 
Q and R-SNAREs can be further split into their respective protein family groups, which are 
introduced below. 
1.3.3.1 Syntaxin family 
The founding member of the syntaxin (Sx) family was first identified in neuronal cells. 
Syntaxin 1a is a 35 kDa protein and is localised to the plasma membrane in pre-synaptic 
neurons (Bennett et al., 1992). There are currently 15 known syntaxins in mammals and 8 
in yeast. Syntaxins localise to multiple intracellular compartments (Figure 1.1). Syntaxins 
are cytosolically orientated and are between 288 and 301 amino acids in length (Bennett 
et al., 1993). 
The syntaxin family of proteins are classed as Qa SNARE proteins. They are anchored to 
membranes by a transmembrane domain at the C-terminus (Bennett et al., 1993). The 
SNARE domain of syntaxin proteins lies adjacent to the C-terminus and is followed by an 
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N-terminal domain consisting of three anti-parallel alpha-helices (Bennett et al., 1993) 
(Figure 1.5). This N-terminal domain, called the Habc domain, links to the SNARE domain 
by a flexible region of the protein (Fernandez et al., 1998). This evolutionarily conserved 
feature is important for regulating syntaxin function. The Habc domain can fold back and 
bind to the SNARE motif, rendering the protein unable to form SNARE complexes 
(Dulubova et al., 1999) (Figure 1.4). Alleviating this intramolecular interaction exposes the 
SNARE motif allowing interaction with other SNARE domains and therefore formation of 
SNARE complexes. This molecular switch has been proposed to be an important 
regulatory feature of syntaxins (Dulubova et al., 1999). Indeed the feature is conserved in 
many syntaxin isoforms including Sx1a, Sx2, Sx3 and Sx4 (Bennett et al., 1992; Bock et 
al., 1996; Wong et al., 1998) and the yeast syntaxin Sso1p, a functional homologue of 
Sx1a (Fiebig et al., 1999).  
  
27 
 
                       
Figure 1.4 Syntaxin proteins undergo a conformational shift 
The Habc domain of many syntaxin family members binds to the SNARE motif due to the 
flexible linker region. In this conformation the protein is ‘closed’ and unable to form 
SNARE complexes. When the interaction between the SNARE motif and the Habc domain 
is alleviated the SNARE motif is free to bind to others and form SNARE complexes, this is 
known as the open conformation.  
 
1.3.3.2 SNAP family 
SNAP family proteins are Qb and Qc SNAREs. As with syntaxins, the family was first 
identified in neuronal cells (Oyler et al., 1989). Other SNAP isoforms since have been 
identified, including SNAP23 (Ravichandran et al., 1996), SNAP29 (Steegmaier et al., 
1998) and SNAP47 (Holt et al., 2006), and are ubiquitously expressed. The proteins 
contain two SNARE motifs that they contribute to the formation of SNARE complexes, 
hence their classification as Qb and Qc proteins (Chen and Scheller, 2001) (Figure 1.5).  
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Unlike other SNARE proteins SNAP family proteins don’t have a transmembrane domain 
but associate with membrane post-translationally. Family members such as SNAP23 and 
SNAP25 are palmitoylated at cysteine residues in the linker region that connects the two 
SNARE motifs (Gonzalo and Linder, 1998). Alternatively, SNAP29 has been shown to 
associate with membranes due to its binary interactions with syntaxin (Steegmaier et al., 
1998).  
1.3.3.3 VAMP family 
VAMPs (vesicle associated membrane proteins) (alternatively called synaptobrevins) are 
small proteins of around 120 amino acids. They were again first described in neuronal 
cells where they were shown to be components of synaptic vesicles (Trimble et al., 
1988a). Like syntaxin family members they comprise three main domains - a hydrophobic 
c-terminal transmembrane domain, a SNARE domain and a proline-rich N-terminal 
domain (Trimble et al., 1988b) (Figure 1.5).  
Seven members of the VAMP family have been identified thus far: VAMP1 (synaptobrevin 
1), VAMP2 (synaptobrevin 2), VAMP3 (cellubrevin), VAMP4, VAMP5 (myobrevin), VAMP7 
and VAMP8 (endobrevin) (Hong, 2005). The proteins are ubiquitously expressed, with the 
exception of VAMP1 which in neuronal specific (Lin and Scheller, 2000). VAMP proteins 
are expressed in multiple intracellular compartments and each VAMP isoform can be 
present in more than one. For example, VAMP7 is present in late endosomes and 
lysosomes (Advani et al., 1999) and at the PM (Williams and Pessin, 2008).  
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Figure 1.5 General domain structures of SNARE proteins 
A comparison of the domain structures of syntaxin, VAMP and SNAP family SNARE 
proteins. Syntaxin proteins are composed of a C-terminal transmembrane domain (TMD), 
a SNARE motif (SNARE), a regulatory Habc domain (Hc,Hb and Ha) and an N-terminal 
domain. VAMP proteins contain a C-terminal transmembrane domain (TMD) and a 
SNARE motif. Whereas SNAP proteins contain two SNARE motifs joined by a linker 
region that can be post-translationally modified to associate the protein with membranes. 
 
1.3.4 Non-mammalian SNARE proteins 
Genome sequencing projects have shown that SNAREs are found in a wide range of 
organisms. One study showed that a basic set of 20 SNARE proteins are present in all 
eukaryotes, and that this set has diversified independently in different organisms to 
provide specificity and increased complexity in higher eukaryotes (Kloepper et al., 2007). 
Research on four species, whose sequenced genomes are readily available, has provided 
insight into the mechanisms of membrane trafficking: yeasts Saccharomyces cerevisiae 
and Schizosaccharomyces pombe, the nematode Caenorhabditis elegans, the fruitfly 
Drosophila melanogaster (Armstrong, 2000). 
In particular, Saccharomyces cerevisiae has proved a very useful model for studying 
membrane trafficking. For example, an early study characterising the yeast SNARE 
complex consisting of Snc2, Sso1 and Sec9, used biochemical assays to show the 
importance of t-SNARE binary interactions to the formation of SNARE complexes, and 
noted striking similarities to the biochemistry of the neuronal SNARE complex (Rossi et al., 
1997). Furthermore, functional homologues have been identified between mammalian and 
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yeast SNAREs. For example, expression of the mammalian t-SNARE syntaxin16 fully 
compliments the phenotypes observed in yeast cells lacking the t-SNARE Tlg2 (Struthers 
et al., 2009). 
Interestingly, compared to the genomes of other eukaryotes, the genomes of higher plant 
species encode a high number of SNARE proteins (Lipka et al., 2007). Indeed two plant 
specific subfamilies have been identified – NPSN (novel plant-specific SNARE) Qb- and 
SYP7 Qc-SNAREs (Sanderfoot et al., 2000). All plant R-SNAREs are so-called longins. 
Longins contain an extended N-terminal domain that, like with syntaxin family proteins, 
can form intramolecular interactions to regulate protein function (Rossi et al., 2004). Very 
few phenotypes have been observed in plant R-SNARE mutants suggesting that they, like 
mammalian R-SNAREs, exhibit some functional redundancy (Lipka et al., 2007). 
1.4 Regulation of SNARE-mediated membrane fusion 
Although SNARE proteins have been shown to be the minimal machinery required for 
bilayer fusion in vitro (Weber et al., 1998), membrane fusion is a rapid process that is 
essential for maintaining cellular integrity and therefore subject to extensive special and 
temporal regulation (Malsam et al., 2008). A number of protein families have been 
implicated in regulating SNARE mediated membrane fusion. 
1.4.1 Sec1/Munc18 (SM) proteins 
This family of proteins was originally identified in genetic studies performed in C. elegans 
that identified the UNC-18 gene (Brenner, 1974). Like SNARE proteins, homologues have 
now been found in all species. For example, the SEC1 gene was identified in yeast 
(Novick and Schekman, 1979). A temperature sensitive mutation of the gene results in the 
accumulation of intracellular vesicles, demonstrating its importance in vesicle exocytosis 
(Novick and Schekman, 1979). Indeed SM proteins have been implicated in all known 
membrane fusion events (Burgoyne and Morgan, 2007).  
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Seven mammalian SM proteins have been identified - Munc18a, b and c (mammalian 
unc-18), VPS33A and B, VPS45 and SLY1 (Hong, 2005; Jahn et al., 2003). Munc18a is 
predominantly expressed in the brain (Hata et al., 1993), whilst Munc18b and Munc18c 
are expressed ubiquitously (Tellam et al., 1995). SM proteins are hydrophilic proteins of 
60-70 kDa and can be cytosolic or associate to membranes via their interaction with 
syntaxin proteins (this interaction is discussed in more detail in section 1.4.1.1) (Misura et 
al., 2000).  
It is apparent SM proteins play a role in regulating more than one membrane trafficking 
event due to the small number of them in each species, whilst mammals express 7 SM 
proteins, only 4 have been identified in yeast (Jahn et al., 2003). However, despite the 
small number of SM proteins, they do not display functional redundancy. For example, 
synaptic transmission is abolished in mice lacking Munc18a, despite expression of 
Munc18b and Munc18c isoforms (Verhage et al., 2000). SM proteins were originally 
identified as syntaxin binding proteins, however interactions with other SNARE proteins 
have since been identified. For example, Munc18c directly interacts with the cytosolic 
domain of VAMP2 (Brandie et al., 2008). Elucidating the mechanism by which SM 
proteins regulate membrane fusion has proven to be complex and challenging. 
Characterising the binding between Munc18 and syntaxins has been the focus of intense 
research, often yielding confusing and contrasting results. 
1.4.1.1 Interaction of Munc18 and syntaxin 
SM proteins are known to be binding partners of syntaxins, with a high binding affinity 
(Smyth et al., 2010). One of the best characterised Munc18/syntaxin interactions if that of 
the neuronal proteins, Munc18a/syntaxin1a. The crystal structure of the interaction 
between Sx1a and Munc18a was solved (Misura et al., 2000). This study provided a 
detailed insight into the interactions between the two proteins. Both the Habc and SNARE 
domain of Sx1a were shown to interact with M18a. The SM protein has three domains that 
form an arch shape, with syntaxin1a in a closed conformation (see section 1.3.2.1) 
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binding to domains I and III of Munc18c in the central cavity (figure 1.6). This observation 
is consistent with biochemical and NMR data that showed that the closed conformation of 
Sx1a is essential for its interaction with Munc18a (Dulubova et al., 1999).  
This mode of binding, termed mode 1, however, is proposed to be inhibitory for SNARE 
complex formation. In order to form SNARE complexes syntaxins must adopt an open 
conformation. These data suggest that Munc18a holds Sx1a in a closed and inactive form. 
However, numerous studies have shown that M18 is not inhibitory to membrane fusion 
(Carr et al., 1999; Scott et al., 2004); indeed its expression is required for synaptic 
transmission (Verhage et al., 2000).  
In contrast to the Sx1a/Munc18a interaction, the yeast syntaxin Sed5 and the SM protein 
Sly1 have been shown to interact in a completely different manner. Biochemical studies 
showed that only the N-terminal 44 residues of Sed5 were required for interaction with 
Sly1 (Yamaguchi et al., 2002). Indeed, despite the structure of Sly1 being very similar to 
Munc18a, structural analysis of the Sly1/Sed5 interaction revealed a very different mode 
of binding (Bracher and Weissenhorn, 2002). Crystal structures solved in this study 
revealed that the N-terminal peptide of Sed5 binds to a hydrophobic pocket on the outer 
surface of Sly1. Similar modes of binding have been identified for other yeast and 
mammalian SNARE/SM protein interactions (Dulubova et al., 2002). Subsequent 
investigations have revealed that the extreme N-terminus of Sx1a also interacts with 
Munc18a (Khvotchev et al., 2007). Moreover, in an in vitro fusion assay, deletion of the N-
terminus of Sx1a abolishes the stimulatory effect of Munc18a on membrane fusion, 
suggesting this interaction is important for SM protein function (Shen et al., 2007). In 
contrast to mode 1 binding, interaction between the syntaxin N-terminus and its cognate 
SM protein (mode 2 binding) is consistent with the protein being in an open or closed 
conformation and therefore not inhibitory to SNARE complex formation.  
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A third, and less well characterised, binding mode between SM and syntaxin proteins has 
also been reported. The yeast SM protein Sec1, which regulates fusion at the plasma 
membrane, was reported to bind to an assembled SNARE complex consisting of Sso1, 
Sec9p and Sncp (Carr et al., 1999). This study found that Sec1 not only coprecipitated 
with the syntaxin Sso1 but with the other proteins too. This study also showed that when a 
GFP tagged Sec1 protein is expressed in yeast mutants that exhibit impaired SNARE 
complex assembly, the protein is mislocalised. Moreover, in an in vitro binding assay 
using recombinant proteins, Sec1 was shown to have a strong interaction with both the t-
SNARE and full ternary SNARE complex and a weaker interaction with free Sso1 (Scott et 
al., 2004). The yeast SM protein Vps45 exhibits multiple modes of binding, leading to the 
protein cycling on and off membranes (Bryant and James, 2003). Vps45 binds to the 
syntaxin protein Tlg2, before dissociating upon trans-complex formation, and then 
reassociates with the fully formed cis-complex. The highly studied Munc18a has also been 
shown to bind to assembled SNARE complexes containing syntaxin1a (Dulubova et al., 
2007).  
Figure 1.6 summarises the diverse binding modes identified between SM and syntaxin 
proteins. The multiple mode of interactions between SM and SNARE proteins suggest 
they may each have a different mode of action, however sequence and structural 
similarities between the family argue that they should have a common function (Toonen 
and Verhage, 2003). Defining the role of SM proteins in regulating SNARE mediated 
membrane fusion is therefore still on going.    
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Figure 1.6 Binding modes of Munc18 to syntaxins 
Munc18 proteins bind to syntaxins through three different binding modes. In mode 1 
binding Munc18 binds to closed syntaxin via its central cavity. Munc18 also binds to the N-
terminal of syntaxin through a hydrophobic pocket on its outer surface (mode 2 binding). 
In mode 3 binding Munc18c binds to the assembled SNARE complex. 
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1.4.2 Rab proteins 
Ras-associated binding proteins are ubiquitously expressed small GTPases, 20-29 kDa in 
size (Hutagalung and Novick, 2011). They are a large family of proteins with 11 isoforms 
in yeast, 29 in C. elegans and more than 60 in humans and mice. Specific Rabs are 
associated with all organelles and transport vesicles, and they are thought to act as 
molecular switches to regulate membrane fusion throughout the cell (Hutagalung and 
Novick, 2011). Rabs exist in two states; an inactive GDP-bound state and an active GTP-
bound state (Fukuda, 2008). This switch is controlled by guanine nucleotide exchange 
factors (GEFs) and GTPase activating proteins (GAPs). The GTP-bound activated Rabs 
are then recruited to transport vesicles where they regulate trafficking by interacting with 
specific effector proteins (Zerial and McBride, 2001).  
Rabs are involved in almost all membrane fusion events (Stenmark, 2009).  A study from 
2009 by Ohya and colleagues used an in vitro fusion assay involving ‘synthetic 
endosomes’ containing Rabs and SNAREs (Ohya et al., 2009). This study reported that 
Rab and SNARE proteins act coordinately to increase the efficiency of membrane 
tethering and fusion.  
1.4.3 Tethering proteins and complexes 
Tethering proteins confer an increase is specificity to membrane trafficking by providing 
the first physical contract between trafficking vesicles and their target membrane (Pfeffer, 
1999). Tethers can be split into two categories; long coiled-coil tethering proteins or multi-
subunit tethering complexes (Whyte and Munro, 2002).  
Long coiled-coil proteins are attached to target membranes and can span lengths several 
times the diameter of trafficking vesicles (Whyte and Munro, 2002). Electron microscopy 
studies have identified these structural features of the yeast tethering protein Uso1p 
(Yamakawa et al., 1996) and its mammalian homologue p115 (Sapperstein et al., 1996).  
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In addition to the coiled-coil proteins, seven multi-subunit tethering complexes have been 
identified along with their involvement at distinct trafficking steps. One such complex is the 
exocyst complex, which acts at the trans-Golgi network and plasma membrane (Yeaman 
et al., 2001). The exocyst complex consists of 8 components that were originally identified 
in genetic studies in yeast, where mutations in exocyst genes caused an accumulation of 
vesicles (Guo et al., 1999; TerBush et al., 1996). This complex has been shown to be an 
important regulator of proper membrane trafficking. For example, over expression of a 
mutated component of the mammalian exocyst complex, Exo70, resulted in inhibited 
insulin-stimulated glucose uptake in adipocytes (Inoue et al., 2003). 
1.4.4 Phosphorylation 
In addition to regulation by the accessory proteins discussed above, SNARE protein 
function can also be regulated by post-translational modification, such as phosphorylation 
(Snyder et al., 2006).  
All three components of the much studied neuronal SNARE complex are can be 
phosphorylated by different kinases. Syntaxin 1a is phosphorylated by casein kinase II 
(CKII) in vitro (Risinger and Bennett, 1999). Syntaxin 1a phosphorylated by CKII exhibits 
an increase in binding to the Ca2+ sensor synaptotagmin 1, suggesting this 
phosphorylation could directly regulate neurotransmitter release (Risinger and Bennett, 
1999). Furthermore, Sx1 phosphorylated by CKII at serine 14 preferentially localises with 
SNAP25 in regions of the axon that are distinct from the localisation of synaptic vesicles 
(Foletti et al., 2000). These labelled regions in the axon may represent fusion sites for 
previously uncharacterised vesicles (Foletti et al., 2000). Phosphorylation of Sx1 at this 
residue has since been shown to regulate the interaction with Munc18a (Rickman and 
Duncan, 2010).  
SNAP25 is phosphorylated by protein kinase A (PKA), however no effects of this 
phosphorylation have been reported in the binary or ternary interactions with Sx1 and/or 
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VAMP2 (Risinger and Bennett, 1999). However, another study has shown that 
phosphorylation of SNAP25 by protein kinase C (PKC) in vitro inhibits its interaction with 
syntaxin 1a (Shimazaki et al., 1996). VAMP2 is phosphorylated in synaptic vesicles by 
both CKII and calmodulin-dependent protein kinase II (CaMKII) (Nielander et al., 1995). 
However, the functional consequences of this phosphorylation are still unclear.  
The effect of syntaxin phosphorylation has been shown to be important in other systems. 
For example, in yeast the t-SNARE Sso (a syntaxin 1 homologue) is dephosphorylated via 
a ceramide activated phosphatase (CAPP) Sit4, a process which increases its ability to 
form a complex with the t-SNARE Sec9 (Marash and Gerst 2001). Furthermore, the PKA 
(Protein Kinase A) pathway, which is involved in growth control, phosphorylates Sso 
inhibiting the assembly of SNARE complexes, highlighting the convergence of two 
signalling pathways on the control of t-SNAREs (Marash and Gerst 2001). Similarly, both 
the CAPP and PKA signalling pathways modulate endocytosis in yeast by modulating 
phosphorylation of Tlg t-SNAREs (Gurunathan et al. 2002). These studies suggest that 
phosphorylation of t-SNAREs plays a functional role and therefore further investigation is 
required into the consequences of such phosphorylation events. 
1.4.5 NSF and α-SNAP – SNARE complex disassembly 
Once SNARE complexes have formed and membrane fusion has occurred, the proteins 
remain in the cis-SNARE complex. It is therefore important that the complex be 
disassembled and the proteins made available to form new SNARE complexes. In order 
to disassemble the tightly bound SNARE complex, three molecules of α-SNAP bind to the 
SNARE core complex, this in turn recruits NSF (Hohl et al., 1998; Wimmer et al., 2001). 
NSF then uses ATP hydrolysis to disassemble the SNARE complex (Hayashi et al., 1995). 
Expression of temperature sensitive NSF in Drosophila resulted in the accumulation of 
SNARE complexes and inhibition of synaptic transmission when the protein was 
inactivated (Littleton et al., 1998). 
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1.5 Glucose transport 
1.5.1 Glucose homeostasis and type II diabetes mellitus 
Glucose is an essential source of energy for mammalian cells, however blood glucose 
levels that are too high or too low are damaging. The levels of blood glucose in humans 
are highly regulated and maintained at a concentration between 4 and 7 mM (Kahn et al., 
2006). This maintenance is achieved by a balance of two hormones – glucagon, which is 
released in response to low blood glucose, and insulin, which is secreted in response to 
high blood glucose. Both hormones are secreted from cells in the islet of Langerhans in 
the pancreas, with insulin being secreted from beta cells and glucagon from alpha cells 
(Bell and Polonsky, 2001). Glucagon primarily acts to increase gluconeogenesis and 
glucose release from the liver. Insulin acts on the liver, skeletal muscle and adipose tissue 
to increase glucose uptake from the blood (Shepherd and Kahn, 1999). Skeletal muscle is 
responsible for around 90 % of glucose uptake (Kraegen et al., 1985). Although it only 
accounts for a small amount of glucose uptake, adipose tissue is essential for regulating 
whole-body energy homeostasis. Adipocytes detect the energy status and release 
hormones to regulate metabolism in the brain, muscle and liver (Leto and Saltiel, 2012). 
Indeed, mice in which the glucose transporter protein GLUT4 has been selectively 
depleted in adipose cells have been shown to develop insulin resistance in skeletal 
muscle and the liver (Abel et al., 2001).  
Diabetes mellitus is a disease that can occur when glucose homeostasis becomes 
dysregulated. There are two types of diabetes; type I, in which insulin is not secreted from 
the beta islet cells in the pancreas, and type II, in which normally insulin responsive 
tissues become insulin resistant. Type I diabetes is normally treated by the administration 
of insulin. Type II diabetes, however is more complex and harder to treat. The world 
health organisation (WHO) estimates that 90 % of cases of diabetes are Type II. A sharp 
rise in the frequency of Type II diabetes has occurred in recent years, with the global 
prevalence in adults rising from 4.7 % in 1980 to 8.5 % in 2014 (World Health 
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Organization, 2016). In 2012 an estimated 1.5 million deaths were directly caused by 
diabetes (World Health Organization, 2016), demonstrating that understanding the 
development of this complex disease is of upmost importance.  
Insulin resistance arises when insulin sensitive cells no longer mobilise a response to 
insulin, and therefore glucose is not absorbed from the blood. Insulin released from the 
pancreas binds to receptors on the surface of muscle and adipose cells, this triggers an 
intracellular signalling cascade. The culmination of this signalling cascade is the 
mobilisation of the glucose transporter protein, GLUT4, to the plasma membrane allowing 
glucose to enter the cells (Bryant and Gould, 2011). It is therefore imperative to 
understand the mobilisation and intracellular trafficking of GLUT4, in order to better 
understand the development of type II diabetes and to develop novel treatment for the 
disease.  
1.5.2 Glucose transporters and GLUT4 
Glucose transporters (GLUTs) are integral membrane proteins, with 12 predicted helical 
membrane-spanning domains and both termini exposed to the plasma membrane (Bryant 
et al., 2002). There are thirteen GLUTs in mammals split into three classes: class I 
(glucose transporters including GLUT1, 2, 3 and 4), class II (fructose transporters GLUT5, 
7, 9 and 11) and class III (atypical members, GLUT6, 8, 10, 12 and the myo-inositol 
transporter HMIT1) (Bryant et al., 2002). GLUT1 and GLUT4 are expressed in insulin 
sensitive tissue, including skeletal and cardiac muscle and adipose. However, only 
GLUT4 shows a change in subcellular localisation in response to insulin (Douen et al., 
1990) .  
In the early 1980s it was shown that adipocytes contain an intracellular pool of glucose 
transporters that, when the cells are stimulated with insulin, translocate to the plasma 
membrane (Cushman and Wardzala, 1980; Suzuki and Kono, 1980). This insulin 
response was subsequently identified in cardiac (Watanabe et al., 1984) and skeletal 
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muscle (Hirshman et al., 1990). The transporter responsible was later identified to be the 
unique insulin-sensitive GLUT4 (James et al., 1988). The GLUT4 gene was later identified 
(Bell et al., 1989; Birnbaum, 1989) and cloned (James et al., 1989).  
1.5.3 Insulin signalling 
Insulin binds to its receptors on the surface of insulin responsive cells triggering a 
downstream signalling cascade. Whilst much research has been carried out into the 
downstream effects of insulin in muscle and adipose tissue, the precise mechanism that 
leads to GLUT4 mobilisation to the plasma membrane is not yet fully understood. 
The insulin receptor (IR) is a cell surface receptor with intrinsic kinase activity. The IR is 
comprised of two α-subunits and two β-subunits, linked with disulphide bonds (Gual et al., 
2005). Insulin binds to the α-subunit resulting in tyrosine autophosphorylation of the β-
subunit. There are two main signalling cascades that are triggered by insulin: the 
phosphoinositide 3-kinase (PI3K) pathway and the adaptor protein with pleckstrin 
homology and Src homoglogy domains (APS) pathway (Figure 1.7). 
1.5.3.1 The PI3K pathway 
Following phosphorylation of the IR, the insulin receptor substrate (IRS) is recruited, 
activating a PI3K dependent signalling cascade (Jewell et al., 2010). IRS then recruits and 
activates PI3K. Active PI3K phosphorylates phosphatidylinositol bisphosphate (PIP2), 
yielding phosphatidylinositol trisphosphate (PIP3). PIP3 then recruits and activates the 
pleckstrin homology (PH) domain-containing serine/threonine kinase phosphoinositide-
dependent kinase (PDK). Activated PDK then phosphorylates another serine/threonine 
kinase, protein kinase B (PKB, also known as Akt), which in turn phosphorylated the Rab-
GTPase activating protein AS160. AS160 then signals downstream to Rab proteins, which 
are thought to coordinate membrane trafficking.  
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The steps that follow AS160 activation, including the Rab proteins recruited and 
mobilisation of GLUT4 from its intracellular stores are not yet fully elucidated. Inhibition of 
PI3K by both pharmacological inhibition using wortmannin (Okada et al., 1994) and 
competitive inhibition (Cheatham et al., 1994) block GLUT4 translocation. 
1.5.3.2 The APS signalling pathway 
Activation of the IR also results in the recruitment of the adaptor protein APS. APS recruits 
a complex of the proto-oncogene c-CBL and c-CBL-associated protein (CAP). This 
triggers the phosphorylation of c-CBL, which then interacts with the adaptor protein CRK. 
CRK is in a complex with the GEF C3G, which stimulates the GTPase activity of TC10, a 
Rho family small G-protein. Active TC10 then interacts with effector protein that regulate 
GLUT4 exocytosis.  
Although over expression of mutant forms of TC10 or CAP reduce insulin stimulated 
GLUT4 translocation, the importance of this pathway has been questioned. siRNA 
depletion of numerous components of this pathway has no effect on insulin stimulated 
glucose transport in 3T3-L1 adipocytes.  
Although the early stages of both the APS and PI3K pathways (section 1.5.3.1) are well 
defined, further research is needed to elucidate the mechanisms linking insulin signalling 
to GLUT4 trafficking. 
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Figure 1.7 The insulin signalling cascade 
Upon insulin binding to the insulin receptor, two downstream signalling cascades are 
triggered. The PI3K signalling pathway is initiated by the recruitment of IRS to the PM. 
Phosphorylated IRS then recruits PI3K, which converts PIP2 to PIP3. PIP3 then interacts 
with PDK and Akt. Akt binds to AS160 that then interacts with downstream Rabs resulting 
in GLUT4 translocation. Recruitment of APS to the insulin receptor triggers a different 
signalling cascade. APS recruits CAP and c-CBL, which then interact with the adaptor 
protein CRK. CRK then associates with C3G, which activates TC10. Active TC10 interact 
with downstream effector proteins, resulting in GSVs being mobilised to the PM. 
 
 
 
1.5.4 The GLUT4 trafficking itinerary 
Although the precise mechanisms by which insulin stimulates GLUT4 translocation to the 
PM are as yet unknown, a model has emerged for the trafficking itinerary of GLUT4 in the 
cell. GLUT4 is localised to numerous intracellular compartments including the PM, 
endosomes, the TGN and other intracellular vesicles (Slot et al., 1991). Figure 1.8 
summarises the current proposed model of the GLUT4 trafficking itinerary. Its is proposed 
that GLUT4 is rapidly trafficked through the endosomal system from the PM, before 
entering a slow recycling pathway between recycling endosomes, the TGN and a pool of 
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specialised GLUT4 storage vesicles (GSVs)(Bryant and Gould, 2011). It is from these 
GSVs that GLUT4 is immobilised to the PM in response to insulin.  
GLUT4 is endocytosed from the plasma membrane via both clatherin and cholesterol 
dependent mechanisms (Blot and McGraw, 2006; Ros-Baro et al., 2001; Shigematsu et 
al., 2003). The connection between the endosomal GLUT4 pool and the TGN/GSV pool 
was established when Zeigerer and colleagues showed that when endosomal trafficking is 
blocked the amount of GLUT4 in the TGN/GSV pool in dramatically reduced (Zeigerer et 
al., 2002).  
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Figure 1.8 A model of the GLUT4 trafficking itinerary 
A schematic of the current model for the trafficking itinerary of GLUT4. GLUT4 is 
continually trafficked through two interlinked trafficking cycles. In the first, GLUT4 is 
internalised into early endosomes (EE), through recycling endosomes (RE) and either 
back to the plasma membrane or into cycle 2. Cycle two is a slow moving cycle where 
GLUT4 moves through the trans-Golgi network (TGN) and is sorted into insulin responsive 
GLUT4 storage vesicles (GSVs). It is from these GSVs that GLUT4 is rapidly mobilised to 
the PM following insulin-stimulation. 
 
1.5.4.1 GLUT4 storage vesicles 
Studies have shown that the majority of intracellular GLUT4 is present in small 
(approximately 50 nm diameter) vesicles that cluster around, but are distinct from, the 
TGN (Kandror et al., 1995; Slot et al., 1991). These vesicles are named GLUT4 storage 
vesicles (GSVs) and have been shown to contain approximately 60 % of intracellular 
GLUT4 (Livingstone et al., 1996). GSVs are formed from either recycled endocytosed 
GLUT4 (Zeigerer et al., 2002) or newly synthesised protein (Watson et al., 2004). This 
study by Watson and colleagues utilised a tagged GLUT4 construct to show that newly 
synthesised GLUT4 becomes insulin responsive after between 9 and 12 hours, 
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suggesting that is when it is incorporated into GSVs. Moreover, they showed that this 
GLUT4 was not first trafficked to the PM before being sorted into GSVs. Proteomic 
analysis of immunopurified GSVs from rat adipocytes revealed around 100 proteins that 
associate with GSVs (Jedrychowski et al., 2010). Of these many proteins several have 
been the subject of further research and have been identified as important for the 
formation of GSVs or for their insulin responsiveness.  
Sortilin has been identified as an important regulator of GSV formation. Sortilin expression 
increases with differentiation of 3T3-L1 adipocytes (Hatakeyama and Kanzaki, 2011). 
shRNA mediated knock-down of Sortilin decreases both GSV formation and insulin-
induced glucose uptake (Shi and Kandror, 2005). Moreover, GLUT4 is degraded when 
expressed ectopically, however co-transfection of Sortilin and GLUT4 results in stable and 
co-localised expression of both proteins in functional GSVs (Shi and Kandror, 2005).  
Whilst Sortilin has been shown to be important for GSV formation, IRAP (insulin-
responsive aminopeptidase) is a protein that has been shown to be involved in the insulin 
responsiveness of GSVs. IRAP is present in GSVs and is translocated to the PM in 
response to insulin (Jedrychowski et al., 2010). Although whole body knockout of IRAP in 
mice had no effect on glucose homeostasis (Keller et al., 2002), siRNA knockdown of 
IRAP in 3T3-L1 adipocytes did impair GSV translocation to the PM (Yeh et al., 2007). The 
discrepancy in these results may result from the system used. In whole life, whole body 
knockout mice it is possible the organisms may have developed compensatory 
mechanisms that do not occur in cultured adipocytes transiently depleted of IRAP (Yeh et 
al., 2007). Interestingly, siRNA mediated knockdown of GLUT4 in this study did not effect 
insulin stimulated IRAP translocation, suggesting GLUT4 is not required for GSV 
translocation (Yeh et al., 2007). 
A third protein that has been shown to be important for GSV function is LRP-1 (low 
density lipoprotein receptor- related protein 1). Depletion of LRP-1 in 3T3-L1 adipocytes 
46 
 
reduces GLUT4 expression and glucose uptake (Jedrychowski et al., 2010). Interestingly 
interactions between the Rab GAP AS160 and LRP-1 (Jedrychowski et al., 2010) and 
IRAP (Peck et al., 2006) have been reported, representing a potentially important 
interaction between the insulin signalling pathway and trafficking machinery. 
1.5.5 SNARE proteins in GLUT4 translocation 
The translocation of GLUT4, like all membrane trafficking events, is mediated by SNARE 
proteins. There are two main sites of SNARE protein action in GLUT4 trafficking – sorting 
GLUT4 into GSV and fusion of GSVs at the PM.  
The t-SNAREs Sx6 and Sx16 have been implicated in sorting of GLUT4 into GSVs. 
Expression of a truncated mutant of Sx4 lacking the transmembrane domain, which acts 
as a dominant negative inhibitor, delays the reinternalisation of GLUT4 following the 
removal of insulin (Perera et al., 2003). Consistent with this observation, Sx6 has been 
shown to be required for recycling of IRAP from the PM to the GSVs (Watson et al., 2008). 
Syntaxin 16 forms a t-SNARE complex with syntaxin 6 (Perera et al., 2003). Sx16 shows 
a high co-localisation with GLUT4 (Shewan et al., 2003). Inhibition of Sx16, using 
morpholino antisense oligonucleotides (MAO) or expression of a dominant negative Sx16, 
reduces insulin-stimulated glucose transport (Proctor et al., 2006). Moreover, GLUT4 has 
been shown to be trafficked from the PM through a sub-domain of the TGN that is 
enriched in Sx6 and Sx16 (Shewan et al., 2003). Taken together these data provide good 
evidence that the t-SNAREs Sx6 and Sx16 facilitate trafficking of GLUT4 into GSVs.  
 In order to elucidate the role of VAMP proteins in GLUT4 translocation Williams and 
Pessin carried out systematic siRNA knockdown of VAMPs 2, 4 and 8 in 3T3-L1 
adipocytes (Williams and Pessin, 2008).  Depletion of VAMP8 results in elevated levels of 
GLUT4 at the plasma membrane under basal condition (in the absence of insulin) due to a 
decrease in GLUT4 endocytosis (Williams and Pessin, 2008). Whilst VAMP4 knockdown, 
a v-SNARE that is known to control traffic between endosomes and the TGN, causes the 
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redirection of a pool of GLUT4 to the plasma membrane under basal conditions (Williams 
and Pessin, 2008). These data suggest that VAMP8 is involved in the sorting of recycled 
GLUT4 to GSVs from the PM, whilst VAMP4 is involved in redirecting missorted GLUT4 
from endosomes and/or the TGN. 
Whilst relatively little is known about the sorting of GLUT4 into GSVs, much of the 
research into SNARE mediated translocation of GLUT4 has focused on GSV fusion with 
the plasma membrane. A SNARE complex consisting of Sx4, SNAP23 and VAMP2 has 
been implicated in this step. 
1.5.5.1 Sx4 
Sx4 is a Qa SNARE present at the plasma membrane and has been implicated in insulin 
mediated GLUT4 translocation in numerous studies. Introduction of anti-Sx4 antibodies 
into permiabilised adipocytes derived from 3T3-L1 cells results in a decrease in insulin 
stimulated glucose transport (Volchuk et al., 1996). The development of heterozygous Sx4 
knockout mice has shown the importance of the protein for proper insulin mediated 
glucose uptake in skeletal muscle (Yang et al., 2001). Sx4 +/- knockout mice show a 50 % 
reduction in whole body insulin stimulated glucose uptake. This study attributed this to a 
similar reduction in GLUT4 translocation in skeletal muscle tissue. Consistent with this, 
mice overexpressing Sx4 in skeletal muscle display a two-fold increase of insulin 
stimulated GLUT4 translocation and glucose uptake (Spurlin et al., 2004).  
In addition to its importance in skeletal muscle Sx4 has been shown to be important for 
GLUT4 translocation to the PM in adipocytes (Kawaguchi et al., 2010). This study showed 
depletion of Sx4 by siRNA results in a reduction of insulin stimulated glucose uptake. 
Moreover, when the effects of Sx4 knockdown were examined in more detail, its role in 
GSV tethering at the PM was demonstrated. In adipocytes expressing GLUT4 harbouring 
a GFP tag at its C-terminus as a Myc tag in the first exofacial loop, the cellular localisation 
of GLUT4 was examined using confocal microscopy. It was shown that siRNA knockdown 
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of Sx4 reduces the amount of GLUT4 in the plasma membrane, as shown by surface 
staining with anti-myc antibodies. Moreover, isolation of insulin stimulated PM lawns 
revealed reduced GLUT4 association with the membrane, suggesting a role for Sx4 in 
GSV tethering at the PM (Kawaguchi et al., 2010).  
1.5.5.2 SNAP23 
SNAP23 was originally identified as a none-neuronal SNAP protein, which binds to both 
syntaxin and VAMP proteins, in a yeast two-hybrid system (Ravichandran et al., 1996). 
Sx4 and SNAP23 colocalise at the PM in 3T3-L1 adipocytes (Tamori et al., 1998) and 
their interaction has been confirmed by co-immunoprecipitation studies in rat adipocytes 
(St-Denis et al., 1999). Inhibition of SNAP23 using a dominant negative truncated 
SNAP23 peptide results in reduced GLUT4 translocation to the cell surface in response to 
insulin (Rea et al., 1998).  
1.5.5.3 VAMP2 
Sx4 and SNAP23 have been shown to form an SDS-resistant SNARE complex with 
VAMP2 by surface plasmon resonance (SPR) (Rea et al., 1998). VAMP2 has since been 
implicated in insulin regulated GLUT4 translocation. Over expression of a SNAP23 mutant 
that was able to bind to Sx4 but not VAMP2 resulted in a reduction of insulin stimulated 
GLUT4 translocation (Kawanishi et al., 2000). However, VAMP2 is not the only v-SNARE 
that has been proposed to play a role in insulin stimulated GLUT4 translocation. Indeed, a 
recent study has shown that VAMPs 2, 3, 4, 5, 7 and 8 can form SDS-resistant SNARE 
complexes with Sx4 and SNAP23 in vitro (Sadler et al., 2015). Early studies showed that 
both VAMP2 and VAMP3 are present in GLUT4 containing vesicles and translocate to the 
PM in response to insulin stimulation of rat and 3T3-L1 adipocytes (Cain et al., 1992; 
Volchuk et al., 1995). Interestingly, when VAMP3 containing vesicles were 
immunoprecipitated they were found to contain GLUT4 but not VAMP2 (Volchuk et al., 
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1995). This finding suggests that there are two pools of GLUT4 containing vesicle that are 
both insulin responsive.  
Expression of the cytoplasmic domains of either VAMP2 or 3 (acting as dominant negative 
mutants) inhibits GLUT4 translocation in 3T3-L1 adipocytes (Olson et al., 1997). However, 
inhibition studies using tetanus toxin cleavage of either VAMP2 or VAMP3 did not impair 
insulin stimulated GLUT4 translocation in rat adipocytes (Hajduch et al., 1997). However, 
a contrasting study has shown that tetanus toxin cleavage of VAMP2 and VAMP3 in L6 
myoblasts impairs GLUT4 translocation by 60-70 % (Randhawa et al., 2000). Moreover, 
this latter study showed that expression of a toxin resistant form of VAMP2 but not 
VAMP3 rescues the effect of tetanus toxin treatment in these cells. 
More recent proteomic analysis of GSVs has shown that VAMPs 2, 3 and 8 are present 
on GSVs (Jedrychowski et al., 2010; Larance et al., 2005). Indeed one study using 
adipocytes derived from mouse embryonic fibroblasts showed that insulin stimulated 
GLUT4 translocation to the PM was only blocked when VAMP2, 3 and 8 were inhibited 
simultaneously (Zhao et al., 2009). This study also showed that reintroduction of only one 
of the VAMP isoforms is needed to rescue GLUT4 translocation highlighting potential 
redundancy in the pathway.  
1.5.6 Regulation of SNARE mediated GLUT4 trafficking 
1.5.6.1 Munc18c 
The SM protein that has been implicated in regulating the Sx4/SNAP23/VAMP2 SNARE 
complex is Munc18c (Tamori et al., 1998). Munc18c binds to monomeric Sx4 via its N-
terminus (mode 2 binding, figure 1.6) (Latham et al., 2006). The crystal structure of the 
Munc18c/Sx4 N-peptide complex was determined, confirming that the peptide bound to a 
hydrophobic pocket on the outer surface of Munc18c (Hu et al., 2007). This interaction is 
compatible with Sx4 in its open conformation, and therefore SNARE complex assembly. 
Systematic analysis of recombinant purified Sx4, tagged at either the N- or C-terminus, 
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and Munc18c revealed that the proteins interact via a second distinct binding mode, most 
likely through mode 1 binding (figure 1.6) (Aran et al., 2009). Indeed, homology modelling 
suggests that the residues required for the interaction of closed Sx1a and M18a are 
conserved in Sx4 (D’Andrea-Merrins et al., 2007). However, low-resolution structural 
analysis of the Sx4/Munc18c complex found that Sx4 was in the open conformation, and 
found no evidence for the proteins interacting when Sx4 is in the closed conformation 
(Christie et al., 2012). Munc18c also binds to binary t-SNARE complexes (Sx4/SNAP23) 
and to the assembled ternary SNARE complex (Latham et al., 2006). In addition, the SM 
protein has been shown to interact with the v-SNARE VAMP2, although with a lower 
affinity that Sx4 (Brandie et al., 2008). 
Contradictory results have been found when assessing the effect of Munc18c on SNARE 
complex assembly and membrane fusion. One study has shown, using a in vitro complex 
assembly assay, that preincubation of Munc18c and Sx4 has been shown to inhibit 
ternary complex formation (Kioumourtzoglou et al., 2014). Whereas a similar assay has 
shown that preassembly of the Sx4/Munc18c complex accelerates complex assembly 
(Latham et al., 2006). Similarly contrasting results have been obtained when analysing the 
effect of Munc18c on membrane fusion. In vitro liposome fusion assays have shown that 
inclusion of Munc18c both inhibits (Brandie et al., 2008) and stimulates (Yu et al., 2013) 
membrane fusion. Heterozygous Munc18c knockout mice have reduced insulin sensitivity 
(Oh et al., 2005), suggesting a positive role for Munc18c in GLUT4 exocytosis. Whereas 
in adipocytes derived from mice embryonic fibroblasts of Munc18c knockout mice insulin-
induced GLUT4 translocation is enhanced (Kanda et al., 2005). This is consistent with a 
negative role for the SM protein. The contrasting data on the role of Munc18c in insulin-
stimulated GLUT4 translocation presents a complex picture of the mechanisms behind the 
process, and suggests that other proteins and regulatory systems may be important.  
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1.5.6.2 Synip 
Synip was identified in a yeast-two hybrid screen as a novel Sx4 binding protein in 3T3-L1 
adipocytes (Min et al., 1999). Association of Synip with Sx4 inhibits the interaction of Sx4 
and VAMP2, but not Sx4 and SNAP23, suggesting the protein negatively regulates 
SNARE complex assembly (Min et al., 1999). Synip dissociates from Sx4 following insulin-
stimulation and expression of a dominant-interfering C-terminal fragment of Synip inhibits 
GLUT4 translocation in 3T3-L1 adipocytes (Min et al., 1999). Synip is phosphorylated by 
Akt at serine 99 (Yamada et al., 2005). Overexpression of a phospho-resistant mutant of 
Synip acts as a dominant-negative and inhibits GLUT4 translocation to the PM in 3T3-L1 
adipocytes (Yamada et al., 2014). As Akt is activated in the PI3K dependent insulin-
signalling cascade, this mechanism could be a potentially important regulatory feature 
linking the signalling and trafficking machinery of GLUT4 transport.   
1.5.6.3 Tomosyn 
Tomosyn was originally identified as a syntaxin 1a binding protein from rat cerebral 
cytosol (Fujita et al., 1998). Subsequently, isoforms have been found in other tissues, 
including a splice variant of the syntaxin 1a binding protein called b-tomosyn that is 
present in adipocytes (Yokoyama et al., 1999). b-tomosyn binds to Sx4 and SNAP23 via 
its coiled-coil VAMP2-like region (Widberg et al., 2003). Overexpression of b-tomosyn in 
this study led to a reduction in insulin-stimulated translocation of GLUT4 to the PM, 
suggesting the protein plays an inhibitory role in regulating the trafficking of the glucose 
transporter. 
1.5.6.4 AS160 
The Rab GTPase activating protein AS160 is recruited and activated following insulin-
stimulation (Sano et al., 2003). AS160 is associated with GSVs via its interaction with 
IRAP (Larance et al., 2005). Four Akt phosphorylation sites have been identified on 
AS160 and mutation of these residues inhibits insulin-stimulated GLUT4 translocation 
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(Sano et al., 2003). This observation led to the model whereby phosphorylation of AS160 
by Akt inactivates the Rab GAP function of the protein, and that this is required for GLUT4 
translocation (Larance et al., 2005). Indeed, siRNA knockdown of AS160 results in a 
partial relocalisation of GLUT4 to the plasma membrane under basal conditions, 
demonstrating the that protein is required for intracellular retention of GSVs (Eguez et al., 
2005).  
Detailed analysis of the function of AS160 has revealed it regulates GSV docking at the 
plasma membrane (Bai et al., 2007). This study by Bai and colleagues used total internal 
reflection microscopy (TIRF) to track and dissect the docking and fusion steps of GSVs at 
the plasma membrane. Expression of a phospho-resistant AS160 mutant, or treating cells 
with the PI3K inhibitor wortmannin, significantly decreases the docking frequency of GSVs 
whilst having no effect on fusion (Bai et al., 2007).  
AS160 has been shown to display GTPase activity towards Rabs 2A, 3A, 10 and 14 in 
vitro (Mîinea et al., 2005). These Rab proteins also associate with GSVs (Larance et al., 
2005; Mîinea et al., 2005) however their precise role in GLUT4 trafficking are as yet 
unclear. 
1.5.6.5 Phosphorylation of Sx4 and Munc18c 
Protein phosphorylation plays an important role in insulin signalling and in controlling 
some of the GLUT4 regulatory proteins discussed above (Jewell et al., 2010). Direct 
phosphorylation of SNARE proteins has been shown to be an important regulatory feature 
of the proteins, as discussed in section 1.4.4.  
Munc18c is phosphorylated in response to insulin (Oh and Thurmond, 2006; Schmelzle et 
al., 2006). The study by Schmelzle and colleagues identified that phosphorylation of 
tyrosine 521 increased >10 fold in response to insulin-treatment of 3T3-L1 adipocytes. 
Subsequent analysis has shown that Munc18c is phosphorylated directly by the insulin 
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receptor kinase (CIRK) in vitro at Y521 (Aran et al., 2011). Moreover, both 
phosphomimetic and CIRK phosphorylated Munc18c no longer bind to Sx4 in an in vitro 
pull down assay (Aran et al., 2011).  These data suggest that phosphorylation of Munc18c 
may alleviate its inhibition of Sx4. Indeed, in a complex assembly assay using 
recombinant proteins purified from bacteria, pre-incubating Sx4 with Y521E phospho-
mimetic Munc18c increases the amount of complex formed when compared to pre-
incubation with WT Munc18c or experiments lacking the SM protein (Kioumourtzoglou et 
al., 2014).  
A second study investigating Munc18c phosphorylation in response to insulin mapped a 
phosphorylation site to tyrosine residue 219 (Oh and Thurmond, 2006). Mutation of this 
phosphorylation site decreases the affinity of Munc18c for Sx4, suggesting that this is 
again a mechanism to relieve the inhibition of Munc18c on SNARE complex assembly (Oh 
and Thurmond, 2006). Furthermore, phosphorylation of Y219 of Munc18c causes a switch 
in binding specificity from Sx4 to the protein Doc2β (Jewell et al., 2008). Doc2β has been 
shown to bind to Munc18c and positively regulate insulin-stimulated GLUT4 translocation 
(Ke et al., 2007) 
Schmelzle and colleagues also reported two sites in Sx4 that show an increase in 
phosphorylation in response to insulin-stimulation, Y115 and Y251 (Schmelzle et al., 
2006). However the consequences of phosphorylation of Sx4 at these residues are as yet 
unknown. 
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Figure 1.9: Sequence alignments of regions of selected Syntaxins and SM proteins 
An alignment of numerous mammalian and yeast plasma membrane Syntaxins (A) and 
SM proteins (B) is shown. Tyrosine residues that have been shown to be phosphorylated 
in response to insulin in Sx4 and Munc18c are highlighted in blue. The regions of Sx4 that 
the sequences reside in are labelled in blue.  
 
 
Figure 1.9 shows an alignment of regions of Sx4 and Munc18c with other PM syntaxins 
and SM proteins. The residues that are phosphorylated in response to insulin are 
highlighted. These residues do not appear to be highly conserved. It has been previously 
noted that residues responsible for forming interactions common to all SNARE proteins, 
such as regions of the SNARE domain that are crucial for SNARE complex formation are 
well conserved, however residues in SNARE and SM proteins that contribute to their 
specificity for their binding partners or their role in specific cellular functions are less well 
conserved (Misura et al., 2000). The lack of conservation of the tyrosine residues that are 
phosphorylated in response to insulin suggests that these residues may be important to 
the function of Sx4 and Munc18c in a manner that is specific to regulating an insulin 
response in these cells.  
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Figure 1.10: Predicted locations of the residues in Sx4 and Munc18c that are 
phosphorylated in response to insulin 
The locations of the residues that have been shown to be phosphorylated on Sx4 and 
Munc18c were predicted based on the structure of the complex between closed Sx1A and 
Munc18a (PDB code 3C98). Syntaxin is shown in blue, the Habc domain is shown in light 
blue and the SNARE domain in dark blue. The predicted location for Y115 and Y251 are 
labelled and highlighted in pink. Munc18 is shown in purple. The predicted location of 
Y521 is labelled and highlighted in cyan. 
 
 
 
Figure 1.10 shows a prediction of the sites of phosphorylation of Sx4 and Munc18c based 
on a structure of Sx1A and Munc18A (Burkhardt et al., 2008). In this structure the syntaxin 
in the closed conformation binds in the cleft of Munc18. The predictions for the locations 
of the phosphosites that this study focusses on are labelled. Though the phosphosites 
aren’t predicted to be located in the regions of Munc18c or Sx4 that are likely to directly 
interact, the structure and conformation of both proteins are important for their function. 
The predicted location of these phosphosites indicates they may impact on the overall 
conformation, and therefore may affect the function, of Sx4 and Munc18c. 
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1.6 Aims 
The aim of this thesis was to assess the effect of insulin-induced phosphorylation of Sx4 
at Y115 and Y251 and of Munc18c at Y521 on SNARE complex assembly and GLUT4 
translocation to the PM. Membrane trafficking is a complex and tightly regulated process. 
Phosphorylation of these two proteins could represent an important regulatory mechanism 
whereby SNARE proteins, and therefore SNARE complex assembly, are directly 
regulated by the insulin signalling cascade. 
In chapter three, I examined the effect of phosphorylation of Sx4 in vitro using 
recombinant phospho-mimetic Sx4 mutants. Complex assembly assays, pull down assays 
and surface plasmon resonance was used to analyse the effect of the phospho-mutants 
on both binary and ternary SNARE complex interactions. Limited proteolysis experiments 
were also carried out to examine any conformational changes of the phospho-mimetic 
mutant proteins. Finally, a Phos-tag SDS-PAGE based mobility shift assay was carried out 
to analyse the phospho-isoforms present following in vitro phosphorylation of Sx4. 
I then examined the effect of phospho-mimetic Sx4 mutants on the translocation of 
GLUT4 in HeLa cells in chapter 4. A HA-GLUT4-GFP reporter construct was used to 
assess the effect of over expression of Myc tagged Sx4 phospho-mutants on GLUT4 
translocation by both microscopy and flow cytometry. I also generated Sx4 knockout 3T3-
L1 cell lines; with the view to differentiating these into Sx4 depleted 3T3-L1 adipocytes.  
Finally, in chapter 5, the effect of both phosphorylation of both Sx4 and Munc18c on their 
interactions is examined. Recombinant phospho-mimetic Sx4 and Munc18c were used in 
pull down and complex assembly assays in order to assess the effect of phosphorylation 
of both proteins on binary and ternary SNARE interactions. 
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Chapter Two 
Materials and Methods 
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2 Materials and Methods 
2.1 Materials 
2.1.1 General reagents 
General laboratory kits and reagents were obtained from the following suppliers: 
• Ambion, Austin, USA  
• BD Biosciences, Oxford, UK  
• BioRad Laboratories Ltd, Hertfordshire, UK  
• Clontech Laboratories Inc, California, USA  
• Fisher Scientific Ltd, Loughborough, Leicestershire, UK  
• FormediumTM, Norfolk, UK  
• GE Healthcare Bio-Sciences Ltd, Buckinghamshire, UK  
• Invitrogen Ltd, Paisley, UK 
• New England Biolads UK Ltd, Hertfordshire, UK  
• Melford Laboratories Ltd, Ipswich, Suffolk, UK  
• Merck Chemicals Ltd, Nottingham, UK 
• Millipore Ltd, Livingston, UK  
• New England Biolabs, Ipswich, USA 
• Pierce, Perbio Science UK Ltd, Cheshire, UK  
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• Promega Ltd, Southampton, UK  
• Roche Diagnostics Ltd, Burgess Hill, UK  
• Severn Biotech Ltd, Worcestershire, UK  
• Sigma Aldrich Company Ltd, Dorset, UK  
• Spectrum Laboratories Inc, Netherlands  
• Stratagene Technologies, California, USA  
• Synaptic Systems, Göttingen, Germany  
• VWR UK Ltd, Leicestershire, UK  
• Whatman Plc, Kent, UK 
2.1.2 Solutions 
High quality pure sterile water was used as the dissolving agent in all solutions in this 
study unless otherwise stated. 
2x Laemmli Sample Buffer (LSB): 100mM Tris, HCl pH 6.8, 4 % (w/v) SDS, 20 % (v/v) 
glycerol, 0.2 % (w/v) bromophenol blue, 10 % (v/v) β-mercaptoethanol 
Buffer C: 25 mM HEPES, 0.4 M KCl, 10 % (w/v) glycerol, pH 7.4 
Coomassie: 0.05 % (w/v) Coomassie brilliant blue R-250, 50 % (v/v) methanol, 10 % (v/v) 
acetic acid  
Coomassie Destain: 15 % (v/v) methanol, 15 % (v/v) acetic acid  
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GST-Elution Buffer: 50 mM Tris base pH 8.0, 25 mM reduced glutathione, 10 % (w/v) 
glycerol 
GST-Preparation Buffer: 100 mM HEPES, 500 mM NaCl, 5 mM MgCl2, 5mM β-
mercaptoethanol, 10 % (w/v) glycerol, 1 tablet of complete protease inhibitor mix per 100 
ml (Roche) 
LB media: 1 % (w/v) peptone, 0.5 % (w/v) yeast extract, 1 % (w/v) NaCl, 1.2 % (w/v) Agar 
(optional) 
PBS: 85 mM NaCl, 1.7 mM KCl, 5 mM Na2HPO4, 0.9 mM KH2PO4, pH 7.4 
PBST: 85 mM NaCl, 1.7 mM KCl, 5 mM Na2HPO4, 0.9mM KH2PO4, 0.1 % (v/v) Tween-20, 
pH 7.4 
Ponceau Stain: 0.2 % (w/v) Ponceau Stain, 1 % (v/v) glacial acetic acid 
SDS-PAGE resolving buffer: 75mM Tris-HCl, pH 8.8, 0.2% (w/v) SDS 
SDS-PAGE stacking buffer: 25mM Tris-HCl, pH 6.8, 0.2% (w/v) SDS 
SDS-PAGE running Buffer: 20mM glycine, 62mM Tris-Base, 0.1% (w/v) SDS 
Semi-dry transfer Buffer: 24mM Tris base, 20mM glycine, 0.1% (w/v) SDS, 20% (v/v) 
methanol 
SOC media: 2% (w/v) tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 
mM MgCl2, 10 mM MgSO4, and 20 mM glucose 
TAE: 40 mM Tris-Acetate pH 8, 1mM EDTA 
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Terrific Broth (TB): 1.2% (w/v) tryptone, 2.4% (w/v) yeast extract, 0.4% (v/v) glycerol, 
17mM KH2PO4, 72mM K2HPO4 (obtained from Melford Labs Ltd) 
TST: 50 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.05% (v/v) Tween-20 
YPD yeast media: 1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glucose, 2% (w/v) 
Agar (optional) 
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2.1.3 Primary antibodies 
Table 2.1: Primary antibodies used in this study 
Antigen Working dilution Description Source 
HA IF: 1:100 Rat, monoclonal, 
clone 3F10 
Roche applied 
sciences (11 867 
423 001) 
His6 IB: 1:10000 Mouse, monoclonal  Sigma-Aldrich 
(H1029) 
GAPDH IB: 1:10000 Mouse, monoclonal Applied Biosystems 
(AM4300) 
VAMP2/ 
Synaptobrevin 
IB: 1:2000 Mouse, monoclonal Synaptic Systems 
(104 211) 
Syntaxin 4 IB: 1:1000-1:5000 Rabbit, polyclonal 
antiserum 
Synaptic Systems 
(110 042) 
BiP (GRP78) IB: 1:1000 Rabbit, polyclonal Abcam (ab21685) 
Myc IB: 1:1000 
IF: 1:300 
Mouse, monoclonal, 
clone 9E10 
Sigma-Aldrich 
(M4439) 
Phosphotyrosine 
(PY20) 
IB: 1:1000 Mouse, purified BD Biosciences 
(610000) 
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2.1.4 Secondary antibodies 
Table 2.2: Secondary antibodies used in this study 
Antigen Working dilution Description Source 
Anti-mouse IgG IB: 1:2000-5000 Peroxidase 
conjugate, produced 
in goat 
Sigma-Aldrich 
(A4416) 
Anti-rabbit IgG IB:1:2000-5000 Peroxidase 
conjugate, produced 
in goat 
Sigma-Aldrich 
(A0545) 
Anti-rat AlexaFluor 
647 
IF/FACS: 1:300 Produced in goat, 
purified, whole IgG 
LifeTechnologies (A-
21247) 
Anti-mouse DyLight 
405 
IF/FACS: 1:300 Produced in Goat, 
whole IgG affinity 
purified 
Jackson 
ImmunoResearch 
(115-475-003) 
 
2.1.5 Mammalian cell lines 
Table 2.3: Mammalian cell lines used in this study 
Cell line Source 
3T3-L1 American Type Culture Collection (ATCC) 
HeLa American Type Culture Collection (ATCC) 
2.1.6 E. coli strains 
Table 2.4: E. coli strains used in this study 
Strain Genotype Source 
BL21 (DE3) F-ompT hsdSB(rB-mB-) gal dcm (DE3) Invitrogen Ltd 
Top10 F- mcrA _(mrr-hsdRMS-mcrBC) 
φ80lacZ_M15 _lacX74 nupG recA1 
araD139 _(ara-leu)7697 galE15 galK16 
rpsL(StrR) endA1 λ- 
Invitrogen Ltd 
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2.1.7 Plasmids 
Table 2.5 Summary of plasmids used in this study 
 
Plasmid Description Source 
pETDuet-1:GST E. coli expression vector 
encoding GST 
Constructed by Dr Fiona 
Brandie 
pETDuet:Sx4-GST E. coli expression vector 
encoding C-terminally GST 
tagged Sx4 cytosolic 
domain  
Constructed by Dr Fiona 
Brandie 
pETDuet:Sx4-GST (Open) E. coli expression vector 
encoding C-terminally GST 
tagged Sx4 cytosolic 
domain. Contains two 
mutations in the hinge 
region (L173A/E174A) 
Constructed by Dr Veronica 
Aran-Ponte 
pETDuet:Sx4-GST (Y115E) E. coli expression vector 
encoding C-terminally GST 
tagged Sx4 cytosolic 
domain. Contains a 
phosphomimetic mutation 
(Y115E) 
Constructed by Dr Veronica 
Aran-Ponte 
pETDuet:Sx4-GST (Y251E) E. coli expression vector 
encoding C-terminally GST 
tagged Sx4 cytosolic 
domain. Contains a 
phosphomimetic mutation 
Constructed by Dr Veronica 
Aran-Ponte 
  (Y251E)  
pETDuet:Sx4-GST 
(Y115,251E) 
E. coli expression vector 
encoding C-terminally GST 
tagged Sx4 cytosolic 
domain. Containing two 
phosphomimetic mutations 
(Y115,251E) 
Constructed by Dr Veronica 
Aran-Ponte 
pGEX-4T-1:GST-VAMP2 E. coli expression vector 
encoding N-terminally GST 
tagged VAMP2 cytosolic 
Constructed by Dr Dimitrios 
Kioumourtzoglou 
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domain (Thombin cleavable) 
pQE30:His-SNAP23 E. coli expression vector 
encoding N-terminally His 
tagged SNAP23 
Constructed by Dr Fiona 
Brandie 
pETDuet:Sx4(Myc)-GST E. coli expression vector 
encoding C-terminally GST 
tagged Sx4 cytosolic 
domain. Contains Myc tag 
positioned between the N-
terminus and Habc domain 
Cytoplasmic domain of Sx4 
was amplified from 
pCR3.1:Sx4(Myc). The PCR 
product was cloned into TA 
TOPO cloning vector 
pCR2.1-TOPO before being 
excised by restriction 
enzyme digest with NheI 
and ApaI 
pCR3.1  Mammalian expression 
vector 
GenScript, Piscataway, NJ, 
USA 
pCR3.1:Sx4(Myc) Mammalian expression 
vector encoding full length 
syntaxin 4. Contains Myc 
tag positioned between the 
N-terminus and Habc 
domain 
Constructed using the 
custom gene synthesis 
service from GenScript, 
Piscataway, NJ, USA 
pCR3.1:Sx4(Myc)-Y115E Mammalian expression 
vector encoding full length 
syntaxin 4 with a tyrosine to 
glutamic acid mutation at 
residue 115. Contains Myc 
tag positioned between the 
Constructed using the 
custom gene synthesis 
service from GenScript, 
Piscataway, NJ, USA 
  N-terminus and Habc 
domain. 
 
pCR3.1:Sx4(Myc)-Y251E Mammalian expression 
vector encoding full length 
syntaxin 4 with a tyrosine to 
glutamic acid mutation at 
residue 251. Contains Myc 
tag positioned between the 
N-terminus and Habc 
domain 
Constructed using the 
custom gene synthesis 
service from GenScript, 
Piscataway, NJ, USA 
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pCR3.1:Sx4(Myc)-
Y115,251E 
Mammalian expression 
vector encoding full length 
syntaxin 4 with a tyrosine to 
glutamic acid mutation at 
residue 115 and 251. 
Contains Myc tag positioned 
between the N-terminus and 
Habc domain 
Constructed using the 
custom gene synthesis 
service from GenScript, 
Piscataway, NJ, USA 
pCMV-Cas9-RFP CRISPR plasmid containing 
syntaxin 4 target guide RNA 
sequence, Cas9 and RFP 
Purchased from Sigma-
Aldrich, St Luois, MO, USA 
 
 
2.1.8 Primers 
Oligonucleotides were purchased from Integrated DNA Technologies. Each primer pair 
was diluted to a concentration of 100μM and stored at -20°C. 
Table 2.6: Oligonucleotides used in this study 
Primer Sequence (5’-3’) 
Sx4-Myc ΔTMD Forward CGG GGC ATA TGC GCG ACA GGA CCC AT 
Sx4-Myc ΔTMD Reverse GGC TCG AGG ACC TTT TTC TTC CTC GCC TTC TTC TG 
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2.2 General Molecular Biology Techniques 
2.2.1 Small scale preparation of plasmid DNA 
A single colony of newly transformed bacteria (section 2.3.1) was used to inoculate 10ml 
sterile LB supplemented with the appropriate antibiotic for selection (section 2.1.3) and 
grown overnight at 37°C in a shaking incubator. Bacteria were pelleted by centrifugation 
(2500 rpm, 10 minutes) and plasmid DNA was extracted using the Promega Ltd Wizard 
Plus SV mini-prep kit following the manufacturer’s instructions. The concentration of DNA 
was determined using a NanoDrop (ThermoScientific) and was examined by agarose gel 
electrophoresis (section 2.2.2). 
2.2.2 Large scale preparation of plasmid DNA 
A single colony of newly transformed bacteria (section 2.3.1) was used to inoculate 50 ml 
of sterile LB media supplemented with the appropriate antibiotic for selection (section 
2.1.3) and grown overnight at 37°C in a shaking incubator. Bacteria were pelleted by 
centrifugation at 2500 rmp for 10 minutes and plasmid DNA was extracted using the 
Qiagen HiSpeed Plasmid Purification midi-prep kit as per manufacturer’s instructions. The 
concentration of DNA was determined using a NanoDrop (ThermoScientific) and was 
examined by agarose gel electrophoresis (section 2.2.2). 
2.2.3 Agarose gel electrophoresis 
DNA samples were routinely visualised by agarose gel electrophoresis. Agarose powder 
(0.8 - 1.5% (w/v)) was dissolved in TAE buffer (40 mM Tris Acetate, 1 mM EDTA, pH 8.0) 
by heating in a microwave. The solution was allowed to cool before SYBR safe DNA gel 
stain was added at a 1:10000 dilution. DNA samples were prepared by addition of 6x DNA 
loading buffer (40% (w/v) ficoll, 0.25% (w/v), bromophenol blue). Samples were loaded 
onto the gel, alongside a 100 bp or 1 kb DNA marker (New England Biolabs Ltd). The gel 
was then run at 100 V in TAE buffer and DNA samples were visualised with a blue light 
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box Syngene U:Genius 3 gel documentation system (Syngene). DNA was extracted from 
agarose gels using a GeneJET Gel Extraction Kit (ThermoScientific). 
2.2.4 PCR 
Forward and reverse oligonucleotide primers were designed and purchased from 
Integrated DNA Technologies. The high fidelity DNA polymerase Pfu was routinely used 
and purchased from Promega UK. Reactions were carried out in PCR tubes in a volume 
of 50μl of sterile dH2O. A typical reaction would be as follows: 
Template DNA (~1 μg/μl)   1μl 
10X Pfu buffer     5μl 
Forward primer (5 pM)   1.5μl 
Reverse primer (5 pM)   1.5μl 
dNTPs (10 mM)    1μl 
Pfu polymerase    1μl (5 units)  
Reactions were carried out in a thermocycler using the following standard conditions: 
 Initial denaturation  95°C  5 mins 
 Denaturation   95°C  1 min 
 Primer annealing  ~55°C* 1 min 
 Elongation   72°C  1 min/kb+1min 
 Final elongation  72°C  10 mins 
30 cycles 
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 Cooling   4°C  hold   
*Primer annealing temperature was set relative to the estimated melting temperature of 
the primers 
PCR products were visualised using agarose gel electrophoresis (section 2.2.2). Where 
appropriate, before restriction endonuclease digestion PCR products were cloned into the 
pCR2.1-TOPO vector using the pCRII-TOPO kit (Thermo Scientific Inc.) following the 
manufacturer’s instructions. 
2.2.5 Restriction endonuclease reactions 
Restriction endonuclease double digests were carried out with two enzymes 
simultaneously. Enzymes were purchased from either Promega UK or New England 
Biolabs. A typical reaction was set up as follows: 
 DNA template    20μl 
 10X Buffer    5μl 
 Enzyme 1    1.5μl 
 Enzyme 2    1.5μl 
 10X BSA    5μl 
 Sterile dH2O    17μl 
Reactions were carried out at 37°C for around 2 hours. Single digests were also carried 
out using half the volumes stated above. Once digests were complete the products were 
routinely analysed using agarose gel electrophoresis and excised by gel extraction 
(section 2.2.2). 
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2.2.6 DNA ligase reactions 
Linearised parental vector and DNA fragment inserts were ligated using T4 DNA ligase 
(New England Biolabs Inc). A typical ligase reaction was as follows; 
Linearised vector DNA (1mg/ml)   2µl  
Fragment DNA (1mg/ml)    6µl 
10 x T4 DNA ligase buffer   1µl 
T4 DNA ligase     1µl (10 units) 
Reactions were carried out at room temperature overnight before being transformed into 
TOP10 cells (Section 2.3.1). 
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2.3 General Protein Techniques 
2.3.1 Bacterial transformation 
15-50μl of the appropriate chemically competent bacterial cell stock was thawed and 
mixed with 3μl of mini-prepped DNA. The mixture was on ice for 30 minutes before being 
heat shocked at 42°C for 30 seconds. The cells were then returned to ice for 2 minutes. 
200μl of SOC media was added and the cells were incubated at 37°C in a shaking 
incubator for 1 hour. 50μl of the culture was spread onto LB agar plates containing the 
appropriate antibiotic for selection and incubated overnight at 37°C. 
2.3.2 General expression and purification of recombinant proteins 
10ml of sterile LB media was inoculated with a single colony of freshly transformed BL21-
DE3 bacteria and grown in a shaking incubator at 37°C overnight. The appropriate volume 
of TB (1-12 L) was then inoculated and cultures grown to an OD600 of 0.6 at 37°C with 
shaking. Protein production was then induced with 0.5mM of IPTG and cultures were left 
to grow overnight at 19-22°C with shaking. Bacteria was harvested by centrifugation at 
5000 rpm for 20 minutes and resuspended in the appropriate buffer (section 2.3.3 and 
2.3.4). Bacteria were lysed using sonication. Lysate was then cleared by centrifugation at 
15000 rpm for 45 minutes. The cleared lysate was incubated with 300μl of the appropriate 
beads, which had been preequilibrated with lysis buffer, overnight at 4°C. Following 
incubation, beads were washed three times by resuspending in wash buffer and 
centrifuging at 1000rpm for 1 minute. Protein bound to the beads was eluted by incubating 
the beads with 1-3ml of elution buffer with rotation at 4°C for 1.5 hours; eluted protein was 
then collected by centrifugation at 1000rpm for 1 minute and the supernatant was 
collected. This elution step was repeated as desired up to three times. Samples from each 
step of the process were analysed by SDS PAGE and Coomassie staining or 
immunoblotting. Eluted protein was dialysed overnight at 4°C using Float-a-Lyzer 
(SpectrumLabs) columns with 20kDa pores against 5L PBS plus 5% glycerol. Purified 
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protein was then aliquoted and snap frozen in liquid nitrogen before being stored at -80°C. 
For details of culture and elution volumes used for each protein see Appendix I. 
2.3.3 Purification of GST-tagged proteins 
To immobilise GST tagged fusion proteins glutathione Sepharose 4 Fast Flow affinity 
medium (GE Healthcare) was used. Bacteria were resuspended in GST preparation buffer 
(100 mM HEPES, 500mM NaCl, 5mM MgCl2, 5mM β-mercaptoethanol, 10% (w/v) glycerol, 
1 tablet of complete protease inhibitor mix (EDTA free) per 100ml (Roche)). Beads were 
also equilibrated with this buffer prior to incubation with cleared lysate. Once protein was 
bound, the beads were washed with PBS, with the last wash being PBS plus 0.5M NaCl. 
Protein was eluted using GST elution buffer (50mM Tris base pH 8.0, 25mM reduced 
glutathione, 10% (w/v) glycerol).  
2.3.4 Purification of His-tagged proteins 
Ni-NTA Agarose (Qiagen) was used to purify His6 tagged fusion proteins. The lysis buffer 
used was Buffer C supplemented with 4 mM imidazole, 5 mM β-mercaptoethanol, 1 tablet 
of complete protease inhibitor mix (EDTA free) per 100ml (Roche). Beads were washed 
with Buffer C supplemented with 20 mM imidazole, 5 mM β-mercaptoethanol. Protein was 
eluted using Buffer C supplemented with 250 mM imidazole, 5 mM β-mercaptoethanol. 
2.3.5 Purification of proteins with cleavable GST tags 
Proteins were purified as per section 2.3.3, however proteins were cleaved from the 
beads and GST tag using thrombin in replace of eluting. Glutathione Sepharose beads 
with protein bound were resuspended in 2ml PBS and 5 units of thrombin was added. The 
beads were incubated with the thrombin for 3 hours at room temperature with rotation. 
Once cleavage was complete thrombin action was inhibited with the addition of 1mM 
phenylmethylsulfonyl fluoride (PMSF) protease inhibitor. Protein was collected by 
centrifuging at 1000 rpm for 1 minute and collecting the supernatant.  
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2.3.6 Estimating protein concentration 
Purified protein samples were thawed on ice. Once thawed samples were diluted in PBS 
by a factor of 1:5 and/or 1:10. Samples were then diluted 1:2 in 2 x Laemmli Sample 
Buffer (LSB) and run on 15% SDS-PAGE gels alongside BSA standards (0.1 µg, 0.2 µg, 
0.4 µg, 1µg, 2µg). Gels were Coomassie stained (Section 2.3.8) and protein 
concentrations were estimated with the aid of densitometry using Image J software. 
2.3.7 SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was carried out 
using a Bio Rad Mini-PROTEAN Tetra cell gel apparatus (Bio-Rad Laboratories Ltd) 
according to the manufacturer’s protocol. Precision Plus Protein Standards from BioRad 
were run along with protein samples. Gels were prepared with either 7.5,12 or 15% (v/v) 
acrylamide resolving gel (75 mM Tris.HCl, pH 8.8, 0.1 % (w/v) SDS, 7.5, 12 or 15% v/v 
acrylamide, 0.05 % (v/v) Ammonium persulfate and 0.01 % (v/v) TEMED) with 4 % 
stacking gel (25 mM Tris.HCl, pH 6.8, 0.1 % (w/v) SDS, 4 % (v/v) acrylamide, 0.05 % (v/v) 
Ammonium persulfate and 0.01 % (v/v) TEMED). Gels were run in SDS running buffer (25 
mM Tris, 190mM glycine and 0.1 % (w/v) SDS) at 120 V.  
2.3.8 Coomassie staining and destaining 
Following SDS-PAGE gels were immersed in Coomassie stain for around 30 minutes. 
Gels were then destained in Coomassie destaining buffer for as long as necessary, the 
buffer was periodically changed during destaining.   
2.3.9 Semi-dry transfer 
Following SDS-PAGE (section 2.3.7) proteins were transferred onto phenylmethylsulfonyl 
fluoride (PVDF) membranes. PVDF was first activated by soaking in methanol. The 
membrane, acrylamide gel and 1.5mm filter paper were then soaked in semi-dry transfer 
buffer (24mM Tris, 20mM glycine, 0.1% (w/v) SDS, 20% (v/v) ethanol). The membrane 
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and gel were sandwiched between two sheets of filter paper in a BioRad Trans-Blot SD 
semi-dry electrophoretic transfer cell, taking care to remove any air bubbles. A constant 
current of 300mA was applied to carry out the transfer for 60 minutes. Transfer efficiency 
was routinely checked by Ponceau S staining (0.1% (w/v) Ponceau S, 5% (v/v) acetic 
acid). 
2.3.10 Immunoblotting 
Following protein transfer (section 2.3.9), the PVDF membrane was blocked for 1 hour in 
5% milk powder in PBST (85mM NaCl, 1.7mM KCl, 5mM Na2HPO4, 0.9mM KH2PO4, 0.1% 
(v/v) Tween-20, pH 7.4). Primary antibodies were diluted to the appropriate concentration 
in 1% milk PBST and incubated with the membrane overnight at 4°C. Membranes were 
then washed three times for 10 minutes in PBST. Horseradish peroxidase (HRP) linked 
secondary antibodies were diluted to the appropriate concentration in 5% milk PBST and 
applied to the membrane for 1 hour at room temperature. The membranes were again 
washed three times in PBST for 10 minutes.  The blots were visualised using enhanced 
chemiluminescence (ECL). 
Equal amounts of ECL solutions A and B (Merck Millipore) were mixed and applied to the 
surface of the membrane. The membrane was incubated with the ECL for 2 minutes 
before the excess was removed. The blot was then visualised using a Syngene 
GeneGenius gel documentation system (Syngene).  
2.4 Complex Assembly Assay 
Equimolar concentrations of (approximately 5 μM) Sx4, SNAP23 and VAMP2 (or GST 
controls) were combined in a volume of 500μl of Buffer C plus 100μg/ml BSA and 
incubated at 4°C, with rotation, for between 15 and 60 minutes. Samples were then 
immediately mixed with 2X LSB and boiled at 95°C for 5 minutes. Samples were analysed 
using SDS-PAGE (section 2.3.7), Coomassie staining (section 2.3.8) and immunoblotting 
(section 2.3.10). 
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2.5 Pull down assays with recombinant proteins 
GST tagged Sx4 was purified and left immobilised to glutathione Sepharose beads 
(section 2.3.3). Alternatively purified Sx4-GST was immobilised to washed glutathione 
Sepharose beads by incubating 200 μl of Sx4 with 60μl of beads for 3 hours at 4°C with 
rotation. Beads were then washed three times in PBS to remove any unbound protein. A 
sample of the beads was analysed by SDS-PAGE and Coomassie staining to check 
immobilisation.  
Once immobilised 1-5 μg Sx4-GST was incubated with an excess of either His-SNAP23, 
His-Munc18c or thrombin cleaved VAMP2 in 500μl binding buffer (PBS, 5mM β-
mercaptoethanol, 100μ/ml BSA). Reactions were carried out by incubating at 4°C with 
rotation for 30, 60 or 120 minutes. Following incubation beads were collected by 
centrifugation at 1000 rpm for 1 minute at 4°C. The beads were then washed at least six 
times in binding buffer to remove any unbound protein. Once washed, beads were 
resuspended in 50μl 2X LSB and boiled for 95°C for 5 minutes. Samples were then 
analysed by SDS-PAGE (section 2.3.7) and immunoblotting (section 2.3.10). Ponceau 
staining was carried out to analyse Sx4 input. 
2.6 Chymotrypsin Assay 
30 ng/μl of chymotrypsin (Sigma-Aldrich) was incubated with roughly 0.3mg/ml of protein 
in PBS at room temperature for 0-30 minutes. Samples were taken at the desired time 
point and immediately mixed with 2X LSB and boiled at 95°C for 5 minutes. Samples were 
then analysed by SDS-PAGE (section 2.3.7) and Coomassie blue staining (section 2.3.8). 
2.7 CIRK phosphorylation assay 
Autophosphorylated CIRK and Sx4 were mixed and made up to a final volume of 50 µl in 
filter sterilised reaction buffer (50 mM HEPES pH 7.5, 4 mM MnCl2, 0.2 mM DTT, 100 µM 
ATP Na-salt). Samples were incubated at 30 ˚C in a water bath for 150 min. The reaction 
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was stopped by the addition of sample buffer. Phosphorylation was analysed by 
immunoblotting. 
2.8 Phos-tag based mobility shift SDS-PAGE 
Phos-tag™ Acrylamide SDS-PAGE was carried out using a Bio Rad Mini-PROTEAN 
Tetra cell gel apparatus (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK) according to 
the manufacturer’s protocol. Precision Plus Protein Standards from BioRad were run 
along with protein samples. Resolving gels were prepared with 50μM Phos-tag, 100μM 
MnCl2, 75 mM Tris.HCl, pH 8.8, 0.1 % (w/v) SDS, 10 % v/v acrylamide, 0.05 % (v/v) 
Ammonium persulfate and 0.01 % (v/v) TEMED, and were left to set for 30 minutes. A 4 % 
stacking gel was then prepared (25 mM Tris.HCl, pH 6.8, 0.1 % (w/v) SDS, 4 % (v/v) 
acrylamide, 0.05 % (v/v) Ammonium persulfate and 0.01 % (v/v) TEMED). Gels were run 
in SDS running buffer (25 mM Tris, 190mM glycine and 0.1 % (w/v) SDS) at 100 V for 210 
minutes. 
Once gels were run they were incubated in semi-dry transfer buffer (24mM Tris, 20mM 
glycine, 0.1% (w/v) SDS, 20% (v/v) ethanol) plus 1 mM EDTA for 10 minutes with 
agitation. Gels were washed twice in semi-dry transfer buffer before proteins were 
transferred onto phenylmethylsulfonyl fluoride (PVDF) membranes (section 2.6.9). The 
membranes were then subject to immunoblot analysis (section 2.6.10).   
2.9 General cell culture techniques 
2.9.1 Growth of HeLa cells 
HeLa cells were purchased from ATCC (USA). A HeLa cell line stably expressing HA-
GLUT4-GFP had been previously generated in the laboratory. HeLa cells were cultured in 
DMEM (Dulbecco’s Modified Eagle’s Medium) supplemented with 10% (v/v) Foetal Calf 
Serum (FCS), 1% Glutamax (ThermoFisher Scientific) (v/v) at 37°C in a humid 
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atmosphere of 5% CO2. Media was changed every other day and cells were passaged 
when confluent.  
2.9.2 Growth of 3T3-L1 cells 
3T3-L1 cells were purchased from ATCC (USA). A 3T3-L1 cell line stably expressing HA-
GLUT4-GFP was previously generated in the lab. 3T3 cells were cultured in DMEM 
supplemented with 10% (v/v) New-born Calf Serum (NCS), 1% Glutamax (v/v) at 37°C in 
a humid atmosphere of 5% CO2. Media was changed every other day and cells passaged 
when 70-80% confluent.  
2.9.3 Passage of cells 
Cells were passaged when they reached the appropriate confluency. Media was aspirated 
and cells washed with 5-10 ml of pre-warmed serum-free media. 5mls of 0.05 % (w/v) 
Trypsin (Invitrogen) was then added and cells returned to the incubator for between 5 and 
10 minutes, until all cells were dissociated. 1 ml of the cell suspension was then added to 
14 ml of media in a 75 cm2 tissue culture flask for continued culture. Alternatively, 
suspended cells were counted, using a haemocytometer, and plated at the appropriate 
density in 6 or 24 well plates. 
2.9.4 Freezing of cells 
Cells were frozen at 70-80 % confluency. Cells were washed and trypsinised as described 
in section 2.7.3. 10 ml of cell culture media was then added the cell suspension and cells 
were pelleted by centrifugation at 800 rpm for 5 minutes. Pelleted cells were then 
resuspended in 1-4 ml of cell freezing media (FBS + 10% (v/v) DMSO, filter sterilized). 1 
ml aliquots of the cell suspension were then frozen in a Nalgene “Mr Frosty” containing 
isopropanol in 1.8 ml cryo-vials and stored at -80 °C for 24 hours, before being transferred 
to liquid nitrogen for long term storage.  
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2.9.5 Resurrection of cells 
Cells were resurrected from liquid nitrogen storage by incubation in a 37°C water bath 
until thawed. Cells were then transferred to a 75 cm2 cell culture flask containing 14 ml of 
the appropriate cell culture media. Cells were left to adhere to the flask for 24 hours 
before the culture media was changed to remove DMSO.   
2.9.6 Transfections 
GeneCellin DNA transfection reagent (Eurobio Lifesciences) was used for all transfections 
as per manufacturer’s instructions, the standard transfection conditions used are 
summarised in table 2.8. Cells were seeded onto the appropriate plate 24 hours prior to 
transfection. Midi-prepped plasmid DNA was combined with serum free DMEM and 
GeneCellin, lightly mixed and incubated for 15 minutes at room temperature. The 
transfection mixture was then added to the cells dropwise and transgene expression was 
analysed 24 hours later.  
 
Table 2.7: Transfection conditions 
Tissue 
culture 
vessel 
Number of 
cells 
seeded 
Volume of 
cell culture 
medium (μl) 
Amount of 
DNA (μg) 
Volume of 
DNA 
solution (μl) 
Volume of 
genecellin 
(μl) 
24 well 50000 500 0.5 100 2 
6 well 250000 2000 2 200 8 
100mm 2000000 10000 10 500 30 
  
2.9.7 Differentiation of 3T3-L1 cells 
Low passage number 3T3-L1 cells were plated at 60-70 % confluence in DMEM 
supplemented with 10 % NCS and 1 % Glutamax. The cells were then grown to full 
confluence, with the media changed every two days. Two days post confluence the media 
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was changed for DMEM supplemented with 10 % FBS, 1 % Glutamax, 1 μg/ml insulin, 5 
μM troglitazone, 0.25 μM dexamethasone, 0.5 mM IBMX. This was considered day 0. On 
day 3 media was changed to DMEM supplemented with 10 % FBS, 1 % Glutamax, 1 
μg/ml insulin, 5 μM troglitazone. On day 6 the media was changed to DMEM 
supplemented with 10 % FBS and 1 % Glutamax. Adipocytes were cultured in this media 
until use. The media was changed every two days. Experiments were carried out on day 
8-10. 
2.9.8 Insulin stimulation of HeLa cells and adipocytes 
Cells were washed two times before being serum starved for 2 hours in serum-free DMEM. 
Culture media was then changed to serum-free DMEM with or without 170 nM insulin for 
20 minutes at 37°C.  
2.10 Immunofluorescence  
Cells were seeded at the appropriate density onto sterilised 13 mm coverslips in 24 well 
plates. Coverslips were sterilised by first autoclaving, then by dipping twice in 70 % (v/v) 
ethanol before being air dried in a cell culture hood for 1 hour. Once the appropriate 
transfections or treatments had been carried out, cells were subject to indirect 
immunofluorescence. Cells were washed three times in PBS before being fixed in 3 % 
(w/v) paraformaldehyde (PFA) for 20 minutes. Cells were then washed three times in PBS 
+ 20mM Glycine to quench the PFA before being blocked for 30 minutes in staining 
solution (PBS + 20mM glycine, 2% (w/v) BSA) supplemented with 5 % (v/v) goat serum 
(Sigma). Where required staining solution also contained 0.1% saponin to permeabilise 
the cells. For subsequent staining and washing coverslips were removed from the wells 
and placed, cell side down, onto 40μl drops of the appropriate solution on clean nescofilm 
that had been fixed to the lab bench with water. Cells were incubated with primary 
antibody in staining solution for 45 minutes. The cells were then washed four times in 
staining solution before being incubated with the appropriate secondary antibody, diluted 
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in staining solution, for 30 minutes. Cells were then washed three times with PBS + 20 
mM glycine. Where required, coverslips were then incubated with 1μg/ml DAPI (4',6- 
diamidino-2-phenylindole) in PBS for 5 minutes to stain cell nuclei. Finally cells were 
dipped in PBS, air dried and mounted onto slides using ImmunoMount (GeneTex). Slides 
were stored in the dark at 4°C for a minimum of 24 hours before being imaged using a 
Zeiss LSM 880 with Airyscan confocal microscope. 
2.11 Generating mammalian cell lysates 
Cells were plated and treated as desired before being washed three times in ice-cold PBS. 
Cells were then scraped in 150 μl PBS containing EDTA free protease inhibitor cocktail 
(Roche) and 2X LSB. Cells were then homogenised by passing through a 26 ⅝ gauge 
needle 10-15 times. The lysates were boiled at 95°C for 5 minutes. Samples were then 
stored at -20°C before being analysed by SDS-PAGE (section 2.3.7).  
2.12 Quantification of HA-GLUT4-GFP translocation by flow 
cytometry 
Translocation of HA-GLUT4-GFP in HeLa cells was analysed by flow cytometry. Roughly 
150000 cells were seeded into a 6 well plate 48-72 hours before analysis. Where cells 
were transfected this was carried out using the standard protocol (section 2.7.6) 24 hours 
prior to analysis. Cells were serum starved for two hours prior to being treated with or 
without 170nM insulin for 20 minutes at 37°C. The plates were then placed on ice and all 
subsequent steps used ice cold solutions. Cells were washed three times with PBS before 
being fixed with 1% (w/v) electron microscopy grade, methanol free PFA for 20 minutes. 
Cells were again washed twice in PBS before non-specific epitopes were blocked with 2 % 
(w/v) BSA in PBS for 45 minutes. GLUT4 was then surface stained with 1:200 anti-HA 
primary antibody in PBS supplemented with 2 % (w/v) BSA for 45 minutes. Cells were 
washed again three times in PBS. Alexa Fluor 647 (ThermoFisher) coupled secondary 
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antibody was then applied in 2 % (w/v) BSA in PBS and incubated for 45 minutes. Cells 
were then washed 3 times in 2 % (w/v) BSA in PBS.  
When required, cells were then fixed again using 4 % electron microscopy grade, 
methanol free PFA for 20 minutes to fix anti-HA antibodies in place. Cells were washed 
three times and then permeabilised and blocked with PBS plus 0.1 % saponin in 2 % BSA 
for 45 minutes. The cells were then stained for Sx4(Myc) expression using an anti-Myc 
antibody in PBS plus 2 % BSA for 45 minutes. Cells were then washed three times in PBS 
plus 2 % BSA. Secondary anti-body was applied, diluted in PBS plus 2 % BSA, for 30 
minutes. Cells were then washed three times in PSB. 
The cells were then dissociated from the tissue culture dish using a cell lifter. Dissociated 
cells were collected and centrifuged at 600 g for 8 minutes at 4°C. The resulting pellet of 
cells was suspended in 350μl of 2 % (w/v) BSA in PBS. Samples were then analysed on a 
Beckman Coulter CyAn ADPs flow cytometer. Data was collected and analysed using 
Summit Software v4.3. 
2.13 Generating a CRISPR knockout cell line 
3T3-L1 and HA-GLUT4-GFP 3T3-L1 cells were plated in 10cm dishes. The cells were 
transfected with Sx4 CRISPR plasmid using GeneCellin as per manufacturers instructions 
(section 2.7.6). 24 hours after transfection cells were washed in pre-warmed serum free 
DMEM and dissociated from the cell culture dish using 4 ml of 0.05 % (w/v) Trypsin 
(Invitrogen) and incubated for 5 minutes at 37 °C. They were then collected, and pelleted 
by centrifugation at 800 rpm for 5 minutes. Cells were resuspended in 1 ml of PBS before 
being sorted based on the presence of RFP fluorescence using a Beckman Coulter MoFlo 
Astrios flow cytometer and Summit 6.2 software. RFP positive cells were serially diluted 
and plated in both 10 cm dishes and 6 well plates. The cells were cultured in DMEM 
supplemented with 10 % NCS and 1 % Glutamax until single colony units were formed. 
During this time the media was changed every 3 days. 
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Individual colonies were then selected, firstly the medium was removed and cells were 
carefully washed three times with prewarmed serum free DMEM. Colonies were isolated 
using autoclave sterilized wide ends of 1 mL pipette tips attached to the plate using 
autoclaved silicon grease. Selected colonies were then incubated with 100 μL trypsin for 
around one minute before being suspended by trituration with the trypsin. The selected 
colonies were then expanded and either frozen in aliquots (section 2.7.4) or lysed for 
immunoblot analysis (section 2.9). 
2.14 Surface plasmon resonance 
Surface plasmon resonance experiments were carried out on a Biacore T100 (GE 
Healthcare). All experiments used a Series S Sensor Chip CM5 (GE Healthcare). Proteins 
were expressed and purified as described previously (section 2.3.2). Sensor chips were 
docked and equilibrated to SPR running buffer (filter sterilised PBS + 5 % glycerol, 0.05 % 
(v/v) Tween-20) for at least 1.5 hours. All binding experiments were carried out at 25 °C at 
a flow rate of 10 μl/min.  
Ligands were immobilised using thiol coupling. This chip surface was activated by 
injecting en equal mix of EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) and NHS 
(N-hydroxysuccinimide) for 420 seconds at a flow rate of 30 μl/min. The ligand was then 
diluted to between 0.1 and 0.5 μM in 10 mM sodium acetate, pH 4.5 and flowed over the 
activated chip for between 120 and 480 seconds until roughly 900 units of ligand were 
immobilised. Running buffer was then run over the chip for 180 seconds to remove any 
unbound ligand. Finally, the remaining uncoupled active groups on the sensor chip were 
deactivating by injecting 1M ethanolamine hydrochloride pH8.5 for 420 seconds.  
All binding experiments were carried out at 25 °C at a flow rate of 10 μl/min, in running 
buffer. Sx4-GST analyte proteins were dialysed into SPR running buffer before being 
diluted to concentrations between 1.2 and 20 μM. Injections of each concentration were 
carried out in duplicate, moving from the lowest concentration to the highest and back 
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down to the lowest. The order of protein mutants injected was randomised. Sx4 proteins 
were injected for 180 seconds, 120 seconds later the chip surface was regenerated by 
injecting 1M ethanolamine hydrochloride pH8.5 for 30 seconds.  
The data obtained was analysed using the affinity analysis functions in BIAevaluation 
Software (GE Healthcare). 
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Chapter Three 
In vitro analyses of phospho-mimetic Sx4 
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3 In vitro analyses of phospho-mimetic Sx4 
3.1 Introduction 
3.1.1 Regulation of GSV fusion at the plasma membrane 
Insulin is an important regulator of whole body glucose homeostasis. In order to maintain 
blood glucose levels insulin binds to its receptor on adipocyte and muscle cells, resulting 
in a downstream signalling cascade (Leto and Saltiel, 2012). The result of this signalling 
cascade is the rapid translocation of GLUT4 containing vesicles to the plasma membrane, 
where they fuse with the PM, allowing glucose to enter the cells (Olson and Pessin, 1996). 
This specialised trafficking event, as with all membrane trafficking, is regulated by SNARE 
proteins. The SNARE complex that has been shown to be responsible for GSV fusion with 
the plasma membrane is comprised of Sx4, SNAP23 and VAMP2 (Kawanishi et al., 2000; 
St-Denis et al., 1999). A functional SNARE complex consisting of the three proteins has 
been shown to form, in vitro (Brandie et al., 2008; Kioumourtzoglou et al., 2014) and in 
3T3-L1 adipocytes and muscle cells (Randhawa et al., 2000; Rea et al., 1998). 
Numerous studies have been carried out that show the importance of Sx4/SNAP23 in 
insulin-stimulated GLUT4 translocation. Sx4 heterozygous knock-out mice show a 50% 
reduction in glucose uptake in insulin stimulated skeletal muscle (Yang et al., 2001). 
Similarly, siRNA depletion of both Sx4 and SNAP23 in adipocytes showed they were 
essential for GLUT4 translocation following insulin stimulation (Kawaguchi et al., 2010)  
Whilst there are a number of studies suggesting that VAMP2 is the v-SNARE responsible 
for fusion of GSVs with the plasma membrane, there is evidence to suggest some 
redundancy in the v-SNARE required. Early studies used competitive inhibition to show 
that introduction of the VAMP2 N-terminus (Martin et al., 1998) or cytosolic domain (Millar 
et al., 1999) inhibits insulin-stimulated GLUT4 translocation. However, it is important to 
note that while these studies saw a reduction in GLUT4 translocation, it was not 
completely blocked. Indeed other studies have found addition of tetanus neurotoxin, which 
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cleaves both VAMP 2 and 3, is not sufficient to block insulin-stimulated glucose uptake 
(Hajduch et al., 1997). A study by Zhao and colleagues showed that GLUT4 translocation 
is only blocked in adipocytes that lacked functional VAMP 2, 3 and 8 (Zhao et al., 2009). 
Proteomic analysis has revealed that VAMP 2, 3 and 8 are all present in GSVs 
(Jedrychowski et al., 2010). Furthermore, it has been suggested that all three of these v-
SNAREs are able to form a functional SNARE complex with Sx4/SNAP23 (Polgar et al., 
2002). Although these studies demonstrate that further investigation is needed to 
establish the role of VAMP proteins in insulin-stimulated GLUT4 translocation, this is 
discussed in more detail in section 1.5.5.3. For this study I have chosen to focus on 
VAMP2 as this is the best characterised and has been consistently shown to play a role in 
insulin stimulated GLUT4 translocation (Bryant and Gould, 2011). 
3.1.2 Phosphorylation as a regulator of SNARE proteins 
Phosphorylation is a vital regulator of cell signalling pathways, including the insulin 
signalling cascade. Upon insulin binding to the insulin receptor a signalling cascade is 
triggered, involving numerous phosphorylation steps, resulting in the fusion of GLUT4 
storage vesicles with the plasma membrane (Olson and Pessin, 1996). The interaction 
between the insulin-mediated signalling cascade and the trafficking machinery required for 
fusion at the plasma membrane could represent an important regulatory point in this 
pathway. 
A number of studies have shown that SNARE proteins can be phosphorylated, and that 
their phosphorylation state can affect their interactions with other SNARE proteins (Gerst, 
2003). Sx4 has been shown to be phosphorylated by cAMP-dependent protein kinase 
(PKA) (Foster et al., 1998). In vitro binding assays showed that PKA phosphorylated Sx4 
displays reduced binding to SNAP23, whereas its interactions with VAMP2 are not 
affected. Another study showed that syntaxin 1A and Sx4 can be phosphorylated by the 
serine/threonine kinase casein kinase II (CKII) in vitro (Risinger and Bennett, 1999). 
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Biochemical analysis carried out in this study showed a reduced interaction between Sx4 
and SNAP25 when Sx4 is phosphorylated. Similarly, it has been shown that, the 
predominantly ER localised, syntaxin17 can be phosphorylated in CHO and MIN6 cells 
(Muppirala et al., 2012). This phosphorylation results in reduced interaction with COPI 
vesicles, suggesting it plays a role in regulating trafficking through the early secretory 
pathway. 
Similar phosphorylation events have been observed in yeast. Research carried out by 
Marash and colleagues showed that dephosphorylation of the yeast t-SNARE Sso1 
increases its assembly in to complexes with the t-SNARE Sec9 both in vitro and in vivo 
(Marash and Gerst, 2001). The role of phosphorylation in regulating SNARE protein 
function is discussed in more detail in section 1.4.4. 
A study by Schmelzle and colleagues in 2006, used quantitative mass spectrometry to 
identify insulin-induced tyrosine phosphorylation sites in 3T3-L1 adipocytes. The study 
found 89 tyrosine phosphorylation sites that changed at least 1.3 fold following insulin 
stimulation, only 20 of these had previously been identified (Schmelzle et al., 2006). 
Amongst the newly identified phosphorylation sites it was found that two residues on Sx4, 
Y115 and Y251, both show a ≥ 3 fold increase in phosphorylation in response to insulin. 
The consequences of this phosphorylation are as yet unknown; however it may represent 
an important step in the communication between signalling and trafficking pathways of 
insulin action.  
3.2 Aims of this chapter 
Sx4 has been shown to be phosphorylated in response to insulin (Schmelzle et al., 2006). 
This may be an important regulatory step in the insulin-stimulated translocation of GLUT4; 
however the consequences of this phosphorylation are unknown. Here I have carried out 
in vitro complex assembly assays, limited proteolysis and pull down assays in order to 
systematically assess the effects of phospho-mimetic mutant forms of Sx4 on both their 
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binary and tertiary interactions with other SNARE proteins. I have further studied the 
binary interactions of Sx4 with SNAP23 and VAMP2 using the more quantitative technique 
of surface plasmon resonance (SPR). Finally, I have begun to investigate the different 
phosphoprotein isoforms of Sx4 using an in vitro phosphorylation assay and Phos-tag 
based mobility shift SDS-PAGE analysis.  
3.3 Results 
3.3.1 Expression and purification of recombinant SNARE proteins 
In order to study the effect of phosphorylation on SNARE protein interactions, I first 
expressed and purified recombinant tagged forms of the proteins of interest. Sx4 
phospho-mimetic mutant plasmids had been made previously by Dr Veronica Aran-Ponte 
(University of Glasgow). The constructs contained mutations in the tyrosine residues that 
have been shown to be phosphorylated in response to insulin. Tyrosine residues 115 and 
251 were mutated to glutamic acid, chosen due to its bulkiness and negative charge to 
mimic phosphorylation. The resulting mutant proteins have been subject to circular 
dichroism (CD) to analyse their secondary structure (Aran-Ponte, 2009). No significant 
change in the secondary structure was seen in the proteins containing the glutamic acid 
mutations.  
The cytosolic domain of Sx4 (residues 1-273) tagged at the C-terminus with GST (Sx4-
GST) was expressed and purified from E. coli (section 2.3.2). Figure 3.1 shows 
coomassie stained SDS-PAGE gels that were typical for Sx4 purifications (See appendix I 
for culture volume details). Wild type Sx4 (Figure 3.1 A) was purified along with phospho-
mimetic mutant forms of the protein; Y115E (B), Y251E (C) and Y115,251E (D). 
Recombinant proteins that make up the other components of the SNARE complex 
responsible for GLUT4 vesicle fusion at the PM were also purified from E. coli (2.3.2). 
Figure 3.2 shows coomassie stained gels from typical purifications of SNAP23 tagged at 
the N-terminus with His (His-SNAP23, A) and VAMP2 (residues 1-91) with a GST tag at 
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the N-terminus (GST-VAMP2, B). Purified GST only was used as a negative control 
protein and was provided by Dr Dimitrios Kioumourtzoglou (University of York). Following 
purification, protein concentration was estimated as described in section 2.3.6. 
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Figure 3.1: Expression and purification of Sx4. 
Sx4-GST was expressed and purified from BL21 (DE3) E. coli as described in section 
2.3.2. 10μl of samples taken during purification were run on 12% SDS-PAGE gels and 
coomassie stained. Shown are examples of typical purifications for Sx4-GST WT A, 
Y115E B, Y251E C and Y115,251E D. Samples corresponding to bacterial lysate (lysate), 
unbound proteins following glutathione Sepharose incubation (flow through), beads wash 
sample (wash), Sx4-GST bound to glutathione Sepharose (beads before), each of the 
three elutions and proteins that remained bound to beads following elution (beads after) 
were run. Elution samples represent 0.25% of total elution. See Appendix I, Table I for 
details of culture and elution volumes. 
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Figure 3.2: Expression and purification of Sx4 SNARE complex components.  
His-SNAP23 A and GST-VAMP2 B were purified from BL21 (DE3) E. coli as described in 
section 2.3.2. 10μl of samples taken during purification were run on an SDS-PAGE gel 
and coomassie stained, shown are examples of typical purifications. Samples 
corresponding to bacterial lysate (lysate), unbound proteins following incubation with 
beads (flow through), beads wash sample (wash), proteins immobilised to beads (beads 
before), each of the three elutions and proteins that remained bound to beads following 
elution (beads after) were run.  Elution samples represent 0.25% of total elution for His-
SNAP23 and GST-VAMP2. See Appendix I, Table I for details of culture and elution 
volumes.  
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3.3.2 In vitro SNARE complex assembly assay 
It has been previously shown that bacterially-produced, tagged versions of the cytosolic 
domains of Sx4 and VAMP2 can form an SDS-resistant complex with SNAP23 in vitro 
(Kioumourtzoglou et al., 2014). I utilised this in vitro assay to examine the consequences 
of Sx4 phosphorylation on ternary complex formation. Approximately equimolar amounts 
of Sx4-GST, His-SNAP23 and GST-VAMP2 were incubated for 15 minutes at 4°C before 
the amount of complex formed was assessed by SDS-PAGE, coomassie staining and 
immunoblot analysis (section 2.4). Figure 3.3A shows that an SDS-resistant complex is 
only formed when all of the components of the complex are present. Figure 3.3 shows that 
when phospho-mimetic mutant Sx4 proteins were used in the assay Sx4-Y115,251E 
showed a 28% increase in the of amount complex formed than the WT (p=0.035, pairwise 
t-test comparison). A one way analysis of variance statistical test was carried out to 
compare the mean amount of complex formed for each mutant, finding a P value of 0.18.  
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Figure 3.3: Sx4-Y115,251E forms more SNARE complex than Sx4-WT.  
Roughly equal amount of Sx4-GST, GST-VAMP2, His-SNAP23 were incubated for 15 
minutes at 4°C with rotation, the reaction was stopped by the addition of 2xLSB and boiled 
at 95°C for 5 minutes (methods section 2.4). The amount of SDS-resistant SNARE 
complex formed was analysed by SDS-PAGE. A Coomassie staining shows that the 
complex is only formed when all three components are present. B Representative anti-
Sx4 immunoblot and coomassie stained gel are shown from complex assembly assays 
using phosphomimetic syntaxin proteins. C The amount of complex formed in four 
independent experiments was analysed by densitometry from anti-Sx4 immunoblot using 
ImageJ software. Error bars show standard error of the mean. Statistical analysis between 
Sx4-WT and Sx4-Y115,251E was assessed using a t-test, *=p<0.05. 
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3.3.3 Limited proteolysis of Sx4 phospho-mimetic mutants 
Figure 3.3 shows that the Sx4-Y115,251E protein formed more complex in an in vitro 
assay than the WT or single phospho-mimetic mutant forms. Given that phosphomimetic 
mutants showed an increase in ternary complex formation the effects of tyrosine 
phosphorylation at residues 115 and 251 was further dissected. An important regulatory 
feature of syntaxins is their ability to adopt an ‘open’ or ‘closed’ conformation. In the 
‘closed’ conformation the Habc domain of the protein can interact with the SNARE domain, 
rendering the protein unable to form SNARE complexes, whilst the ‘open’ form renders 
the SNARE domain available to bind to other proteins (Aran et al., 2009; Dulubova et al., 
1999).  
The effect of phosphorylation on the conformation of Sx4 was therefore investigated using 
limited proteolysis. Previous studies have shown that mutating Sx4 residues L165 and 
E166, which are in the linker region, to alanine results in the protein maintaining an ‘open’ 
conformation that is more susceptible to proteolysis than the WT (Aran et al., 2009). 
Limited proteolysis experiments are based on the principle that the more unstructured, or 
in this case open, a protein is the more susceptible they are to cleavage by the protease 
(Hubbard, 1998).  
Initially, Sx4 WT or phosphomimetic mutants were incubated with chymotrypsin at room 
temperature for between 0-30 minutes before being analysed by SDS-PAGE (methods 
section 2.6). The amount of full length Sx4 remaining after incubation with chymotrypsin 
was analysed by densitometry using ImageJ software. This data was analysed for 
statistical significance using one-way ANOVA (Figure 3.4B) and t-test (Figure 3.4D). 
Figure 3.4A+B shows that Sx4-Y115E was cleaved faster than both Sx4-WT and Sx4-
Y251E after 1 minute (p = 0.025 and 0.032 respectively). After 5 minutes, both Sx4-Y115E 
and Sx4-Y251E were degraded faster than Sx4-WT (p = 0.038 and 0.022 respectively). 
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Similarly, figure 3.4C+D shows that Sx4-Y115,251E was cleaved faster than Sx4-WT after 
1 minute of incubation with chymotrypsin (p = 0.041). 
The rate of proteolysis of phosho-mimetic Sx4 mutants was then compared to that of the 
‘open’ Sx4 mutant. The cytosolic region of Sx4 (residues 1-273) tagged at the C-terminus 
with GST and including L165A, E166A mutations (Sx4-Open) was purified from E. coli (as 
described in section 2.3.2).  A limited proteolysis experiment was then carried out as 
before (section 2.6). Figure 3.5 shows that Sx4-Y115E and Sx4-Y115,251E were digested 
by chymotrypsin at a comparable rate to that of the open mutant. One way ANOVA 
statistical analysis was carried out. This found a statistically significant difference in the 
proportion of Sx4 remaining between Sx4-WT and Sx4-Y115,251E ( 63 % and 30 % 
respectively, p = 0.024) and between Sx4-Y251 (68 % remaining) and both Sx4-
Y115,251E and Sx4-Open (39 % remaining) (p = 0.010 and 0.044 respectively). This data 
suggests that phosphorylation of Sx4 may alter the conformation of the protein.  
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Figure 3.4: Phospho-mimetic Sx4 shows increased sensitivity to proteolysis when 
compared to WT.  
Equal amounts of Sx4 WT, Y115E, Y251E and Y115,251E were incubated with 
chymotrypsin at room temperature for various time points before the reaction was stopped 
by the addition of 2xLSB and samples boiled at 95°C for 5 minutes (section 2.6). Samples 
were analysed by SDS-PAGE and coomassie staining. A and C show representative gels. 
A negative control of Sx4 incubated at room temperature with no chymotrypsin is included 
in C. B and D show densitometry analysis of the amount of full length protein remaining 
when compared to the amount at 0. n=3, error bars show standard error of the mean. 
Statistical significance was calculated using one-way ANOVA with a post-hoc Tukey test 
(B) and t-test (D), * p < 0.05. 
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Figure 3.5: Sx4-Y115E and Sx4-Y115,251E  show comparable sensitivity to limited 
proteolysis to the Sx4 open mutant.  
Equal amounts of Sx4 WT, Y115E, Y251E, Y115,251E and Sx4-Open were incubated 
with chymotrypsin at room temperature for 0 and 1 minutes before the reaction was 
stopped by the addition of 2xLSB and samples boiled at 95°C for 5 minutes (section 2.6). 
Samples were analysed by SDS-PAGE and coomassie staining. A shows a 
representative coomassie stained gel. B Data was analysed using densitometry to 
calculate the amount of full length protein remaining compared to the protein at 0 minutes. 
n=3, error bars show standard error of the mean. Statistical significance was calculated 
using one-way ANOVA with a post-hoc Tukey test, * p < 0.05. 
  
98 
 
3.3.4 Investigating the binary interactions between Sx4 phospho-mimetic 
mutants and SNAP23/VAMP2 using in vitro pull down assays 
The data presented thus far suggests that Sx4 phosphorylation at tyrosine residues 115 
and/or 251 increases the propensity of Sx4 to form SDS-resistant complexes and has an 
effect on protein conformation. The consequences of Sx4-phosphorylation on the binary 
interactions between Sx4 and the other components of the SNARE complex, SNAP23 and 
VAMP2 were then investigated. 
First the interaction between Sx4 and SNAP23 was investigated using an in vitro pull 
down assay. Sx4-GST and His-SNAP23 were expressed and purified as described 
previously (Figure 3.1 and 3.2). Equimolar amounts of Sx4-GST WT, Y115E, Y251E, 
Y115,251E, Sx4-Open and GST only were immobilised to glutathione Sepharose beads 
and incubated with His-SNAP23 for 30 or 60 minutes (section 2.5). The beads were then 
extensively washed to remove any unbound protein before being analysed by SDS-PAGE. 
Figure 3.6A shows a representative immunoblot of the amount of SNAP23 pulled down by 
Sx4. Pull down assays were quantified by densitometry using ImageJ software. The 
amount of SNAP23 pulled down was calculated relative to the amount of Sx4 in that 
sample. Figures 3.6 B + C show the relative amount of SNAP23 bound to Sx4 plotted 
against time. The data show that Sx4-Y115,251E and Sx4-Open display a two fold 
increase in binding to SNAP23 after 60 minutes, compared to WT (figure 3.6C). Both 
single phospho-mimetic mutants showed around a 50% increase (Figure 3.6B). 
Undetectable amounts of SNAP23 were pulled down with the GST control protein, 
demonstrating that any observed interaction was not due to the presence of the GST tag. 
One way analysis of variance statistical analysis was carried out and p values were found 
to be 0.2 when comparing means at 30 minutes, and 0.5 after 60 minutes.  
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Figure 3.6: Phosphomimetic Sx4 mutants bind more SNAP23 than WT Sx4. 
Immobilised Sx4-GST was incubated with His-SNAP23 for up to 60 minutes at 4°C with 
rotation. Beads were collected and washed extensively before being subject to SDS-
PAGE and immunoblotting to analyse the amount of SNAP23 bound (section 2.5).  A 
Representative anti-His immunoblot and ponceau stained membrane. The amount of 
bound protein was quantified using densitometry and expressed as a proportion of Sx4 
(from the same sample). B Sx4-phosphomutants and the Open mutant showed an 
increase in SNAP23 binding compared to the WT protein, C A simplified graph 
demonstrating the difference between the Sx4-Y115,251E and Sx4-Open mutant and the 
WT protein. 
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Next the interaction between Sx4-phosphomutants and the v-SNARE VAMP2 was 
investigated.  For this assay VAMP2 that had been cleaved from the N terminal GST tag 
using thrombin was used (section 2.3.5), as the GST tag would interact with the 
glutathione Sepharose to which Sx4 is immobilised. Figure 3.7 shows an example of 
cleaved VAMP2 purification.  
                                
 
Figure 3.7: Purification of thrombin cleaved VAMP2 
N-terminally GST tagged VAMP2 was expressed in BL21 (DE3) E. coli before being 
immobilised to glutathione Sepharose beads (beads before sample). VAMP2 was then 
cleaved from the beads by incubating with 5 units of thrombin in 3 mls PBS (section 2.3.5). 
Elution sample corresponds to 0.3% of the total elution (See Appendix I for details of 
culture and elution volume). The beads after the elution were run (beads after) along with 
previously purified GST-VAMP2 (0.5% of total elution) for comparison. 
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A pull down assay using immobilised Sx4-GST and VAMP2 was then carried out, as 
described previously (section 2.5). A representative immunoblot of VAMP2 pull down by 
Sx4 is shown in figure 3.8A. The negative GST only control pulled down very little VAMP2. 
The amount of VAMP2 bound was again calculated relative to the amount of Sx4 in that 
sample by densitometry using ImageJ software. As with the previous SNAP23 pull down 
experiment (figure 3.6), Sx4-Y115,251E showed a 2 fold increase in VAMP2 bound when 
compared to WT. In contrast, the Sx4-Open mutant, although it showed a 50 % increase 
when compared to WT, pulled down less VAMP2 after 60 minutes than the Sx4-
Y115,251E mutant. Furthermore, the Sx4-Y251E phospho-mutant pulled down the most 
VAMP2, with a 2.5 fold increase over WT. One way analysis of variance statistical 
analysis was carried out to assess significance; P values were found to be 0.19 when 
comparing means at 30 minutes, and 0.24 after 60 minutes. 
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Figure 3.8: Phosphomimetic Sx4 mutants show increased binding to VAMP2 
compared to WT 
Immobilised Sx4-GST was incubated with VAMP2 for up to 60 minutes at 4°C with 
rotation. Beads were collected and washed extensively before being subject to SDS-
PAGE and immunoblotting to analyse the amount of VAMP2 bound (section 2.5).  A 
Representative anti-VAMP2 immunoblot and ponceau stain. The amount of bound protein 
was quantified using densitometry and expressed as a proportion of Sx4 (from the 
equivalent sample). B Quantification of Sx4 binding to VAMP2. Sx4 mutant proteins show 
increased binding to VAMP2 when compared to WT C A simplified graph demonstrating 
the difference between the Sx4-Y115,251E and Sx4-Open mutant and the WT protein. 
n=3, error bars show standard error of the mean. 
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3.3.5 Investigating the binary interactions between Sx4 phospho-mimetic 
mutants and SNAP23/VAMP2 using surface plasmon resonance (SPR) 
Data presented in figure 3.6 and 3.8 suggest that the phosphorylation state of Sx4 does 
affect its binary interactions with VAMP2 and SNAP23. These interactions were then 
examined using a more quantitative technique. Figures 3.6 and 3.8 demonstrate that Sx4 
phospho-mutants consistently pulled down more SNAP23 and VAMP2 than the WT 
protein however the numbers obtained from densitometry quantification showed some 
variability; hence the large error bars representing standard error of the mean and large p 
values when calculating statistical significance. The interactions between phospho-
mimetic Sx4 and SNAP23 or VAMP2 were therefore examined further using surface 
plasmon resonance (SPR). 
SPR measures protein interactions in a quantitative manner by detecting a change in 
mass near a surface by measuring changes in the refractive index. Experiments are 
carried out with one reactant (ligand) immobilised to the surface, another molecule 
(analyte) is passed over in solution and the binding is measured (Torreri et al., 2005).   A 
number of different sensor chips are available for SPR. For this study I used a CM5 chip. 
The CM5 sensor chip consists of a matrix of carboxymethylated dextran covalently linked 
to a thin gold layer. The ligand is immobilised by first activating the dextran matrix by 
flowing over an equal mix of EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) and 
NHS (N-hydroxysuccinimide). This creates reactive succinimide esters on the chip surface. 
The chip surface carries a negative charge at a pH >3.5, and so the ligand is then passed 
over the activated chip surface in a buffer with a pH higher than 3.5 but lower than the PI 
of the protein. This gives the protein a positive charge, whilst the chip carries a negative 
charge, the protein is therefore attracted to the chip surface allowing the activated dextran 
to spontaneously react with amine groups on the protein, covalently coupling the ligand to 
the chip surface (Figure 3.9A). Once any unlinked ligand has been washed away by buffer, 
the remaining uncoupled active groups on the chip surface are deactivated using 1M 
ethanolamine hydrochloride pH8.5.  
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Figure 3.9: Schematic of SPR ligand immobilisation and analyte binding 
A Schematic of ligand immobilisation. An activation reagent is passed over the chip 
surface; the ligand is then passed over the activated surface until a sufficient amount has 
bound. The remaining activated groups on the chip surface are then deactivated with a 
different reagent. The level of the base line after deactivation shows how many units of 
ligand have been immobilised. B Schematic of analyte/ligand binding. Analyte is flowed 
over the chip surface and association with the ligand is measured by a change in the 
refractive index, measured in response units (RU). The dissociation is then measured, 
seen by a reduction in RU. If the analyte doesn’t fully dissociate with buffer alone, a 
regeneration reagent is passed over to remove the bound analyte. Following the 
regeneration the baseline should return to its pre-binding level. 
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First, the binding of Sx4 mutants to immobilised VAMP2 was examined. Around 900 
response units of GST-VAMP2 were immobilised (section 2.14). Sx4-GST WT, Y115E, 
Y251E, Y115,251E, Open and GST alone were then flowed over the immobilised VAMP2 
at a flow rate of 10 μl/minute for 300 seconds (section 2.14). Figure 3.9B shows a 
schematic of a typical binding curve obtained using SPR. A control cell with no bound 
ligand was used and so binding sensorgrams produced show the response from the 
experimental cell minus any background detected in the control cell.  Figure 3.10 shows 
binding curve sensorgrams for Sx4 phospho-mutants binding to VAMP2. Sensorgrams 
show that Sx4 binding to VAMP2 increases with increasing Sx4 concentration. GST alone 
shows very little binding to VAMP2 even at high concentrations. Interestingly, Sx4-WT and 
Sx4-Open exhibited very similar binding to VAMP2 at each concentration; both in the 
shape of the binding curves and the point at which binding reached saturation. 
Contrastingly, the binding curves from Sx4-Y115E, Sx4-Y251E and Sx4-Y115,251E show 
a clear difference in binding compared with both WT and Open Sx4, particularly at higher 
concentrations. Sensograms show that unlike the WT and Open Sx4 measurements the 
Sx4 phospho-mutants did not reach saturation levels at concentrations up to 20 µM. Both 
the association and dissociation curves of Sx4 binding to VAMP2 appear to be biphasic. 
The gradient of the binding curves suggests that there might be two modes of binding that 
are detected. However it is important to note that this may be an experimental artefact 
(discussed in more detail in section 3.4).  
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Figure 3.10: Sx4-WT and phospho-mutants binding to VAMP2 by SPR 
Approximately 900 units of GST-VAMP2 was immobilised to a CM5 sensor chip via amine 
coupling. Sx4-GST was then flowed over the chip surface at 10 μl/minute (section 2.14). 
Sx4-WT, Sx4-Y115E, Sx4-Y251E, Sx4-Y115,251E, Sx4-Open or GST only at 2 (A), 6 (B), 
12 (C) or 20 (D) μM were injected for 300 seconds. All samples were injected in duplicate, 
shown are representative sensograms. For raw data see Appendix II.  
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SPR was then used to assess Sx4 binding to SNAP23. Figure 3.10 shows that as Sx4 is 
injected a sharp dip in the response units is seen, resulting in a spike below 0. This is 
likely due to slight differences between the protein buffer and the running buffer. Although 
both were in the same buffer (PBS, 5 % (v/v) Glycerol and 0.05 % (v/v) Tween-20), two 
separate batches of buffers were used and so some slight discrepancies are likely. Sx4 
proteins were therefore dialysed into fresh buffer, and this same buffer was used as 
running buffer in subsequent experiments.  
Approximately 900 units of His-SNAP23 was immobilised by amine coupling (section 
2.14). Again GST tagged Sx4-WT, Sx4-Y115E, Sx4-Y251E, Sx4-Y115,251E, Sx4-Open 
and GST only were flowed over the chip surface at 10 μl/minute for 300 seconds. All Sx4 
samples were injected in duplicate. Figure 3.11 shows representative binding 
sensorgrams. Again, GST showed very little binding to VAMP2. In contrast to data 
presented in figure 3.10, figure 3.11 shows that Sx4-Open binds to more SNAP23 than 
the other Sx4 proteins. In addition, the initial binding rates (shown by the gradient of the 
binding curve) of both Sx4-WT and Sx4-Open are faster than the Sx4 phospho-mutants. 
Moreover, the peak binding points for both Sx4-WT and Sx4-Open are higher than those 
of the Sx4 phospho-mutants (with the exception of 20 μM Sx4-Y115E). 
Figure 3.12 shows a summary of the peak binding points of Sx4 binding to both VAMP2 
(Figure 3.12A) and SNAP23 (Figure 3.12B) as obtained from SPR analysis. Figure 3.12A 
shows that the peak binding response to VAMP2 of Sx4 phospho-mimetic mutants was 
higher than both the WT and Open mutant. In contrast, figure 3.12B shows the peak 
SNAP23 binding response of Sx4-Open was greater than the other Sx4 mutants. Affinity 
analysis of Sx4 binding to both VAMP2 and SNAP23 was carried out using Biacore T200 
evaluation software. The resulting equilibrium dissociation constant (KD) values are 
summarised in appendix II table II.1.  
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Figure 3.11: Sx4-WT and phospho-mutants binding to SNAP23 by SPR 
Approximately 900 units of His-SNAP23 was immobilised to a CM5 sensor chip via amine 
coupling. Sx4-GST was then flowed over the chip surface at 10 μl/minute (section 2.14). 
Sx4-WT, Sx4-Y115E, Sx4-Y251E, Sx4-Y115,251E, Sx4-Open or GST only at 2 (A), 6 (B), 
12 (C) or 20 (D) μM were injected for 300 seconds. All samples were injected in duplicate, 
shown are representative sensograms. For raw data see Appendix II.  
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Figure 3.12: Summary of binding of Sx4 to SNAP23 and VAMP2 by SPR 
Approximately 900 units of GST-VAMP2 (A) or His-SNAP23 (B) were immobilised to a 
CM5 sensor chip via amine coupling. Sx4-GST was then flowed over the chip surface at 
10 μl/minute (section 2.14). Sx4-WT, Sx4-Y115E, Sx4-Y251E, Sx4-Y115,251E, Sx4-Open 
or GST only at 1.2, 2, 6, 12 or 20 μM were injected for 300 seconds. All samples were 
injected in duplicate. Shown are plots of the mean peak binding response for each Sx4 
mutant. 
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3.3.6 Analysing the phosphoprotein isoforms of CIRK phosphorylated Sx4 
The data presented in this chapter thus far suggests that the phosphorylation state of Sx4 
affects both its ability to form a SNARE complex with SNAP23 and VAMP2 and the binary 
interactions between the proteins. Moreover, limited proteolysis experiments suggests that 
phosphorylation effects the conformation of Sx4, resulting in the protein being in a more 
open conformation. In the majority of the experiments carried out in this chapter, the 
double phosphomimetic Sx4 mutant has shown the biggest change when compared to the 
WT protein. However, whilst mass spectrometry analysis has identified both Y115 and 
Y251 are phosphorylated in response to insulin (Schmelzle et al., 2006), the analysis was 
carried out on fragmented proteins and so it is not yet known whether one molecule of 
Sx4 can be phosphorylated on both residues simultaneously. In order to investigate this 
Phos-tag based SDS-PAGE analysis to detect mobility shifts of in vitro phosphorylated 
Sx4 was utilised. 
In 2003, Koike and colleagues at Hiroshima University reported their finding of a selective 
phosphate-binding tag molecule, Phos-tag (1,3-bis[bis(pyridin-2-ylmethyl)amino]propan-2-
olato dizinc(II) complex) (Takeda et al., 2003). It has since been shown that a 
polyacrylamide bound Mn2+-Phos-tag can be used to separate phosphoprotein isoforms 
by simple SDS-PAGE (Kinoshita et al., 2006). Figure 3.13 shows the structure of 
polyacrylamide bound Mn2+-Phos-tag and how this interacts with phosphate groups.  
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Figure 3.13 Structure of acylamide-pendant Phos-tag ligand 
Phosphate groups on proteins form stable complex interactions with Mn2+-Phos-tag in the 
polyacrylamide gel. 
 
 
In order to assess the phosphorylation state of Sx4 in vitro phosphorylation assay was first 
carried out using cytosolic insulin receptor kinase. Whilst investigating phosphatases 
involved in insulin signalling, Kuhné and colleagues produced a recombinant cytosolic 
insulin receptor kinase (CIRK), consisting of residues 941-1343 of the β subunit of the 
insulin receptor, and containing the intrinsic tyrosine kinase domain (Kuhné et al., 1994). 
CIRK was purified from the insect cell line Sf9 using baculovirus infection, following a 
protocol developed by Villalba and colleagues (Villalba et al., 1989), and was kindly gifted 
to the lab by Prof Gustav E. Lienhard (Dartmouth University, USA). Previous work in the 
laboratory by Dr Veronica Aran-Ponte has shown that Sx4 is phosphorylated by CIRK in 
vitro (Aran-Ponte, 2009). 
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In order to be active CIRK needs to first be autophosphorylated, this had been previously 
carried out by Dr Veronica Aran-Ponte (University of Glasgow) (Aran et al., 2011).  
Activated CIRK was then incubated with WT Sx4-GST at 30 °C for 150 minutes, and Sx4 
phosphorylation analysed by SDS-PAGE and immunoblot using an anti-phosphotyrosine 
(PY20); the assay was carried out in duplicate (section 2.7). Sx4 only, CIRK only and 
Sx4/CIRK –ATP negative controls we included to be sure any phosphorylated bands seen 
are Sx4.  Firgure 3.14A shows that Sx4-GST is phosphorylated by CIRK in vitro. The no 
ATP control shows low background levels of Sx4 phosphorylation, seen in the upper band 
in the PY20 blot. This phosphorylation is increased by the inclusion of ATP in the reaction. 
The samples from the kinase assay were then run on a Mn2+-Phos-tag SDS-PAGE gel 
(50μM Phos-tag, 100μM MnCl2) (Figure 3.14B). Proteins on Phos-tag gels do not run at 
their expected molecular weights. Figure 3.14B shows that the CIRK kinase does not run 
at the same rate as Sx4, as demonstrated by the lack of PY20 signal in the CIRK only 
samples. The α-PY20 blot in figure 3.14B shows multiple phosphorylated Sx4-GST bands, 
suggesting the protein is phosphorylated at numerous residues as expected. 
In order to further dissect the phosphoprotein isoforms of Sx4 phospho-resistant mutant 
forms of the protein were used to analyse the migratory patterns of these proteins once 
they are phosphorylated. Typically, phospho-resistant mutants are made by mutating the 
phosphorylated tyrosine residues to phenylalanine. However, for this purpose I have used 
the existing phospho-mimetic Y to E mutant proteins. These phospho-mutants will be 
unable to be phosphorylated on the mutated residue. As the function of the protein is not 
crucial for this experiment the effects of the phospho-mimetic mutations should not affect 
any conclusions relating to which residues are phosphorylated. The migratory pattern of 
Sx4 phospho-mutants was first examined to ensure they are comparable to WT, and that 
the negative charge of the glutamic acid does not affect migration of the protein through 
the gel. Samples of Sx4-WT, Sx4-Y115E, Sx4-Y251E and Sx4-Y115,251E were run on a 
10 % SDS-PAGE, and 10 % SDS-PAGE 50 μM Phos-tag gel, before being stained with 
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coomassie. Figure 3.15 shows very little difference in the migration of the Sx4 
phosphomimetic mutants on a standard SDS-PAGE gel (top panel). This difference in 
migration is no more pronounced on the Phos-tag gel (bottom panel). 
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Figure 3.14: Sx4-GST is phosphorylated by CIRK in vitro 
Sx4 was incubated with activated CIRK with or without 100 μM ATP at 30°C for 150 
minutes (methods section 2.7). A Samples were run on a 10% SDS-PAGE gel and blotted 
for Sx4 (top panel) or phospho-tyrosine (PY20, bottom panel). Autophosphorylated CIRK 
is detected just below the 50 kDa marker, whereas phosphorylated Sx4 can be seen just 
above the 50 kDa protein marker. B The same samples were ran on a Phos-tag gel (100 
μM Phos-tag) and blotted for Sx4 (top panel) or phosphotyosine (PY20, bottom panel). 
Autophosphorylated CIRK is not detected on the Phos-tag gel. Multiple phosphorylated 
Sx4 bands can be seen. Assays were run in duplicate. 
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Figure 3.15: Migration of Sx4-GST phospho-mimetic mutants is comparable to WT 
on Phos-tag SDS-PAGE gel 
Sx4 WT and phosphomimetic mutants were run on a 10% SDS-PAGE gel (top panel) and 
a Phos-tag gel (50 μM Phos-tag). Proteins were visualised by coomassie staining. Both 
gels show little difference in the migration of all Sx4 proteins.  
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Given that the migration of Sx4 phospho-mutants were comparable to Sx4-WT a CIRK 
phosphorylation assay was carried using Sx4 WT, Y115E, Y251E and Y115,251E. The 
proteins were incubated with or without CIRK for 150 minutes at 30 °C, along with a CIRK 
only control (section 2.7). The samples were then analysed by SDS-PAGE. Figure 3.16A 
shows that Sx4-WT, Y115E and Y251E are phosphorylated by CIRK, whereas the Sx4-
Y115,251E phospho-mutant is not phosphorylated (anti-PY20 blot). This is as expected as 
both of the known phosphorylated tyrosine residues in Sx4-Y115,251E have been 
mutated. The amount of phosphorylation of the single phospho-mutants is less than the 
WT protein. Again this is as expected as one of the phosphorylated residues has been 
mutated. 
The samples were then analysed by 50 μM Phos-tag SDS-PAGE. Figure 3.16B shows 
several different mobility shift patterns of phosphorylated Sx4. In samples of Sx4-Y115E 
incubated with CIRK a phosphotyrosine positive band (corresponding to phosphorylated 
Y251) that runs lower through the gel that the phosphotyrosine band seen in the Sx4-
Y251E sample (corresponding to phosphorylated Y115) is detected. The Sx4-WT sample 
has both of these bands present, as expected. In addition a higher phospho-tyrosine 
positive band can be seen in the WT sample that is not present in any of the mutant 
protein samples. This band is likely to correspond to Sx4 that has been phosphorylated on 
both Y115 and Y251.  
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Figure 3.16: In vitro phosphorylated Sx4 is phosphorylated at more than one 
residue 
Sx4-GST WT, Y115E, Y215E and Y115,251E were phosphorylated in vitro by incubating 
with activated CIRK for 150 minutes at 30 °C (section 2.7). A Samples of phosphorylated 
Sx4 were run on 10 % SDS-PAGE gels and analysed by immunoblotting (section 2.3.10). 
Anti-Sx4 blot (top panel) shows that Sx4 was present in all samples. Anti-PY20 blot 
(bottom panel) shows that Sx4-WT, Y115E and Y251E were phosphorylated by CIRK, 
whereas the Sx4-Y115,251E mutant was not phosphorylated. Autophosphorylated CIRK 
can be detected in all samples were it was present (bottom band). B Samples of 
phosphorylated Sx4 were run on 10 % Phos-tag SDS-PAGE gels (section 2.8). Top panel 
shows that the Sx4 mutants run at roughly the same rate, with the Y251E and Y115,251E 
mutant showing a slight shift in mobility. Bottom panel shows that multiple phosphorylated 
forms of Sx4 are present in the WT sample. Shown are representative immunoblots from 
three separate experiments.  
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3.4 Discussion 
Translocation of GLUT4 is a regulated membrane trafficking event. As with all 
membrane trafficking events it is regulated by SNARE proteins. The SNARE complex 
that has been implicated in regulating GLUT4 translocation at the PM consists of Sx4, 
SNAP23 and VAMP2 (Bryant and Gould, 2011). Sx4 is phosphorylated in response to 
insulin in 3T3-L1 adipocytes (Schmelzle et al., 2006), however the consequences of 
this phosphorylation are unknown. This chapter aimed to elucidate the effects of 
phosphorylation of Sx4 at Y115 and Y251 on its interactions with SNAP23 and VAMP2 
in vitro.  
First, a complex assembly assay was carried. I showed that Sx4-Y115,251E had an 
increased ability to form SNARE complexes when compared to Sx4-WT (figure 3.3). 
However, although SNARE complex assembly consistently increased in assays using 
the Y115,251E mutant assessing the statistical significance of this increase was 
challenging. Variability in the intensity of immunoblot images between experiments 
meant that densitometry quantification resulted in a large standard deviation. A 
comparison between the amount of complex formed by Sx4-WT and Sx4-Y115,251E  
using a t-test showed that the difference was significant. In order to make more direct 
measurements of the effect of the phospho-mimetic mutants on SNARE complex 
assembly, SPR could be used. SPR has been previously used to examine SNARE 
complex assembly (Rea et al., 1998), and would negate the need to carry out 
immunoblots and therefore result in more quantitative results. 
I then showed using limited proteolysis, that phosphorylation of Sx4 may affect protein 
conformation (figure 3.5). The ability to adopt an ‘open’ or ‘closed’ conformation is an 
important regulatory feature of syntaxins (Dulubova et al., 1999; MacDonald et al., 
2010). Phosphorylation of the yeast syntaxin Sso1 is known to regulate its ability to 
form SNARE complexes (Marash and Gerst, 2001) and it has been suggested this 
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occurs by altering the conformation of the protein (Marash and Gerst, 2003). Data 
presented in figure 3.5 suggests that phosphorylation of Sx4 at Y115 and Y251 may 
stabilise the open form of the protein, leading to an increased ability of the protein to 
form SNARE complexes (figure 3.3).  
I next sought to investigate the effect of Sx4 phosphorylation on its binary interactions 
with SNAP23 and VAMP2. Initially, this was investigated using pull down assays 
(figure 3.6 and 3.8). Pull down assays suggested that Sx4 phospho-mutants bound to 
more SNAP23 and VAMP2 that Sx4-WT. Again this data was hard to quantify 
accurately and so these interactions were further investigated using SPR. Figures 3.10 
and 3.11 show that Sx4-WT, Open and phosphomutants bound to both SNAP23 and 
VAMP2 with differing affinities. Interestingly the off rates of Sx4-WT and –Open are 
faster than for the phosphomutants (shown by the gradient of the curve following 
binding). A slower off rate suggests that the complex formed between Sx4-
phosphomutants and SNAP23/VAMP2 is more stable than with WT or Open. 
Moreover, Sx4-phosphomutant binding to VAMP2 exceeds both the WT and Open 
mutant (figure 3.10 and 3.12) whereas both Sx4-WT and Open exhibit more binding to 
SNAP23 than the phospho-mutants (figure 3.11 and 3.12). It is important to note 
however that these binding curves have not yet reached equilibrium, therefore more 
thorough characterisation of the interactions between VAMP2/SNAP23 and the 
syntaxin mutants could be carried out. Immobilising less ligand to the sensor chip and 
increasing the flow rate would improve the chance of the reaction reaching equilibrium.   
SPR experiments also suggested there may be more than one binding mode or site 
between VAMP2 and Sx4. The binding curves for Sx4 phospho-mutants were biphasic 
(Figure 3.10). Whilst this may indicate there may be more than one binding mode 
between Sx4 and VAMP2, it would be important to confirm this with further 
experiments. There can be several reasons for biphasic binding curves including: 
conformational change; sample heterogeneity; steric hindrance or non-specific binding 
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events (Hulme and Trevethick, 2010). The nature of the immobilisation used here 
means there could be two populations of VAMP2 on the chip surface. Amine coupling 
results in random immobilisation of the ligand in potentially different orientations, and 
so the availability of the binding domain for the analyte may vary. Previous studies 
have shown that the SNARE domain of VAMP2 is essential for interaction with Sx4 
(Kioumourtzoglou, 2012). It may therefore be that the SNARE domain is less 
accessible in a proportion of the VAMP2 immobilised on the chip surface. In order to 
establish whether this is the case, a different method of ligand immobilisation could be 
used. Amine coupling was chosen due to the high efficiency of the method, however it 
would be possible to immobilise the VAMP2 via the GST tag at the C-terminus using 
an antibody capture method, resulting in a uniform orientation of the ligand. 
Finally, the phospho-isoforms of in vitro phosphorylated Sx4 were investigated. A 
Phos-tag based mobility shift assays suggests, for the first time, that both Sx4 Y115 
and Y251 can be phosphorylated on a single molecule of Sx4 (figure 3.16). This is 
important as data presented in this chapter suggests the Sx4-Y115,251E phosho-
mutant has the biggest impact on the interactions of Sx4 in vitro. In order to confirm 
that both these residues are phosphorylated, whole protein electrospray-based mass 
spectrometry could be used (Compton et al., 2011). Using in vitro phosphorylated Sx4 
it would be possible to show either a mass shift corresponding to one or two 
phosphate groups present on a single molecule of Sx4.  
In summary, data presented in this chapter suggests that phosphorylation of Sx4 at 
Y115 and Y251 affects SNARE protein interactions. I have shown that Sx4-Y115,251E 
increases SNARE complex assembly in an in vitro assay, and that this may be due to 
a conformational change in the protein. In addition, analysis of the binary interactions 
of the protein suggests that phosphorylation may differentially effect the interactions of 
Sx4 with SNAP23 and VAMP2. Finally, I have provided evidence that one molecule of 
Sx4 can be phosphorylated on both Y115 and 251. Further characterisation of the 
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interactions of Sx4 mutants and SNAP23 and VAMP2 could be carried out to attempt 
to elucidate the mechanisms by which phosphorylation of the protein increases 
SNARE complex assembly. In addition, the effect of Sx4 phosphorylation on GLUT4 
translocation should be determined; I will address this in the next chapter.  
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Chapter Four 
Analyses of the effects of phospho-mimetic Sx4 
on GLUT4 translocation 
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4 Analyses of the effects of phospho-mimetic Sx4 on GLUT4 
translocation 
4.1 Introduction 
4.1.1 Regulation of GLUT4 translocation 
Insulin stimulation results in a 10-20 fold increase in cell surface GLUT4 in adipocytes and 
muscle cells (Bryant and Gould, 2011). This increase is predominantly due to an 
upregulation of the rate of exocytosis from GSVs (Yang et al., 1992). The current model 
for GLUT4 trafficking is that the protein is trafficked through multiple intracellular 
compartments, including endosomes, the trans-Golgi network and GSVs (Larance et al., 
2008) (section 1.5.4). Although this pathway has been heavily studied, dissecting and 
identifying the points at which GLUT4 translocation is actively regulated has proved 
challenging. 
One important development in identifying regulators of GSV fusion at the plasma 
membrane has been in the characterisation of the protein AS160. The protein contains 
GTPase activating domains for Rab proteins (Sano et al., 2003). AS160 is phosphorylated 
by Akt in response to insulin and mutation of the phosphorylated sites to alanine results in 
impaired insulin-stimulated GLUT4 translocation (Sano et al., 2003). Thus a model has 
been proposed whereby phosphorylation of AS160 inactivates its Rab GAP function and 
that this event is necessary for GLUT4 translocation (Larance et al., 2005; Sano et al., 
2003).  
Improvements in microscopy techniques have also gone some way to aid in the dissection 
of events leading to GSV fusion at the plasma membrane. Total internal reflection 
microscopy (TIRF) allows examination of fluorescent events that occur within 150 nM of 
the plasma membrane (Axelrod et al., 1983). High resolution TIRF microscopy has been 
used in studies investigating the frequency of fusion of GFP-GLUT4 vesicles at the 
plasma membrane in 3T3-L1 adipocytes (Bai et al., 2007; Huang et al., 2007). These 
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studies demonstrated that insulin-treated cells display an increased rate of fusion 
frequency when compared to basal, and that the docking/tethering time of GSVs is 
reduced upon insulin stimulation. In addition, the study by Bai and colleagues showed that 
inhibition of AS160 decreases docking frequency of GSVs at the plasma membrane, 
under both basal and insulin stimulated conditions (Bai et al., 2007). This suggests that 
AS160 plays a role in GSV docking at the plasma membrane rather than in fusion of 
vesicles at this step. 
The development of cell free fusion assays has also been an important step in elucidating 
the mechanisms regulating GSV docking and fusion. Koumanov and colleagues carried 
out an important study that investigated GSV fusion at the plasma membrane in 2005. 
They developed a cell free assay which they used to show that GSV fusion with the 
plasma membrane is not constitutively active but is stimulated by insulin (Koumanov et al., 
2005). GSVs and plasma membrane, in the form of plasma membrane liposomes, were 
isolated from rat adipose cells in either the basal or insulin stimulated state. A 
fluorescence resonance energy transfer (FRET) based content mixing fusion assay was 
then carried out. The study found that insulin stimulation increases fusion by 8 fold. 
Moreover they concluded that the insulin-regulated fraction is the plasma membrane, as 
insulin stimulated cytosol or GSVs are not sufficient to drive fusion with basal plasma 
membrane liposomes. 
Taken together, the research to date shows that GSV fusion at the plasma membrane is 
an activated rather than constitutive trafficking event (Bryant and Gould, 2011; Larance et 
al., 2008). What is known about the regulation of GSV tethering/docking/fusion at the 
plasma membrane thus far is discussed in more detail in section 1.5.6.  
4.1.2 Cell systems used to study GLUT4 translocation 
Much of the work into elucidating GLUT4 trafficking mechanisms has been carried out in 
mouse 3T3-L1 adipocytes. However, transiently expressing transfected proteins in 
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differentiated 3T3-L1 adipocytes is very challenging as most commercial transfection 
protocols require sub-confluent cells and the expression of the protein declines with time. 
3T3-L1 cells must be confluent to differentiate to adipocytes; moreover differentiation 
takes up to two weeks and so expression levels of any DNA transfected prior to 
differentiation would likely no longer be detectable.   
Therefore, in order to manipulate the trafficking machinery required for GLUT4 
translocation, a readily transfectable and insulin responsive, cell line must be used. Both 
HeLa (Hernandez et al., 2001) and CHO (Wei et al., 1998) cells have been shown to be 
insulin responsive. For this study HeLa cells have been used. Insulin stimulation of HeLa 
cells has been shown to result in the translocation of GLUT4 to the PM (Haga et al., 2011), 
and is known to induce PI3K signalling (Dubois et al., 2009). These results suggest that 
HeLa cells possess the basic machinery required for GLUT4 trafficking. Indeed, HeLa 
cells express the insulin-like growth factor-I receptor (IGFR), which binds to insulin with a 
low affinity (Dubois et al., 2009; Entingh-Pearsall and Kahn, 2004). It is likely that insulin 
works through this cell surface receptor to elicit a response in HeLa cells.  
HeLa cells however, do not express GLUT4 (Rodríguez-Enríquez et al., 2009). Therefore 
a HA-GLUT4-GFP reporter construct was used in this study, allowing for quantitative 
analysis of GLUT4 translocation. The construct contains a HA tag in the first exofacial 
loop and a GFP tag at the C-terminus. This construct is widely used in the field and been 
characterised in numerous studies. Importantly, the protein has been shown to be 
trafficked in a manner that is indistinguishable from endogenous GLUT4 (Lampson et al., 
2000; Martin et al., 2006). 
4.2 Aims of this chapter 
The data presented in the previous chapter suggest that tyrosine phosphorylation of Sx4, 
at residues 115 and 251, effects its interactions with the SNARE proteins SNAP23 and 
VAMP2 in vitro. The translocation of GLUT4 is a regulated membrane trafficking event 
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facilitated at the plasma membrane by a SNARE complex consisting of Sx4, SNAP23 and 
VAMP2. This chapter aims to examine the impact of Sx4 phosphorylation on GLUT4 
translocation to the plasma membrane. In order to do this I have utilised a HeLa cell line 
expressing GLUT4 that harbours an HA tag in the first exofacial loop and a C-terminal 
GFP tag. I have used a combination of confocal microscopy and flow cytometry to assess 
the effect on GLUT4 translocation of overexpressing phosphomimetic mutant Sx4 proteins 
on GLUT4 translocation in the presence of the endogenous protein. Ultimately it will be 
important to extend these studies into adipocytes and/or muscle cells and so have 
concomitantly used CRISPR-Cas9 technology to create Sx4 knockout cell lines in 3T3-L1 
fibroblasts, with the view of differentiating these into 3T3-L1 adipocytes lacking 
endogenous Sx4. Using a combination of approaches to study the effects of 
phosphorylation of Sx4 on GLUT4 translocation, in the presence or absence of 
endogenous Sx4, will allow for a more complete picture of the mechanisms that regulate 
the process to emerge. 
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4.3 Results 
4.3.1 Characterising a Myc tagged Sx4 construct 
In order to assess the impact of Sx4 phosphorylation at Y115 and Y251, full length 
phosphomimetic Sx4 constructs were created, as opposed to the truncated versions 
lacking the trans-membrane domain used in the previous chapter. It was important to 
introduce an epitope tag to the constructs in order to distinguish them from endogenous 
Sx4 expressed in the HeLa cells. An internal Myc tag was introduced to the protein, 
between the N-terminus and the Habc domain (Figure 4.1A). The tag was introduced here 
so as to confer as little disruption to the function of the protein as possible, as both the N 
and C terminals of the protein are important to its function (D’Andrea-Merrins et al., 2007; 
Latham et al., 2006). For example, analysis of the interactions of Sx4 proteins containing 
point mutations or truncations have shown that both the N- and C-terminus are required 
for Munc18c binding (D’Andrea-Merrins et al., 2007; Latham et al., 2006).  
Full length Sx4(Myc) WT,  Y115E, Y251E and Y115,251E constructs were generated 
using the custom gene synthesis service from GenScript (NJ, USA). Before the constructs 
were expressed in cells I carried out some in vitro characterisation to determine whether 
the Myc tag has any discernable effect on the protein’s behaviour. In order to do this a 
version of Sx4(Myc) lacking the transmembrane domain and tagged at the C-terminus 
with GST was created. Primers were designed (table 2.5) and the cytosolic portion of Sx4 
from the Sx4(Myc) plasmid was amplified by PCR (section 2.2.4), before being cloned into 
the pETDuet vector, used for the bacterially expressed Sx4 proteins discussed in chapter 
3 (section 2.2.5 and 2.2.6). Cytosolic Sx4(Myc) (residues 1-273), with a C-terminal GST 
tag was then expressed and purified from E. coli as described in section 2.3.2. In order to 
test the function of Sx4(Myc) an in vitro binding assay was set up with the SM protein 
Munc18c. Sx4-GST has been shown to bind to Munc18c in vitro (Aran et al., 2009). 
Sx4(Myc)-GST, Sx4-GST and GST were immobilised to glutathione Sepharose beads and 
incubated with Munc18c-WT and a phospho-mimetic mutant Munc18c-Y521E tagged at 
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the N-terminus with His (For purification details see section 5.3.1). Following incubation 
for 60 minutes at 4 °C, beads were collected and washed extensively (section 2.5). 
Samples were then subject to SDS-PAGE and immunoblot analysis. Figure 4.1B shows a 
representative immunoblot and Coomassie stained gel showing protein input. Both Sx4-
WT and Sx4(Myc) bind to Munc18c WT and Y521E. Sx4(Myc)-GST exhibited more 
binding to Munc18c than Sx4-GST alone. This gave me confidence to proceed with the 
Myc-tagged constructs as it indicates that the gross structure of the protein is not 
detrimentally affected by the presence of the tag. 
The expression of full length Sx4(Myc) was next examined. HeLa cells were transfected 
with Sx4(Myc)-WT, Y115E, Y251E and Y115,251E, as described in section 2.9.6. The 
protein was then detected by either immunofluorescence (section 2.10)(figure 4.2A) or 
immunoblotting (section 2.11)(figure 4.2B). Figure 4.2B shows all Sx4(Myc) constructs are 
expressed in HeLa cells and can be detected by immunoblot using an anti Myc antibody. 
Two bands can be detected in cells expressing Sx4(Myc), this may be due to protein 
truncations. The ratio of the two bands is the same for each of the mutants and so this 
should not affect any future experiments comparing the effects of expressing the mutants. 
Figure 4.2A shows Sx4(Myc) is also detected by immunofluorescence.  
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Figure 4.1 Sx4(Myc) characterisation 
A Domain structure of Sx4, showing the location of the Myc tag. Sx4 comprises of an N-
terminal domain, a Habc domain, SNARE domain and transmembrane domain (TMD). A 
Myc tag has been placed between the N-terminus and the Habc domain, a site that has 
been predicted to have minimal impact on the structure and function of the protein. B Pull 
down assay showing comparison of Sx4(ΔTMD)-GST and Sx4(Myc)(ΔTMD)-GST binding 
to Munc18c. Sx4-GST, Sx4(Myc)-GST and GST were immobilised to glutathione 
Sepharose beads before being incubated with His-Munc18c-WT or His-Munc18c-Y521E 
for 60 minutes at 4 °C. The beads were then collected and washed before being analysed 
by SDS-PAGE and immunoblot (section 2.5). Representative immunoblot and coomassie 
stained gels from three experiments are shown.  
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Figure 4.2: Expression of Sx4(Myc) in HeLa cells 
A HeLa cells were plated onto glass cover slips in a 24 well plate before being transfected 
with 0.5 μg Sx4(Myc) (section 2.9.6). Cells were fixed, permiabilised and stained for 
Sx4(Myc) using an anti-Myc antibody (section 2.10) (Green). Cell nuclei were stained with 
DAPI (Blue). B HeLa cells were plated in 6 well plates before being transfected with 2 μg 
of Sx4(Myc) (section 2.9.6). Cells were then lysed into PBS plus sample buffer and 
lysates analysed by SDS-PAGE and immunoblotting (section 2.11). Upper gel shows 
Sx4(Myc) as detected by an anti-Myc antibody. BiP was used as a loading control. 
Untransfected cells were used as a negative control. 
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4.3.2 The effect of Sx4(Myc) phospho-mimetic mutants on GLUT4 
translocation in HeLa cells 
In order to examine the effects of Sx4 phosphorylation on GLUT4 translocation, a HeLa 
cell line expressing HA-GLUT4-GFP was used. The GLUT4 expressed in these cells 
contains a HA tag in the first exofacial loop of the protein, and a GFP tag at the C 
terminus (Dawson et al., 2001). This allows the translocation of GLUT4 to be examined, 
with the GFP signal equating to total GLUT4 levels and surface stained HA detecting the 
GLUT4 that has been inserted into the plasma membrane (Dawson et al., 2001). This 
construct has been previously characterised and has been shown to exhibit insulin 
stimulated translocation in a manner indistinguishable from endogenous GLUT4 
(Lampson et al., 2000; Martin et al., 2006). Figure 4.3 shows confocal microscopy images 
of HA-GLUT4-GFP HeLas that have been treated with or without (basal) insulin, prior to 
surface staining with an anti-HA antibody in the absence of cell permeabilisation (section 
2.9.8 and 2.10). An increase in the surface staining of HA-GLUT4-GFP was seen in 
insulin-stimulated cells (bottom panel). In addition, the localisation of GLUT4 (GFP) 
changed upon insulin stimulation. Under basal conditions (top panel) the GFP signal was 
in intracellular puncta, whereas upon insulin stimulation (bottom panel) the GFP signal 
was largely redistributed to the cell periphery. 
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Figure 4.3: Insulin stimulates GLUT4 translocation in HeLa cells 
HA-GLUT4-GFP HeLa cells were plated onto glass coverslips before either being treated 
with 170nM insulin for 20 minutes (insulin) or not (basal) (section 2.9.8). GLUT4 at the cell 
surface was then detected by surface staining for HA (purple) (section 2.10). Total GLUT4 
is visualised using GFP (green). Upon insulin stimulation a change in cellular location and 
an increase in cell surface signal of GLUT4 can be seen. Scale bar = 20 μm 
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Figure 4.3 shows that HA-GLUT4-GFP is translocated to the cell surface upon insulin 
stimulation in HeLa cells. This HeLa cell line was therefore utilised in order to examine the 
effect of over expression of Myc tagged phosphomimetic Sx4. Cells transfected with 
Sx4(Myc) WT, Y115E, Y251E, Y115,251E or an empty vector control (pCR3.1)(section 
2.9.6).  24 hours after transfection, cells were treated with or without insulin (sections 
2.9.8). The cells were then stained for cell surface HA-GLUT4-GFP, prior to 
permeabilisation and staining for Sx4(Myc) (Section 2.10). Immunofluorescence was 
imaged using a Zeiss LSM 880 invert confocal microscope. 
Figure 4.4 suggests that overexpression of Sx4(Myc) phosphomutants affected GLUT4 
localisation under basal conditions. The intracellular localisation and insulin response in 
cells overexpressing Sx4(Myc)-WT was comparable to that of untransfected cells and the 
empty plasmid control. Similarly, no distinguishable change can be seen in the localisation 
of GLUT4 (GFP) under basal conditions when Sx4(Myc)-Y115E is overexpressed. 
Although high levels of basal cell surface HA staining can be seen in all samples, changes 
in the total GLUT4 localisation (GFP) in cell expressing Sx4(Myc)-Y251E or Sx4(Myc)-
Y115,251E were noted under basal conditions. When either of these mutants was 
expressed total GLUT4 (GFP) localisation resembled that of insulin-stimulated cells.     
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Figure 4.4 Effect of Sx4 phosphomutant over expression in HA-GLUT4-GFP HeLa 
cells 
HeLa cells expressing HA-GLUT4-GFP were grown on glass cover slips and transfected 
with 0.5 μg per well of Sx4(Myc) WT, Y115E, Y251E or Y115,251E or an empty pCR3.1 
plasmid (section 2.9.6). 24 hours later cells were serum starved and treated with (insulin, 
right) or without (basal, left) 170 nM insulin (section 2.9.8). Cells were then surface 
stained for HA in the absence of cell permeabilisation, before being permeabilised and 
stained for Myc (section 2.10). Immunofluorescence images were taken using a Zeiss 880 
invert confocal microscope. Panels show GFP (total GLUT4, green), surface stained 
AlexaFluor 647 HA (cell surface GLUT4, magenta) and Sx4(Myc) stained with anti-Myc 
and DyLight 405 (cyan). Scale bar = 20 μm. 
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4.3.3 Quantification of HA-GLUT4-GFP translocation in HeLa cells by flow 
cytometry 
Overexpression of Sx4 phosphomimetic mutants, Y251E and Y115,251E, in HA-GLUT4-
GFP HeLa cells showed a change in the subcellular localisation of GLUT4 under basal 
conditions. Whilst immunofluorescence and microscopy can be used to observe changes 
in proteins, data from these experiments are hard to quantify. I next sought to quantify the 
translocation of HA-GLUT4-GFP in HeLa cells using flow cytometry.  
In order to optimise conditions for quantification of surface stained of HA by flow cytometry 
an antibody titration was carried out. HA-GLUT4-GFP HeLa cells were treated with or 
without (basal) insulin. Cells were then fixed and surface stained for HA before being lifted 
from the culture dish and analysed by flow cytometry (section 2.12). Figure 4.5 shows flow 
cytometry data represented in bar graphs (for raw data see appendix III). The median 
GFP fluorescence intensity, and therefore total GLUT4, was unchanged upon insulin 
stimulation (Figure 4.5A). Figure 4.5B shows an increase in the median fluorescence 
intensity of cell surface GLUT4 (HA) could be detected upon insulin stimulation. The ratio 
of basal/insulin median fluorescence intensity of cell surface HA was calculated. Figure 
4.5C shows that a primary antibody dilution of 1:200 (500 ng/ml) was optimum for 
detecting insulin stimulated GLUT4 translocation. 
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Figure 4.5 Quantification of HA-GLUT4-GFP translocation in HeLa cells by flow 
cytometry 
HA-GLUT4-GFP HeLa cells were serum starved before being treated with or without 
(basal) 170 nM insulin for 20 minutes. Cells were then fixed and surface stained using an 
anti HA antibody (section 2.12). Cells were lifted and analysed using a Beckman Coulter 
CyAn ADPs flow cytometer. Data was collected and graphs show the median 
fluorescence intensity (For raw data see appendix III) A GFP shows total GLUT4 levels 
were unchanged upon insulin stimulation. B An increase in the median fluorescence 
intensity of surface HA staining was seen upon insulin stimulation. C The ratio of the 
median fluorescence intensity of insulin compared to basal cell surface HA signal. An 
antibody dilution of 1:200 showed the biggest fold change of cell surface HA signal upon 
insulin stimulation 
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Figure 4.5 shows that an insulin response in HA-GLUT4-GFP HeLa cells was detected by 
flow cytometry. The effect of overexpressing Sx4(Myc) phospho-mutants on HA-GLUT4-
GFP translocation was then examined. HA-GLUT4-GFP HeLa transfected with Sx4(Myc) 
WT and phospho-mimetic mutants, along with an empty vector control and an 
untransfected control treated with transfection reagent only (section 2.9.6). Cell surface 
HA-GLUT4-GFP was stained using an anti-HA antibody, before cells were permiabilised 
and stained for Sx4(Myc) expression. The fluorescence intensity of total (GFP) and cell 
surface (HA) HA-GLUT4-GFP was measured in cells that were positive for Sx4(Myc) 
(transfected) in addition to those that had no Sx4(Myc) signal (untransfected) in each 
sample (For raw data see appendix IV). 
Figure 4.6A shows the median fluorescence intensity of surface stained HA in transfected 
and untransfected cells under basal or insulin-stimulated conditions. Over expression of 
Sx4-WT increased cell surface HA-GLUT4-GFP under basal conditions. This is likely due 
to the high level of expression of Sx4(Myc). Over expression of Sx4-Y115E or Sx4-Y251E 
increased basal cell surface GLUT4 by a factor of 2.5 and 2.4 fold respectively when 
compared to untransfected cells. Moreover, overexpression of Sx4-Y115,251E increased 
basal cell surface HA-GLUT4-GFP by 3.7-fold. Figure 4.6B shows the ratio of median 
fluorescence intensity of basal/insulin, and therefore the insulin response of HA-GLUT4-
GFP in the cells. Cells that had no transfection treatment (untransfected) exhibited a 1.8 
fold increase in surface stained HA in insulin-treated cells compared to basal. Cells that 
had been transfected with an empty pCR3.1 control plasmid (control) displayed a slightly 
reduced insulin response of a 1.3 fold increase of basal/insulin cell surface HA-GLUT4-
GFP. Untransfected cells from Sx4-WT, Sx4-Y115E and Sx4-Y115,251E samples showed 
a similar increase in cell surface GLUT4 in response to insulin (1.43, 1.34 and 1.43 fold 
respectively). Cells that had been transfected with Sx4-WT (positively stained for Myc) 
showed a reduced insulin response, with a 1.16 fold increase in cell surface HA staining of 
insulin stimulated cells compared to basal. Whereas, the insulin response in cells that 
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were Myc positive, and expressing Sx4-Y115E, Sx4-Y251E or Sx4-Y115,251E, was 
eradicated (with a basal/insulin cell surface HA ratio of 0.86, 0.65 and 0.7 respectively) 
due to the increase in cell surface HA-GLUT4-GFP under basal conditions. Figure 4.6C 
shows that GFP fluorescence intensity, and therefore total HA-GLUT4-GFP, is similar 
across all samples, demonstrating that the changes in cell surface HA staining were not 
due to changes in HA-GLUT4-GFP expression.  
Figure 4.7 shows histograms representing the fluorescence intensity of cell surface HA of 
cells that are Sx4(myc) negative (untransfected, green) and those that are expressing 
Sx4(myc) (transfected, blue) under basal conditions. An increase in the number of cells 
with high fluorescence intensity (greater than 103) was seen when Sx4-Y115E, Sx4-
Y251E and Sx4-Y115,251E were overexpressed. Figure 4.7 also shows the ratio of the 
median HA fluorescence intensity of untransfected/transfected cells. This ratio increases 
in cells expressing Sx4 phospho-mimetic mutants, again showing that expression of the 
phospho mutants increases cell surface GLUT4 under basal conditions.  
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Figure 4.6 Expression of Sx4 phospho-mutants increases cell surface GLUT4 
HA-GLUT4-GFP HeLa cells were transfected with Sx4(Myc) WT, Y115E, Y251E, 
Y115,251E or empty plasmid control (section 2.9.6). 24 hours after transfection cells were 
treated with or without insulin for 20 minutes (section 2.9.8) before being surface stained 
for HA. Cells were then stained for transfected syntaxin using a Myc antibody and 
analysed using flow cytometry (section 2.12). A Median fluorescence intensity for the HA 
epitope of basal and insulin treated transfected (Myc positive) and untransfected (Myc 
negative) cells. Expression of Sx4 phospho-mutants increases cell surface HA. B Ratio of 
median fluorescence intensity (HA epitope) basal/insulin for untransfected (Myc negative) 
and transfected (Myc positive). Ratio shows insulin response in cells is decreased in 
transfected cells due to high levels of basal cell surface HA. C Median fluorescence 
intensity of GFP signal for basal and insulin stimulated cells. GFP fluorescence intensity 
(representing total GLUT4) remains similar across all samples. A total of ~5000 cells were 
analysed for each sample. For raw data see Appendix IV.  
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Figure 4.7 Histograms showing increase in basal cell surface GLUT4 in Sx4 
phospho-mutant expressing HA-GLUT4-GFP HeLa cells 
HA-GLUT4-GFP HeLa cells were transfected with Sx4(Myc) WT, Y115E, Y251E, 
Y115,251E or empty plasmid control (section 2.9.6). Cells were stained for transfected 
syntaxin using a Myc antibody and analysed using flow cytometry (section 2.12). Shown 
are histograms of the fluorescence intensity (HA epitope) comparing untransfected (green) 
and transfected (blue) cells under basal condition. A total of ~5000 cells were analysed 
from each sample. The ratio of the median fluorescence of cell surface HA-staining of 
untransfected/transfected cells is shown. Expression of Sx4 phopsho-mimetic mutants 
increases the ratio of cell surface HA-GLUT4-GFP of untransfected/transfected cells.  
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4.3.4 Generating Sx4 knockout 3T3 cell lines using CRISPR-Cas9 technology 
Previous data presented in this chapter shows that phosphorylation of Sx4 at Y115 and/or 
Y251 increases cells surface GLUT4 under basal condition in HeLa cells in the presence 
of endogenous Sx4. Expressing Sx4 phosphomutants in cells that lack endogenous Sx4 
would allow more detailed examination of the consequences of phosphorylation and 
eliminate competition of the endogenous and transfected proteins. A Sx4 knock out cell 
line was then generated using CRISPR-Cas9 technology.  
The CRISPR-Cas9 technology is based on CRISPRs (clustered regularly interspaced 
palindromic repeats) found in the genomes of bacteria and archaea (Horvath & Barrangou 
2010). The CRISPRs along with cas (CRISPR associated) genes encode proteins as part 
of an adaptive defence mechanism to provide immunity from viruses (Barrangou et al., 
2007). Increased understanding of CRISPR in bacteria led to the development of 
CRISPR-Cas technology for mammalian genome editing. Cas9 is an endonuclease that, 
when used in conjunction with CRISPR guide RNA, introduces a site-specific double 
strand break in the target gene (Doudna & Charpentier 2014). This results in an easy to 
use genome editing tool, whereby a single plasmid can encode the guide RNA and Cas9 
to knock out expression of the target gene.  
3T3-L1 fibroblasts were chosen to generate the knock out cell lines as these can be 
differentiated into adipose cells, which are insulin responsive and are important regulators 
of glucose homeostasis in mammals (Bryant and Gould, 2011). Before generating the 
knockout cell lines the transfection efficiency of 3T3-L1 fibroblasts was investigated. In 
order to do this a construct expressing cellugyrin harbouring an N-terminal td-Tomato tag 
was transfected into both 3T3-L1 cells and 3T3-L1 cells stably expressing HA-GLUT4-
GFP at varying concentrations (section 2.9.6). Figure 4.8 shows that both cell lines were 
successfully transfected. Furthermore, 0.5 μg of plasmid resulted in the best transfection 
efficiency.  
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Figure 4.8 3T3-L1 and HA-GLUT4-GFP 3T3-L1 fibroblasts are successfully 
transfected 
3T3-L1 (A) and HA-GLUT4-GFP 3T3-L1 (B) fibroblasts were plated on glass cover slips 
before being transfected with 0.125, 0.25, 0.5, 1 or 2 μg of plasmid expressing tdTomato-
cellugyrin (section 2.9.6). After 24 hours in transfection media the transfection efficiency of 
the cells was examined by microscopy. Nuclei were stained using DAPI (blue). Td-
Tomato-cellugyrin is shown in red. Both cell lines were successfully transfected.  
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A CRISPR plasmid with guide RNA targeting a region of exon 2 of Sx4 was purchased 
from Sigma-Aldrich (Sigma-Aldrich Ltd., Gillingham, Dorset, UK). The plasmid also 
expressed an RFP marker, allowing for rapid sorting of transfected cells by fluorescence-
activated cell sorting (FACS).  
3T3-L1 and HA-GLUT4-GFP 3T3 cells were transfected with Sx4 CRISPR plasmid. After 
24 hours, transfected cells were sorted using a Beckman Coulter MoFlo Astrios flow 
cytometer. Figure 4.8 shows dot plots of FACS analysis of both 3T3-L1 (Figure 4.8A) and 
HA-GLUT4-GFP 3T3-L1 (Figure 4.8B) cells. The fluorescence intensity of RFP is plotted 
against that of GFP for both cell lines. HA-GLUT4-GFP 3T3 cells show a positive shift in 
GFP signal demonstrating that they are expressing the tagged GLUT4. Each event plotted 
corresponds to a cell. Cells from region R2 in each sample were sorted and kept for 
further culture. FACS analysis revealed that both cell lines had good transfection 
efficiency, at 49% for 3T3-L1 cells and 48% for HA-GLUT4-3T3 cells. 
RFP positive cells were cultured to allow single colonies to form, before a number of 
colonies were selected and expanded (section 2.13). Immunoblot analysis was carried out 
on the selected colonies to screen for Sx4 knock out. Cell lysates were then run on 12 % 
SDS-PAGE gels and analysed by immunoblot detection of Sx4 and tubulin (loading 
control). Positive controls of WT 3T3-L1 or HA-GLUT4-GFP 3T3-L1 cell lysates were also 
run. Figure 4.9 shows that Sx4 knock down was successful in several colonies in both 
3T3-L1 and HA-GLUT4-GFP 3T3-L1 cells. Colonies that showed no Sx4 signal but a 
strong tubulin loading control signal were then chosen to be characterised. Colonies 7, 8, 
13 and 14 were selected from the 3T3-L1 cells (Figure 4.9A). Colonies 2, 3 5 and 8 were 
chosen from HA-GLUT4-GFP 3T3-L1 cells (Figure 4.9B).  
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Figure 4.9 Fluorescence-activated cell sorting of CRISPR-Cas9 transfected 3T3-L1 
cells 
3T3-L1 (A) and HA-GLUT4-GFP 3T3-L1 (B) were plated before being transfected with a 
CRISPR plasmid targeting Sx4. 24 hours after transfection cells were lifted and analysed 
by fluorescence-activated cell sorting (FACS) (section 2.13). Shown are dot plots 
representing fluorescence intensity of RFP plotted against the fluorescence intensity of 
GFP. Each dot represents one event (cell). Cells in box R2 represent RFP positive cells 
that were kept for further culture.  
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Figure 4.10 Immunoblots of 3T3-L1 Sx4 CRISPR knockout cell lines 
3T3-L1 and HA-GLUT4-GFP 3T3-L1 cells were transfected with an Sx4 CRISPR plasmid 
before transfected cells were sorted using flow cytometry. Cells were then cultured until 
single colonies formed. Colonies were selected and expanded before being lysed and 
subject to immunoblot analysis (section 2.13). A 3T3-L1 CRISPR colonies. B HA-GLUT4-
GFP 3T3-L1 CRISPR colonies. Lysates were blotted with an anti-tubulin antibody as a 
loading control. Anti-Sx4 blots show numerous colonies have been successfully depleted 
of Sx4.  
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4.3.5 Characterising Sx4 CRISPR knockout 3T3-L1 cell lines 
Figure 4.9 shows that Sx4 was successfully knocked out of 3T3-L1 and HA-GLUT4-GFP 
3T3-L1 cells. Colonies that were negative for Sx4 expression were then chosen to 
continue to culture and characterise.  
The propensity for the Sx4 knockout cells to differentiate was first examined. Sx4 
knockout 3T3-L1 and HA-GLUT4-GFP 3T3-L1 along with WT cells were plated and 
treated with adipocyte differentiation media (section 2.9.7). The cells were then examined 
by microscopy to assess their differentiation. Figure 4.11 shows differentiation of 3T3-L1 
(A) and HA-GLUT4-GFP 3T3-L1 (B) cells to adipocytes. WT cells exhibit the 
morphological features expected when cells are differentiated (Armani et al., 2010). The 
cells become spherical and lipid droplets can be seen. Figure 4.11A shows that, with the 
exception of C13, Sx4 knockout 3T3-L1 fibroblasts are capable of differentiating. In 
contrast, none of the HA-GLUT4-GFP 3T3-L1 knockout cells showed the morphological 
changes associated with differentiation.  
The insulin-response in Sx4 knockout HA-GLUT4-GFP 3T3-L1 cells was then examined. 
Cells were plated before being differentiated (section 2.9.7) and treated with insulin 
(section 2.9.8). Cells were surface stained for HA and imaged using confocal microscopy 
(section 2.10). Figure 4.12 shows that HA-GLUT4-GFP in WT 3T3-L1 adipocytes 
translocated to the PM in response to insulin. Although Sx4 depleted cells did not 
differentiate (Figure 4.11 and 4.12), ectopically expressed GLUT4 has been shown to 
translocate in response to insulin in 3T3-L1 fibroblasts (Huang et al., 2013).  Figure 4.12 
shows that no change was seen in the intracellular localization (GFP) or surface staining 
(HA) of HA-GLUT4-GFP in Sx4 depleted cells.   
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Figure 4.11 Differentiation of Sx4 knockout 3T3-L1 fibroblasts to adipocytes 
3T3-L1 fibroblasts were plated and treated with adipocytes differentiation media (section 
2.9.7). Cells were then imaged using a light microscope. A WT 3T3-L1 cells along with 
Sx4 knockout colonies C7, C8, C13 and C14. B WT and Sx4 knockout C2, C3, C5 and C8 
HA-GLUT4-GFP 3T3-L1 cells. Images show WT cells were successfully differentiated 
whereas cells depleted of Sx4 showed a varied response to the differentiation treatment. 
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Figure 4.12 HA-GLUT4-GFP does not translocate to the cell surface in insulin-
stimulated cells depleted of Sx4 
HA-GLUT4-GFP 3T3-L1 cells were plated and treated with adipocyte differentiation media 
(section 2.9.7). Following differentiation, cells were serum starved and stimulated with 170 
nM insulin for 20 minutes (section 2.9.8). The cells were then fixed and surface stained for 
GLUT4 using an anti-HA antibody (section 2.10). Cells were analysed using confocal 
microscopy. Images show that Sx4 knockout cells (C2, C3, C5 and C8) failed to 
differentiate and were not insulin responsive. Whereas WT 3T3-L1 adipocytes (top panel) 
showed a robust relocalisation of HA-GLUT4-GFP following insulin treatment. Scale bar = 
10 μm.  
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4.4 Discussion 
GLUT4 is a glucose transporter protein that, upon insulin-stimulation, is rapidly 
translocated from its intracellular stores to the plasma membrane in fat and muscle cells 
(Bryant et al., 2002).  This regulated membrane trafficking event is controlled by a SNARE 
complex consisting of Sx4, SNAP23 and VAMP2 at the PM (Kawanishi et al., 2000; St-
Denis et al., 1999). Sx4 has been shown to be phosphorylated at tyrosine residues 115 
and 251 in 3T3-L1 adipocytes in response to insulin (Schmelzle et al., 2006). This chapter 
therefore aimed to examine the effect of Sx4 phosphorylation on the translocation of 
GLUT4 to the PM. 
In order to study the effect of Sx4 phosphorylation at Y115 and Y251 on GLUT4 
translocation Myc tagged phospho-mimetic Sx4 mutants were generated. An in vitro pull 
down assay using the cytosolic domain of recombinant purified Sx4(Myc)-GST and Sx4-
GST was carried out (Figure 4.1). The assay showed that Sx4(Myc)-GST bound to more 
Munc18c than Sx4-GST. This increase may be due to slight structural changes in the 
protein due to the presence of the Myc tag. The tag was introduced between the N-
terminal domain and the Habc domain in an attempt to cause as little disruption to the 
function of Sx4 as possible. As the protein was still functional the slight increase in binding 
to Munc18c was not concerning as any effect of phosphorylation of Y115 and Y251 when 
expressing phospho-mimetic mutants should be seen in addition to the effects of 
expressing the WT protein.  
I then examined the effect of over expressing Myc-tagged phospho-mimetic Sx4 mutants, 
in the presence of the endogenous protein, in HeLa cells expressing a HA-GLUT4-GFP 
reporter protein (figure 4.4). Over expression of phospho-mimetic mutants appeared to 
have an effect on the localisation of HA-GLUT4-GFP when compared to cells expressing 
Sx4(Myc) WT or no Sx4(Myc). However, quantifying this change is particularly hard in 
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HeLa cells as they show fairly high levels of cell surface GLUT4 under basal conditions, 
and a smaller insulin response than adipocytes or muscle cells.  
Given that it proved hard to analyse the effect of overexpressing phospho-mimetic 
Sx4(Myc) in HA-GLUT4-GFP HeLa cells, I sought to study this using a more quantitative 
technique. Figure 4.5 shows that flow cytometry was an effective way of quantifying cell 
surface GLUT4 and that an insulin-induced increase in the levels of the protein at the cell 
surface was detected. This method also allowed for rapid quantification of roughly 5000 
cells per sample. Analysing this many cells by microscopy would not be possible. The 
effect of over expressing Sx4(Myc) phospho-mimetic mutants on HA-GLUT4-GFP 
translocation was then analysed using flow cytometry (figure 4.6 and 4.7). Expression of 
the phospho-mimetic mutants increased cell surface GLUT4 under basal conditions, this 
is consistent with data from the previous chapter showing that phospho-mimetic Sx4 
forms more SNARE complexes when compared to Sx4-WT (figure 3.3). It is tempting to 
speculate that insulin-induced phosphorylation of Sx4 at Y115 and/or Y251 regulates 
GLUT4 translocation by increasing the propensity of Sx4 to form SNARE complexes and 
therefore increasing the rate of GSV fusion. However, more detailed analysis of GSV 
fusion in the presence of phospho-mimetic Sx4 is needed to elucidate whether GSV 
fusion frequency is increased. For example, TIRF microscopy could be used to resolve 
the discrete steps of GLUT4 trafficking at the plasma membrane (Bai et al., 2007).  
It will also be important to examine the effect of phosphorylation of Sx4 in adipocytes 
and/or muscle cells. In addition, analysis of the effect of Sx4 phospho-mutants in the 
absence of endogenous Sx4 will be important. Depleting endogenous Sx4 will remove the 
competition for any phospho-mutants expressed, this may be especially important when 
analysing phospho-resistant mutants where WT endogenous Sx4 may rescue and mask 
the effects of the mutants. I therefore sought to generate knockout cell lines in 3T3-L1 
fibroblasts that will be differentiated into adipocytes lacking endogenous Sx4. The cell 
lines were generated using CRISPR-Cas9 technology that allowed for rapid and accurate 
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targeting of Sx4 (figures 4.9 and 4.10). Interestingly, when the Sx4 depleted cells were 
characterised a difference in their propensity to differentiate was observed (figure 4.11). 
3T3-L1 cells that were depleted of Sx4 were capable of differentiating, however the 
morphology of 3T3-L1 fibroblasts that were expressing HA-GLUT4-GFP and depleted of 
Sx4 did not change following treatment with differentiation media. Sx4 is up-regulated 
upon differentiation of 3T3-L1 fibroblasts to adipocytes (Torrejón-Escribano et al., 2002). 
So it is logical that the morphological changes seen in Sx4 knockout 3T3-L1 cells were not 
as striking and those seen in WT 3T3-L1 cells. It has been noted from observations in the 
laboratory that HA-GLUT4-GFP expressing 3T3-L1 cells do not differentiate as well as 
those not expressing the reporter protein (unpublished observations). These cells are a 
higher passage number than the 3T3-L1 cells normally used for differentiation 
experiments. It may therefore be that the cells have a reduced propensity to differentiate 
and so depletion of Sx4 has a greater negative effect on these cells than it does on 3T3-
L1s not expressing HA-GLUT4-GFP. One way to test whether any differentiation response 
occurs in the Sx4 knockout cells would be to blot for markers of adipocyte differentiation. 
Several molecular markers have been identified in adipogenesis, such as PPARγ, C/EBPs, 
lectin and FABP4 (Baxa et al., 1989; Hwang et al., 1997; Rosen and MacDougald, 2006). 
Immunoblot analysis of cells that had been treated with differentiation media would 
indicate whether the cells show the molecular markers of differentiation but no 
morphological changes. Additionally, analysis of the glucose uptake of the cells would be 
important for characterisation of Sx4 knockout cells not expressing the HA-GLUT4-GFP 
reporter construct. Sx4 is required for GLUT4 translocation to the plasma membrane 
(Tellam et al., 1997; Volchuk et al., 1996), therefore successful knockout of Sx4 would 
reduce the amount of insulin-stimulated glucose uptake in the cells. Indeed, figure 4.12 
shows that HA-GLUT4-GFP does not translocate to the plasma membrane in Sx4 
knockout cells. 
152 
 
In summary, this data shows that Sx4 phosphorylated at Y115 and Y251 increases cell 
surface GLUT4 in HeLa cells. Further analysis is needed to elucidate the precise 
mechanism by which this phosphorylation regulates GLUT4 trafficking. In order to do this 
Sx4 knockout 3T3-L1 cells have been generated which can be used in the future to 
examine the effects of Sx4 phospho-mutants in adipocytes depleted of the endogenous 
proteins. 
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Chapter Five 
In vitro analyses of the interactions of phospho-
mimetic Sx4 and Munc18c 
  
154 
 
5 In vitro analyses of the interactions of phospho-mimetic Sx4 
and Munc18c 
5.1 Introduction 
5.1.1 SM proteins 
Although SNARE proteins have been shown to be the minimal machinery required for 
fusion (Weber et al., 1998), a number of other proteins have been implicated in regulating 
SNARE proteins and membrane trafficking (Jahn et al., 2003)(see section 1.4 for more 
detail). The Sec1/Munc18 (SM) family of proteins are amongst those that regulate 
membrane fusion. SM proteins bind to syntaxins with high affinity and through a number 
of different binding modes (section 1.4.1) (Rizo and Südhof, 2012).  Inhibition or depletion 
of SM proteins in cells generally leads to a reduction in membrane fusion, however 
elucidating the mechanisms by which SM proteins regulate membrane fusion has proved 
challenging and contradictory (Carr and Rizo, 2010; Toonen and Verhage, 2003).  
5.1.2 Sx4 and Munc18c interaction 
The SM protein that interacts with Sx4 is Munc18c. Munc18c binds to both monomeric 
syntaxin, binary SNARE complex intermediates and the tertiary SNARE complex of Sx4, 
SNAP23 and VAMP2 (Latham et al., 2006). However, the effect of Munc18c on SNARE 
complex assembly and membrane fusion has been hard to elucidate. Munc18c has been 
shown to both enhance (Latham et al., 2006) and inhibit (Kioumourtzoglou et al., 2014) 
SNARE complex assembly in vitro. Munc18c was found to be inhibitory to membrane 
fusion mediated by Sx4, SNAP23 and VAMP2 in an in vitro assay using artificial 
liposomes (Brandie et al., 2008). Moreover, in adipocytes derived from mice embryonic 
fibroblasts of Munc18c knockout mice insulin-induced GLUT4 translocation is enhanced 
(Kanda et al., 2005). Contrastingly another study reported that heterozygous Munc18c 
knockout mice show reduced insulin sensitivity (Oh et al., 2005). These data present a 
complex picture of the role of Munc18c in regulating GLUT4 translocation and suggest 
that there may be other factors regulating function of the protein.  
155 
 
5.1.3 Munc8c phosphorylation 
Two studies in 2006 reported that Munc18c is phosphorylated (Oh and Thurmond, 2006; 
Schmelzle et al., 2006). The study by Thurmond’s laboratory showed an increase in 
Munc18c phosphorylation in insulin-stimulated MIN6 pancreatic beta cells and 3T3-L1 
adipocytes. They identified the residue that is phosphorylated as tyrosine 219. Meanwhile, 
Schmelzle and colleagues carried out quantitative mass spectrometry on insulin-treated 
3T3-L1 adipocytes in order to identify changes in the phosphorylation state of protein in 
the cells. They identified that Munc18c phosphorylation at tyrosine 521 increases >10 fold 
following insulin-stimulation. 
As with Sx4 (section 3.3.6), Munc18c can be phosphorylated directly by CIRK in vitro 
(Aran et al., 2011) and this phosphorylation occurs only on Y521 not Y219 in vitro (Aran-
Ponte, 2009). In an in vitro pull down assay both phosphomimetic and CIRK 
phosphorylated Munc18c no longer bind to Sx4, suggesting that phosphorylation of 
Munc18c relieves its inhibitory effect on SNARE complex formation (Aran et al., 2011). 
Moreover, preassembly of the Sx4/Munc18c-Y521E complex has a stimulatory effect on 
SNARE complex assembly (Kioumourtzoglou et al., 2014).  
Further investigations into the effect of phosphorylation of Munc18c at tyrosine 219 
showed that phosphorylation at this residue causes the protein to dissociate from Sx4 (Oh 
and Thurmond, 2006). Interestingly, phosphorylation Y219 phosphorylation of Munc18c 
causes a switch in binding specificity from Sx4 to the protein Doc2β (Jewell et al., 2008). 
Doc2β is a ubiquitously expressed C2 domain-containing protein (Sakaguchi et al., 1995). 
Immunoprecipitation experiments from 3T3-L1 adipocytes revealed the protein binds to 
Munc18c (Ke et al., 2007). The Doc2β/Munc18c complexes showed no interaction with 
Sx4, suggesting the two proteins bind in a mutually exclusive manner (Ke et al., 2007). 
Moreover, increased expression of Doc2β enhanced insulin-stimulated GLUT4 
translocation, whereas inhibition of the protein decreased it (Ke et al., 2007). These data 
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suggest that the switch in binding of Munc18c from Sx4 to Doc2β may be an important 
regulatory mechanism in the trafficking of GLUT4 (Jewell et al., 2008). 
5.2 Aims of this chapter 
The data presented thus far in this study suggests that phosphorylation of Sx4 affects its 
interactions with the SNARE proteins VAMP2 and SNAP23 and that this in turn effects 
GLUT4 translocation to the PM. The SM protein Munc18c has also been shown to be 
phosphorylated in response to insulin, on tyrosine residue 521 (Schmelzle et al., 2006). 
The aim of this chapter was to dissect the effect of both Sx4 and Munc18c phospho-
mimetic mutants on their interactions in vitro. In order to do this a number of pull down 
assays and complex assembly assays have been carried out using recombinant purified 
proteins.  
5.3 Results 
5.3.1 Purification of His tagged Munc18c 
In order to assess the effect of both Sx4 and Munc18c phosphorylation in vitro WT and 
phospho-mimetic mutants of both proteins were expressed and purified (section 2.3.2). 
Sx4-WT, Sx4-Y115E, Sx4-Y251E, Sx4-Y115,251E and Sx4-Open tagged at the C-
terminus with GST were expressed and purified from E. coli (see figure 3.1). Munc18c 
tagged at the N-terminus with His was also expressed and purified from E. coli (2.3.2). 
Figure 5.1 shows representative Coomassie stained gels and anti-His immunoblots of 
Munc18c-WT and Munc81c-Y521E. Anti-His immunoblots were used in addition to 
Coomassie staining to visualise Munc18c as a contaminating protein of 75 kDa was 
purified with Munc18c and so using Coomassie staining alone to compare the amount of 
the protein was inaccurate.  
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Figure 5.1: Expression and purification of His-Munc18c.  
Munc18c tagged at the N-terminus with His was expressed in and purified from BL21 
(DE3) E. coli as described in methods section 2.3.2. 10μl of samples taken during 
purification were analysed by SDS-PAGE and either coomassie stained or immunoblotted 
with anti-Munc18c antibody. A Representative Munc18c-WT purification. B 
Representative His-Munc18c Y521E purification. Elution samples represent 0.12 % of the 
total elution (see appendix I for details). Samples corresponding to bacterial lysate (lysate), 
unbound proteins following incubation with nickel beads (flow through), protein bound to 
beads (beads before), each of the two elutions and proteins that remained bound to beads 
following elution (beads after) were run. 
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5.3.2 The effect of Sx4 and Munc18c phospho-mimetic mutants on SNARE 
complex assembly 
The effect of both Sx4 and Munc18c phosphorylation on SNARE complex assembly was 
then assessed. A complex assembly assay was carried out in the presence or absence of 
Munc18c-WT or –Y521E phospho-mimetic mutant (section 2.4). Samples were analysed 
by SDS-PAGE and immunoblot. Figure 5.2 shows the amount of complex formed with 
Sx4-WT or Sx4-Y115E in the presence or absence of Munc18c-WT or Munc18c-Y521E. 
The presence of Munc18c did not affect the amount of complex formed in samples 
containing Sx4-WT (lanes 1-3). Sx4-Y115,251E in the absence of Munc18c formed 23 % 
more SNARE complex than Sx4-WT in the absence of Munc18c as expected. In the 
presence of both Munc18c-WT and Munc18c-Y521E, Sx4-Y115,251E formed more 
complex than in the absence of the SM protein (22 % and 13 % increase respectively). 
Sx4-Y115,251E in the presence of WT Munc18c also was seen to form 39 % more 
complex than Sx4-WT in the presence of Munc18c-WT. 
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Figure 5.2 Sx4-Y115,251E pre-incubated with Munc18c-WT or –Y521E forms more 
SNARE complex than Sx4-WT 
GST tagged Sx4 (Sx4-GST) WT or Y115,251E phospho-mutant was pre-incubated with 
either WT or Y521E phospho-mimetic Munc18c tagged at the N-terminus with His, for 1 
hour at 4 °C. His-SNAP23 and GST-VAMP2 were then added and all proteins were 
incubated for 15 minutes at  4 °C. The reaction was then stopped and analysed by SDS-
PAGE and immunoblot analysis (section 2.4). Input samples were run to show the amount 
of each protein used in the assay. A Representative Coomassie stained gels and 
immunoblots. Top panel shows the amount of complex formed in an anti-Sx4 immuno blot. 
Middle panel shows equal Munc18c input. Coomassie stained gel (bottom panel) shows 
the amount of complex formed and the protein input. B Densitometry analysis of the 
amount of complex formed using anti-Sx4 immunoblot. Sx4-Y115,251E forms more 
complex than the Sx4-WT in the absence or presence of Munc18c. Munc18c WT and 
phospho-mimetic mutants show little difference in the amount of complex formed. n=3, 
error bars show standard error of the mean.  
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5.3.3 Binary interactions of phosphomimetic Sx4 and Munc18c 
The effect of Sx4 and Munc18c phosphorylation on their binary interactions was then 
investigated. Purified Sx4-GST was immobilised to glutathione Sepharose beads before 
being incubated with purified His-Munc18c for 60 minutes at 4 °C (section 2.5). Samples 
were analysed by SDS-PAGE and immunoblot. Figure 5.3A shows a representative 
immunoblot of the amount of Munc18c pulled down by Sx4 and a panceau stained 
membrane showing Sx4 input. Figure 5.3B shows quantification of the data. In contrast to 
previously reported data (Aran et al., 2011), Sx4-WT bound to both Munc18c-WT and the 
phospho-mimetic mutant. Contrastingly, Sx4-Open pulled down very little Munc18c-WT or 
Munc18c-Y521E. Sx4 phospho-mimetic mutants showed reduced binding to Munc18c; 
however no difference was seen in between their interaction with Munc18c-WT or 
Munc18c-Y521E.  
161 
 
       
Figure 5.3 Sx4-WT pulls down more Munc18c than Sx4 phospho-mimetic mutants 
Sx4 tagged at the C-terminus with GST was immobilised to glutathione Sepharose beads 
before being incubated with Munc18c tagged at the N-terminus with His for 60 minutes at 
4 °C. Beads were washed extensively before being analysed by SDS-PAGE and 
immunoblot (section 2.5). A Representative anti-His immunoblot and ponceau stained 
membrane showing Sx4-GST loading. B Densitometry quantification of the amount of 
Munc18c pulled down as a proportion of Sx4. Sx4-WT pulled down more Munc18c WT 
and Y521E than other Sx4 phospho-mutants.  
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5.4 Discussion 
SM proteins are important regulators of SNARE complex assembly via their interaction 
with syntaxin proteins (Toonen and Verhage, 2003). The SM protein that regulates Sx4 is 
Munc18c (Tamori et al., 1998). Both Sx4 and Munc18c are phosphorylated in response to 
insulin (Schmelzle et al., 2006). In this chapter I aimed to investigate the effects of 
phosphorylation of Munc18c and Sx4 on binary and ternary SNARE interactions.  
Phospho-mimetic Munc18c tagged at the N-terminus with His was expressed and purified 
from E. coli (Figure 5.1). Bacterial expression and purification of Munc18 proteins is 
notoriously challenging (Hu et al., 2003). Problems with contaminants and with low yields 
are common and so the construct used in this study had been codon optimised for 
bacterial expression. Never the less, it was noted that a contaminant of the same 
molecular weight as Munc18c was purified and so distorted the amount of protein seen by 
coomassie. Anti-His immunoblots were therefore used as a more reliable method of 
ensuring equal Munc18c-WT and –Y521E loading in experiments.  
First an in vitro complex assembly, like that used in chapter 3, was carried out (Figure 5.2). 
Sx4-WT or Y115,251E was incubated with SNAP23 and VAMP2 in the presence or 
absence of Munc18c-WT, -Y521E or no Munc18c. Sx4-Y115,251E showed an increased 
ability to form SNARE complex, in both the presence and absence of Munc18c, consistant 
with data from figure 3.3. However, no change was seen in the amount of SNARE 
complex formed by Sx4-WT or Sx4-Y115,251E, in the presence of either Munc18c-WT or 
the phospho-mimetic mutant. This is in contrast to previously published results 
(Kioumourtzoglou et al., 2014). This study found that Munc18c has an inhibitory effect on 
SNARE complex assembly, whereas Munc18c-Y521E stimulates formation of the 
complex. The chief difference between the assay from this publication and the assay 
performed here is that they pre-incubated Munc18c with Sx4 immobilised to beads, and 
then removed any unbound Munc18c before the other components of the complex were 
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added. Here, Sx4 and Munc18c were preincubated, however unbound Munc18c was not 
removed from the assay before SNAP23 and VAMP2 were added. It is therefore possible 
that, in the assay using immobilised Sx4, the Sx4/Munc18c complexes formed are 
inhibitory and that this inhibition is not relieved during the time allowed for SNARE 
complex assembly. Whereas in the assay carried out in this study, free Munc18c may be 
able to interact with either binary Sx4/SNAP23 complexes or with VAMP2, in a manner 
that is not inhibitory for SNARE complex assembly. Repeating the assay carried out by 
Kioumourtzoglou et al, with Sx4-WT and Sx4-Y115,251E would resolve this difference.  
The binary interactions between phospho-mimetic Sx4 and Munc18c were also examined 
(Figure 5.3). All phospho-mimetic Sx4 mutants, along with Sx4-Open mutants, bound to 
less Munc18c that Sx4-WT. Munc18c has been reported to be inhibitory for both SNARE 
complex assembly and GLUT4 translocation (Brandie et al., 2008; Kanda et al., 2005). In 
addition, data from chapters 3 and 4 suggests that phosphorylation of Sx4 may enhance 
GLUT4 translocation and SNARE complex assembly. A reduction in binding of 
phosphorylated Sx4 to Munc18c would therefore be consistant with both these 
observations. However, a previous study has reported that phosphorylated Munc18c can 
no longer bind to Sx4 in vitro (Aran et al., 2011). This contrasting data suggests 
differences in the protein purified or assay conditions.  
The Munc18c construct used in this study has been codon optimised for expression in E. 
coli, in contrast to constructs used in the previously mentioned contrasting studies (Aran 
et al., 2011; Kioumourtzoglou et al., 2014). Codon optimisation aims to overcome low 
protein yield by optimising rare codons in the target gene to mirror those that are more 
commonly used in the host (Burgess-Brown et al., 2008). However, limitations in protein 
expression are not always solely down to the limitated availability of rare tRNAs. mRNA 
sequence and structure are important for proper translation and folding of proteins 
(Rosano and Ceccarelli, 2014). Changes in the codons used may have an effect on 
mRNA structure and therefore effect the folding of the translated protein. It would 
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therefore be beneficial to compare the structures of both codon optimised Munc18c and 
Munc18c used in the afforementioned studies in order to confirm their overall structure is 
the same. In order to optimise purification of Munc18c, some studies have used Sf9 insect 
cells (Hu et al., 2003; Yu et al., 2013). However, whilst they may provide improved protein 
folding they are also capable of more complex posttranslational modifications, such as 
phosphorylation, and so would present another complication when studying the effect of 
Y521 phosphorylation on Munc18c interactions. 
The data presented in this chapter suggests that phosphorylation of Sx4 Tyr-115 and Tyr-
251 and Munc18c Tyr521 may effect interactions of the proteins. However, like with the 
data in chapter three, assessing the statistical significance of the data presented in this 
chapter showed was difficult. Future work investigating the structure and function of 
purified Munc18c will be crucial in order to understand this data in the context of 
previously published results. In addition, analysis of the binary interactions of the two 
proteins using a more quantitative technique would help to elucidate the effect of 
phosphorylation of both proteins on the formation of the inhibitory Sx4/Munc18c complex, 
such as SPR that has been used previosuly in this study (section 3.3.5). In addition, it will 
be important to assess the effect of these phosphorylation events on GLUT4 translocation 
in a cell based system.  
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6 Discussion 
6.1 Discussion of results 
The translocation of GLUT4 from intracellular stores to the PM in response to insulin is a 
regulated membrane trafficking event (Bryant et al., 2002). Fusion of GLUT4 storage 
vesicles with the PM is mediated by a SNARE complex consisting of Sx4, SNAP23 and 
VAMP2 (Bryant and Gould, 2011). One important regulator of this SNARE complex is the 
SM protein Munc18c (Jewell et al., 2010). Both Sx4 and Munc18c are tyrosine 
phosphorylated in response to insulin (Schmelzle et al., 2006), however the 
consequences of these phosphorylation events are not fully understood. One aim of this 
study was therefore to dissect the effects of Sx4 and Munc18c phosphorylation of SNARE 
complex assembly and insulin-stimulated GLUT4 translocation. 
Chapter three examined the effects of phospho-mimetic Sx4 mutants on in vitro SNARE 
protein interactions. Using a complex assembly assay I found that Sx4-Y115,251E had an 
increased ability to form SNARE complexes than WT Sx4 (Figure 3.3). Furthermore, I 
demonstrated that this may be due to a conformational change in the protein. Sx4-open 
has previously been shown to be digested more quickly than Sx4-WT in a limited 
proteolysis assay (Aran et al., 2009). A similar assay I carried out showed that Sx4-
Y115,251E was digested at a comparable rate to Sx4-open (Figure 3.5). The 
conformational change of syntaxins from ‘closed’ to ‘open’ is an important regulatory 
mechanism in SNARE complex assembly (Dulubova et al., 1999; MacDonald et al., 2010). 
These data suggests that phosphorylation of Sx4 at tyrosine residues 115 and 251 
potentially represents an important regulatory feature, facilitating the switch between the 
open and closed conformation of the protein and increasing SNARE complex assembly. It 
would be interesting to perform further structural analysis of both phospho-mimetic and in 
vitro phosphorylated Sx4. NMR spectroscopy would provide more detail of any structural 
changes observed in the protein following phosphorylation. 
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The binary interactions of Sx4 phospho-mimetic mutants with the SNARE proteins 
SNAP23 and VAMP2 were then investigated. In vitro pull down assays suggested that 
Sx4 phosphorylation increased binding to both S23 and VAMP2 (Figures 3.6 and 3.8). 
These interactions were then investigated using SPR. I showed that Sx4 mutants bound 
to SNAP23 and VAMP2 with differing affinities to Sx4-WT and Open (Figure 3.10 and 
3.11).  Moreover, SPR experiments suggested that Sx4 phospho-mutants exhibited 
different affinities for SNAP23 and VAMP2. The binary interactions of Sx4 with SNAP23 
and VAMP2 have been shown to be important for regulating SNARE complex assembly 
(Kawanishi et al., 2000; Kioumourtzoglou et al., 2014; St-Denis et al., 1999). 
Phosphorylation may regulate the affinity of Sx4 to form binary complexes with SNAP23 
and VAMP2 differently, which in turn could regulate SNARE complex assembly. However, 
it is important to note that more work is needed to characterise the effect of 
phosphorylation on these binary complexes. Further SPR experiments using less 
immobilised ligand and lower concentrations of analyte would be needed to obtain more 
accurate equilibrium dissociation constants (Hulme and Trevethick, 2010). 
Finally, in this chapter I presented data demonstrating that Sx4 could be phosphorylated 
on two residues simultaneously, using a Phos-tag based mobility shift assay (Figure 3.16). 
Analyses of the interactions of phospho-mimetic Sx4 in chapter three showed that Sx4-
Y115,251E increases SNARE complex assembly, alters conformation of the protein and 
has an effect on binary interactions with SNAP23 and VAMP2. However, although mass 
spectrometry analysis has shown that both these residues are phosphorylated in 
response to insulin (Schmelzle et al., 2006), it was not yet known whether both can be 
phosphorylated on one molecule of syntaxin at the same time. In order to ascertain 
whether Sx4 is phosphorylated on both Y115 and Y251 simultaneously, I first used an in 
vitro phosphorylation assay with cytosolic insulin receptor kinase (CIRK). Sx4 is 
phosphorylated by CIRK in vitro (Aran-Ponte, 2009)(Figure 3.14). I then used a Phos-tag 
based mobility shift assay to show that a phospho-isoform that likely corresponds to Sx4 
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phosphorylated at both Y115 and Y251 was detected (Figure 3.16). Electrospray-based 
mass spectrometry (Compton et al., 2011) on non-fragmented Sx4, phosphorylated in 
vitro by CIRK, could be carried out to provide definitive proof that both residues can be 
phosphorylated on one residue.  
Having investigated the interactions of phospho-mimetic Sx4 proteins in vitro, their effect 
on GLUT4 translocation was then examined. In order to do this I generated full length Sx4 
WT and phospho-mimetic mutants harbouring an internal Myc tag (Figure 4.1). By 
overexpressing these proteins in the presence of endogenous Sx4, I showed that cell 
surface GLUT4 levels increased under basal conditions upon expression phospho-
mimetic mutants compared to WT (Figure 4.4, 4.6 and 4.7). One study in 2014 provided 
evidence that insulin stimulates the formation of SNARE complexes containing Sx4, 
SNAP23 and VAMP2 in 3T3-L1 adipocytes (Kioumourtzoglou et al., 2014). This study 
used a proximity ligation assay (PLA) to show that insulin stimulation of adipocytes results 
in an increase in SNARE complex formation and that this increase is likely due to the 
mobilisation of a pool of Sx4 that is inactive under basal conditions. Phosphorylation of 
Sx4, which is increased following insulin-stimulation, may represent an important point of 
regulation in this model. It is tempting to hypothesise that insulin-stimulated 
phosphorylation of this pool of inactive Sx4 could activate the protein, potentially via a 
conformational change (Figure 3.5) and increase SNARE complex assembly (Figure 3.3) 
therefore increasing fusion of GSVs at the plasma membrane. The observation that 
expression of Sx4 phospho-mimetic mutants increases cell surface HA-GLUT4-GFP in 
HeLa cells (Figure 4.6 and 4.7) is consistent with this hypothesis. 
To date, relatively little is known about the mechanisms by which insulin signalling 
regulates GLUT4 trafficking. AS160 has been identified as an important regulatory factor 
(Larance et al., 2005; Sano et al., 2003) and the protein directly interact with the insulin 
signalling pathway through its phosphorylation by Akt (Sano et al., 2003). However, 
AS160 has been implicated in regulating GSV docking at the PM (Bai et al., 2007) 
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whereas the fusion frequency of GLUT4 containing vesicles is known to increase in 
response to insulin (Huang et al., 2007). Data presented in chapters three and four of this 
study suggest that phosphorylation of Sx4 could play a role in increasing the fusion 
frequency of GSVs at the plasma membrane. More direct investigations into the effect of 
Sx4 phosphorylation on GSV fusion at the plasma membrane could be carried out using 
TIRF microscopy or by studying fusion of isolated GSVs and plasma membrane 
liposomes from cells expressing Sx4 phospho-mutants, similar to the assay developed by 
Koumanov and colleagues (see section 4.1.1 (Koumanov et al., 2005)).  
Carrying out assays such as those mentioned above would require Sx4 phospho-mutants 
to be expressed in the absence of endogenous Sx4, so as to be sure all fusion events 
observed would be regulated by the mutant of interest. With this in mind I also created 
Sx4 knockout cell lines using CRISPR-Cas9 technology. Sx4 knockout HA-GLUT4-GFP 
3T3-L1 and 3T3-L1 fibroblasts were made (Figure 4.10). Following conformation of the 
depletion of Sx4 the cells were treated with adipocyte differentiation media (Figure 4.11). 
Interestingly whilst 3T3-L1 Sx4 knockout cells showed some morphological differentiation 
those expressing HA-GLUT4-GFP did not. It is likely that this difference is due to the HA-
GLUT4-GFP 3T3-L1 cell line differentiating poorly, even in the presence of Sx4, as 
discussed in more detail in section 4.4. Although further characterisation of these Sx4 
knockout cell lines is needed (see section 4.4), they could prove a very useful tool in 
dissecting the effect of Sx4 phosphorylation on GSV fusion at the plasma membrane.  
Data discussed thus far suggests that phosphorylation of Sx4 may represent an important 
regulatory step in GLUT4 trafficking. The SM protein that regulates Sx4, Munc18c, is also 
phosphorylated in response to insulin on tyrosine residue 521 (Schmelzle et al., 2006). It 
is therefore important to understand the effect of this phosphorylation on the Munc18c/Sx4 
interaction and the implications for SNARE complex assembly. In chapter five I aimed to 
investigate the effect of phosphorylation of Sx4 and Munc18c on their interactions in vitro. 
However, analysing the effect of phosphorylation of both proteins proved to be challenging. 
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In a complex assembly assay the presence of either Munc18c-WT or phospho-mimetic 
mutant had no effect on the amount of SNARE complex formed by either Sx4-WT or Sx4-
Y115,251E (Figure 5.2). However, in an in vitro pull down assay, Sx4 phospho-mimetic 
mutants bound to less Munc18c that Sx4-WT (Figure 5.3). Moreover, Munc18c-Y521E 
showed no difference in binding to Sx4 than Munc18c-WT. On one hand, as the 
Munc18c/Sx4 interaction has been shown to be inhibitory to SNARE complex assembly 
(Brandie et al., 2008; Kioumourtzoglou et al., 2014), relief of this inhibition by Sx4 
phosphorylation would make sense. However, Sx4 can also bind to Munc18c via its N-
terminus in a manner that is complimentary to Sx4 being in an open and active 
conformation (Hu et al., 2007; Latham et al., 2006). Furthermore, Sx4-Open has been 
shown to bind to Munc18c in an in vitro assay at levels comparable to Sx4-WT (Aran et al., 
2009). It is therefore confusing that binding of Sx4-open to Munc18c is reduced in this 
assay (Figure 5.3). In a similar contrasting manner, phosphorylated Munc18c has been 
reported to no longer bind to Sx4 (Aran et al., 2011) and to stimulate SNARE complex 
assembly (Kioumourtzoglou et al., 2014). One main reason for the discrepancies in the 
published data and the data presented in chapter 5 is that the Munc18c used in this study 
was produced using a codon-optimised plasmid. Whilst optimising the codon usage for 
expression in E. coli should ultimately result in the same protein being produced, it is 
possible that some structural differences could occur during translation (discussed in more 
detail in section 5.4). SM proteins are notoriously difficult to purify. Indeed previous 
studies have co-purified the protein with a chaperone to improve solubility (Scott et al., 
2004) or used different cell lines for purification (Hu et al., 2003). Therefore, optimisation 
and characterisation of purified recombinant Munc18c from both codon-optimised and 
non-optimised plasmids is required before any conclusions can be drawn from this data.  
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6.2 Proposed model and future work 
 
Figure 6.1: Proposed model of the effects of insulin stimulated Sx4 phosphorylation 
at Y115 and Y251 
A Under basal conditions Sx4 (blue) is unphosphorylated and in a closed conformation 
that is incompatible with SNARE complex formation, SNAP23 (green) is also localised to 
the PM. VAMP2 (red) is shown on GSVs.  B Upon insulin (purple spot) binding, the insulin 
receptor (grey) directly phosphorylates Sx4 at Y115 and Y251 (1). Following 
phosphorylation Sx4 favours a more open conformation (2). This results in the increased 
formation of SNARE complexes with SNAP23 and VAMP2 (3) and leads to an increase in 
the amount of GLUT4 at the PM. 
 
 
The data presented in this thesis suggests that phosphorylation of Sx4 at tyrosine 
residues 115 and 251 in response to insulin may be an important point of regulation of 
GLUT4 trafficking. Figure 6.1 shows a summary of the proposed model of Sx4 
phosphorylation based on the data presented in this study. Under basal conditions the 
majority of unphosphorylated Sx4 is in the closed conformation and is unable to form 
SNARE complexes (Dulubova et al., 1999)(Figure 6.1A). Upon activation, the insulin 
receptor then directly phosphorylates Sx4, this results in Sx4 adopting a more open 
conformation and the increased formation of SNARE complexes. This increase in SNARE 
complex formation leads to an increase of GLUT4 at the PM (Figure 6.1B). It is likely that 
this phosphorylation event represents a switch, whereby transient phosphorylation of Sx4 
leads to an increase in cell surface GLUT4 allowing the rapid uptake of glucose in a 
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controlled manor. It would therefore be intriguing to examine the kinetics of the 
phosphorylation and dephosphorylation of the protein following insulin stimulation. 
Phosphorylation of Sx4 also effects the binary interactions between the protein and 
SNAP23 and VAMP2, however the precise mechanism by which this effects SNARE 
complex formation and the implication on GLUT4 trafficking is not yet clear. 
Data presented in this study supports the hypothesis that phosphorylation of Sx4 at 
tyrosine residues 115 and 251, and potentially Munc18c at Tyr-521, represents an 
important feature in the regulation of SNARE complex assembly and insulin-stimulated 
GLUT4 translocation. Never the less, there is more work that can be done to identify the 
precise mechanisms by which this phosphorylation regulates GLUT4 trafficking. 
In an in vitro complex assembly assay Sx4-Y115,251E formed more complex than Sx4-
WT. However, quantifying the amount of complex formed by densitometry analysis of 
immunoblots is relatively indirect and more prone to error. Assessing the amount of 
complex formed by Sx4 phospho-mimetic mutants by a more quantitative method would 
therefore be desirable. Both in vitro membrane fusion assays (Brandie et al., 2008; Yu et 
al., 2013) and surface plasmon resonance (Rea et al., 1998) could be used in order to 
achieve this.  
Similarly, systematic analysis of the interactions of both phospho-mimetic Sx4 and 
Munc18c will need to be carried out. Initially, structural comparisons of both codon 
optimised and non-optimised Munc18c could be carried out. Circular dichroism 
experiments would establish whether the secondary structure of the protein has changed 
with the optimisation. Similarly, the binding of both forms of the protein to Sx4 or VAMP2 
would be systematically assessed. Once the codon optimised Munc18c has been fully 
characterised, interactions with Sx4-phosphomutants could be analysed, again using 
quantitative techniques such as SPR or ITC (isothermal titration calorimetry).  
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It would also be informative to quantify the interactions of phosphorylated Sx4 and 
Munc18c in adipocytes and/or muscle cells. Development of phospho-specific antibodies 
for both proteins would allow immunoprecipitation experiments to be carried out on 
insulin-stimulated cells. Immunoprecipitation of phosphorylated Sx4 or Munc18c following 
insulin-stimulation, and therefore phosphorylation, may reveal changes in the interactome 
of the proteins and build on data obtained in this study by SPR (Figure 3.9 and 3.10) that 
phosphorylation of Sx4 has differing effects on interactions with SNAP23 and VAMP2.  
Finally, a crucial experiment would be to express phospho-resistant Sx4 in either HeLa 
cells or Sx4 depleted 3T3-L1 adipocytes to analyse the effect of this mutation on insulin-
stimulated GLUT4 translocation. Data obtained in this study would lead to the hypothesis 
that expression of Sx4 that is unable to be phosphorylated would reduce insulin-
stimulated GLUT4 translocation to the PM. It will be important to address this point to 
assess the importance of phosphorylation and whether it is necessary for an increase in 
GLUT4 exocytosis following insulin-stimulation.  
Elucidating the mechanisms by which the insulin signalling pathway acts on the machinery 
required for trafficking of GLUT4 is a challenging but important step in understanding this 
regulated trafficking event. Understanding the mechanisms that lead to GLUT4 exocytosis 
may help to understand other regulated trafficking events. Moreover, new insights into the 
regulation of GLUT4 trafficking machinery may provide novel treatment targets for patients 
with Type II diabetes and insulin resistance.   
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Appendix I: Summary of purified recombinant proteins used in 
this study 
Table I: Summary of purified recombinant proteins used in this study 
 
 
   
Protein Size 
(kDa) 
Culture 
volume 
(L) 
Elution method Elution 
volume 
(ml) 
Typical yield 
(mg/ml) 
Sx4-GST 
(WT) 
57 3 Reduced 
glutathione 
6 1 
Sx4-GST 
(Y115E) 
57 3 Reduced 
glutathione 
6 1 
Sx4-GST 
(Y251E) 
57 3 Reduced 
glutathione 
6 1 
Sx4-GST 
(Y115,251E) 
57 3 Reduced 
glutathione 
6 1 
His-SNAP23 24 3 Imidazole 6 2 
GST-VAMP2 36 4 Reduced 
glutathione 
6 1 
VAMP2 10 4 Thrombin 
cleaved 
3 0.5 
GST 26 1 Reduced 
glutathione 
3 2 
His-Munc18c 
(WT) 
 6 Imidazole 4 n/a 
His-Munc18c 
(Y521E) 
 6 Imidazole 4 n/a 
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Appendix II: Raw SPR data 
      
Figure II.1 Raw data showing repeats of Sx4 binding to SNAP23 by SPR 
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Figure II.2 Raw data showing repeats of Sx4 binding to VAMP2 by SPR 
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Table II Summary of KD values of Sx4 binding to VAMP2/SNAP23 obtained by SPR 
 
 
  
VAMP2 SNAP23 
Sx4 KD (μM) Sx4 KD (μM) 
WT 7.6 WT 0.14 
Y115E 25.2 Y115E 13.2 
Y251E 16.6 Y251E 19.7 
Y115,251E 4.3 Y115,251E 10.6 
Open 23.5 Open 0.26 
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Appendix III: Raw data from flow cytometry analysis of cell 
surface HA-GLUT4-GFP antibody titration 
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Figure III.1 Summary of raw data from analysis of antibody titration of cell surface 
HA-GLUT4-GFP by flow cytometry  
181 
 
Appendix IV: Raw data of the flow cytometry analysis of the effect 
of overexpressing Sx4 on cell surface HA-GLUT4-GFP levels 
         
Figure IV.1 Summary of quantification of basal cell surface HA-GLUT4-GFP in cells 
expressing Sx4(Myc) phospho-mimetic mutants by flow cytometry 
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Figure IV.2 Summary of quantification of cell surface HA-GLUT4-GFP in insulin-
stimualted cells expressing Sx4(Myc) phospho-mimetic mutants by flow cytometry 
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